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2PREFACE
Terminology
Although autoantibodies to spermatozoa is strictly 
correct, the term "antisperm antibodies" has come to be 
widely accepted: thus, in 32 papers listed in Index Medicus 
in 1989 and 1990, "antisperm antibodies" was used in the 
title of 24, "sperm antibodies" in 4 and "antibodies or 
autoantibodies to spermatozoa" in 4. In accordance with 
common usage, antisperm antibodies (usually abbreviated to 
ASA) is used throughout this thesis. Titres are shown as 
the reciprocal (4-1024) of two-fold dilution (1:4 to 
1:1024). Other abbreviations are listed on page 21.
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SUMMARY
The diagnosis and treatment of immunological 
infertility in human males has been the subject of much 
controversy. Antisperm antibodies (ASA) have therefore been 
measured in all subfertile males seen by the author since 
1975. A number of separate studies were completed, and 
these have been amalgamated and critically reviewed to form 
this thesis.
The first problem was to find out which tests gave 
results which were clinically significant. Sera from over 
500 subfertile men were tested for circulating unbound 
antibody by gelatin agglutination test (GAT), sperm 
immobilisation test (SIT) and an indirect immunofluorescence 
test (IFT) using standardised internationally accepted 
laboratory methods. The results were compared with each 
other, and correlated with the results of sperm-cervical 
mucus contact (SCMC) tests, since failure of penetration was 
known to be associated with impaired fertility. Significant 
titres of GAT, which correlated with SIT and with failure of 
cervical mucus penetration were found in 8.5% of patients. 
IFT gave disparate results and was discontinued. Over the 
ensuing years GAT, a macroscopic spermagglutination test, 
was gradually superceded by the microscopic tray 
agglutination test (TAT) which was slightly more sensitive 
and allowed more tests to be done on serum and seminal 
plasma.
A screening test for ASA bound to patients' 
spermatozoa was also needed. The direct mixed
erythrocyte-spermatozoa antiglobulin reaction (MAR) was 
carefully assessed in 2 separate studies and found to be
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quick and technically simple, it gave reproducible results, 
and it was applicable to most semen samples. Furthermore, 
the results correlated well with estimations of serum 
unbound antibody measured by GAT or TAT. This technique was 
also used to define the class of antibody bound to the 
patients' spermatozoa. Failure of penetration of cervical 
mucus was found to be associated with IgA antibodies, which 
correlated with estimations of ASA in seminal plasma. A 
direct immunobead test (IBT) was compared with MAR and found 
to give similar results, but was more labour intensive and 
time consuming since the spermatozoa had to be washed free 
of unbound immunoglobulin in the seminal plasma.
Medical treatment was developed for men with ASA. 
Criteria for entry to treatment studies were as follows: 
GAT or TAT positive in serum at titre 32 or more, and/or in 
seminal plasma at any titre, plus a poor post coital test 
(PCT) in the female partner with demonstrably impaired sperm 
penetration of cervical mucus on crossed hostility testing. 
After preliminary medical checks, and after ensuring that 
the female partner was ovulating and had patent fallopian 
tubes, various corticosteroid regimes were used. Initially, 
long term low dose prednisolone (15mg daily for 6 months), 
was compared with cyclical high dose methylprednisolone 
(96mg daily from day 21-28 of female partner's cycle). 
Although the success rate was higher with the latter regime, 
serious side effects occurred and it was abandoned. An 
alternative cyclical regime was introduced (prednisolone 
40/80mg daily from day 1-10 of female partner's cycle) which 
was as effective as the higher dose regime, and free of 
serious side effects. It was then subjected to prospective
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multicentre double blind controlled trial and shown to be 
significantly more effective than placebo.
The relationship between ASA and testicular 
obstruction was studied in infertile men with unilateral or 
bilateral blocks, and in men undergoing vasectomy reversal. 
ASA were found, often in high titres, in three quarters of 
80 men with unilateral blocks, half of whom had moderate or 
severe oligozoospermia despite having normal testicular 
biopsies. Following surgical and/or medical treatment 
one-third of those with adequate follow-up produced 
pregnancies; paradoxically, the best results occurred in 
those starting with the lowest sperm counts. Removal of 
irreparably blocked testes lead to profound falls in ASA 
titres in 10 men. Histological examination of the removed 
testes showed mononuclear cell infiltration in epididymes, 
rete testes and in some cases, seminiferous tubules. 
Amongst 370 infertile men with bilateral blocks, serum ASA 
were found in over half of those with acquired obstruction 
following infection, but in few (167<>) of those with 
congenital absence of vasa. Follow up studies on 60 men 
after surgical correction of obstructive azoospermia showed 
that pregnancies were produced by a significantly higher 
proportion (607>) of those negative for ASA compared to those 
positive for ASA in any titre, only one-third of whom were 
successful. Unfortunately, the best surgical groups were 
those with post infective blocks, who also had the highest 
incidence of ASA.
Men undergoing vasectomy reversal were different. 
Although ASA were found in sera of almost 807o of men before 
reversal, seminal plasma ASA were present in only 107» before
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reversal rising to almost 30% afterwards, which was 
significantly less than the 657> observed in an unselected series 
of spontaneously infertile men, and in the men with unilateral 
testicular obstruction. Patency was restored in over 90% of 
cases, and similar pregnancy rates were observed in the two 
collaborating centres (Brighton 44%, St. Bartholomew's 45%). No 
reduction in fertility was observed amongst partners trying to 
conceive until ASA titres in the men rose to very high levels 
(>512 in serum, > 32 in seminal plasma). Subsequent studies by 
Dr. J.M. Parslow (PhD thesis, University of London) showed that 
the vasectomy reversal men had much less sperm-bound IgA, and 
much better mucus penetration than spontaneously infertile men.
Evidence of focal mononuclear cell infiltration resembling 
auto-immune orchitis was found in a few severely oligozoospermic 
and azoospermic men with very high (>512) serum titres of ASA. 
Sperm concentration in these, and in some other men without 
these histological changes, improved with long term low dose 
prednisolone and 2 produced pregnancies.
In vitro fertilization studies are ongoing, but results so 
far indicate that the ovum fertilization rate is reduced with 
spermatozoa from men with ASA, but once fertilised the 
implantation rate is similar to that observed in other couples.
Autoantibodies to spermatozoa occur commonly in subfertile 
men, both as a primary local phenomenon and secondary to 
testicular obstruction. They can be detected sensitively, and 
their significance checked selectively by appropriate laboratory 
tests. Modern medical and surgical treatment is both effective 
and safe.
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CHAPTER 1: Introduction
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1.1 GENERAL STATEMENT OF PROBLEM
This work has been done to study the relevance of 
autoimmunity to spermatozoa in subfertile men. First the 
tests to detect antisperm-antibodies (ASA) and measure them 
how reliable are they, do they give false positive 
results, and when are they significant? Next, medical 
treatment: which drug, what dose, when should it be given
and for how long - is it safe, and is it as effective as it 
seems? Then testicular obstruction, naturally of interest 
to the surgeon - does the blockage provoke autoimmunity to 
spermatozoa? If unilateral, is this important in subfertile 
males? If bilateral, does the cause of the obstruction 
affect the nature of the ASA response, and is this relevant 
in determining whether the ASA impair fertility after 
successful surgical reconstruction? Finally cell mediated 
immunity - is there evidence that autoimmune orchitis occurs 
spontaneously in subfertile men? These are the questions to 
be addressed in this thesis, based on work carried out 
during the past 15 years.
1.2 HUMAN INFERTILITY
1.2.1. Incidence
From the point of view of the world population, there 
is no need to treat infertility; from the point of view of 
the couple concerned, who find themselves unable to have 
children, there may be the strongest compulsion to seek 
medical help. Infertility is a most potent cause of anxiety 
and emotional disturbance (Platt et al , 1973). It has been 
estimated that as many as 107, of couples may experience 
difficulty or delay in starting their families; amongst 
these couples, the abnormality lies solely with the husband
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in 20%, but in a further 20% there is abnormality in both 
husband and wife (Buxton and Southam, 1958). Two more 
recent studies from the United Kingdom have shown that 
infertility is even more common now. Hull et al (1985) 
estimated that 1 in 6 couples in a single Health District 
needed specialist help because of infertility, the average 
duration of which was years. The commonest single cause 
was sperm defects or dysfunction, which were found in 247o of 
708 couples investigated. Similarly, Templeton et al (1990) 
found that 14% of 766 women aged 46-50 had had infertility, 
defined as delay in production of pregnancy for more than 2 
years: of these only half eventually conceived. There can 
be no doubt, therefore, about the need for an efficient and 
well coordinated infertility service to define the cause of 
the problem as clearly as possible, and thus provide the 
couple with guidance and counselling based on an accurate 
prognosis. This is particularly important nowadays since 
many couples leave starting their family until relatively 
late in life, and there are few babies available for
adoption.
In considering the results of any treatment for
infertility, it has to be remembered that pregnancy seldom 
occurs instantaneously even in normal couples - rather, 
there is a cumulative conception rate which rises 
asymptotically with the passage of time. Typical figures, 
derived by Cooke et al (1981) from data published by Vessey 
et al (1978) on outcome of pregnancies in parous women after 
stopping barrier contraception (UK data) indicate pregnancy 
rates of 0.32 at 3 months, 0.54 at 6 months, 0.82 at 1 year
and 0.95 at 2 years. Even in this idealised setting, nature
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takes its time for conception to occur, and it follows that 
much patience is required in treating infertility, and that 
the results of any treatment regime must be judged against a 
certain natural conception rate that would have occurred 
anyway.
1.2.2 Co-ordination of care
The diagnosis and treatment of subfertility is unusual 
in that the medical care of two separate adult individuals 
must be closely coordinated. Efficient communication 
between the doctors looking after the male and female 
partners is essential if confusion, and resulting loss of 
confidence, is to be avoided. This thesis is concerned with 
the diagnosis and treatment of immunological infertility in 
the male. Great care was taken throughout, however, to 
ensure that investigation and any necessary treatment 
proceeded simultaneously in the female partner, except when 
the male was azoospermic or presented for vasectomy 
reversal. This was easily achieved at Chelsea Hospital for 
Women, where much of the initial work was carried out in the 
specialised Fertility Clinics attended by both male and 
female partners. Both sets of notes were filed together, 
and gynaecologist and andrologist met regularly to discuss 
joint problems. Laboratory staff were included in all 
discussions relating to the ASA work at weekly joint 
meetings (’’sandwiches in seminology") . In the busy setting 
of a general teaching hospital (St. Bartholomew's) this 
ideal was more difficult to achieve; however, full 
information was always obtained from gynaecological 
colleagues on the female partner and her problems, and 
included in all ASA treatment protocols, which did not
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permit therapy to proceed in the male until certain basic 
preconditions had been fulfilled in the female (see section 
2.4.1). Regular meetings were held with the staff of the 
Williamson Laboratory, where the ASA work was done.
Correspondence regarding the results of investigations 
and any recommendations for treatment (including entry into 
the clinical trials) was invariably sent to the general 
practitioner with a copy to the female partner's 
gynaecologist and a further copy was kept in the patient's 
notes. Separate personal records were kept on punch cards 
on all ASA and testicular obstruction patients.
1*2.3. Modern Technology
The advances in scientific technology that lead to the
production of pregnancy by in vitro fertilisation (IVF)
(Steptoe and Edwards, 1978) and by gamete intrafallopian
transfer (GIFT)(Asch et al, 1986) raised hopes that any man
with even a few motile spermatozoa in the ejaculate had a
chance of fatherhood - a fact which could perhaps open the
way to successful treatment of some subfertile males
previously regarded as hopeless (Cohen et al, 1985). Does
this mean that investigation and treatment of male
subfertiliity is now unnecessary? Statistically, ovum
fertilization is much less likely (39.6% versus 88.670 in the
Norfolk, Virginia experience) if sperm quality is poor, and
£
fertilization is unlikely to occur with less than 1.5 x 10
spermatozoa with rapidly progressive motility (van Vem et
al, 1985). Similar experience has been reported from other
centres (Sharma et al, 1988), and most will not accept
couples for IVF or GIFT unless a reasonably adequate sperm
preparation can be obtained from the male partner. The
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effects of ASA on ovum fertilization are variable and 
unpredictable (see Section 4.5.1). Although IVF or GIFT 
offers an attractive alternative to other treatments for 
some couples where the man has ASA (Alexander, 1990), there 
are many others in whom fertilisation does not occur due to 
impaired sperm function (see section 4.5.2) even with 
sub-zonal insemination (Fishel, 1992; Fishel et al, 1992).
1.3 MALE INFERTILITY
1.3.1 The "Male Factor"
An air of pessimism still surrounds much of the 
treatment of male infertility (Wardle, 1990), with
azoospermia in particular being widely regarded as virtually 
incurable (Thornton and Cooke, 1991); indeed, many
practitioners feel that further investigation is simply a 
waste of time. Seminal analysis is the first investigation 
to be done in an infertile couple, and it is the easiest to 
criticise. Too little, too few, too sluggish, too abnormal 
- the cause of the problem is al1-too-often assigned to the 
man's spermatozoa, with little or no attempt made to define 
the underlying pathology, and donor insemination on offer as 
a temptingly easy solution. The use of the term "male
factor" as a diagnostic category’is mentioned here only to 
be condemned, lumping together as it does so many different 
causes of impairment of male reproductive function. The
elucidation of the cause of subfertility in an individual 
male requires a careful and methodical approach (Hendry et 
al, 1973, Hendry 1975, 1979 - see Volume 2 for reprints).
1.3.2 Incidence of problems
A survey of 1025 consecutive referrals of men who had 
been trying for a pregnancy for at least 1 year, seen by the
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author between 1971 and 1978 at Chelsea Hospital for Women, 
revealed that a definable medical or surgical condition was 
present in only 387o (Stanwell-Smith and Hendry, 1984 - see 
volume 2). Varicocele was the most common, being found in 
173 patients. There was a history of maldescent, or 
previous inguinal hernia in 73, of mumps or other orchitis 
in 35, of torsion or other trauma in 13, and there was 
testicular atrophy or aplasia in 16, absent testis or vas in 
17. Dubin and Amelar (1971) analysed 1294 consecutive cases 
of male infertility and found varicoceles in 397,, endocrine 
abnormalities in 11.8%, sexual problems in 5.17,, ductal 
obstruction in 7.47,, testicular failure in 147o, 
cryptorchidism in 4.47, and miscellaneous other factors in a 
further 47,. Greenberg et al ( 1978) analysed 425 subfertile 
males and found varicoceles in 37:47,. ductal obstruction in 
6.17,. cryptorchidism in 6.17,, testicular failure in 9.47> and 
true endocrine abnormalities in only 0.97,; 108 (25.47,) were 
considered to be idiopathic. The much lower incidence of 
varicoceles in our series (177,) resulted from our refusal to 
accept this diagnosis in the absence of demonstrable 
thermographic abnormality (Hendry and Jones, 1981).
In over 607, of our 1025 cases, the exact cause for the 
infertility could not be accurately defined. However, 
amongst; 208 azoospermic men the cause was easier to define. 
In 103, there was severely depressed or absent 
spermatogenesis, and in a further 16 there was maturation 
arrest. Thus in 89, there was normal spermatogenesis with 
obstruction to the testicular outflow passages most commonly 
in the epididymes. There was oligozoospermia (less than 20 
million spermatozoa per ml) in 459 patients and
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asthenozoospermia (motility less than 30% moving actively)
in the remaining 345 patients. The majority of patients
therefore had idiopathic infertility in the period under
study (1971-1978). Prospective study of 200 subfertile
males showed somatic chromosome abnormalities in 3.5%, and
definite abnormalities in meiotic chromosomes in 207>,
including supernumerary chromosomes, low chiasma frequency
and asynapsis and translocations; in 4 cases a previously
unrecognised abnormality in pachynemas was defined (Hendry
et al, 1976 - see volume 2). It was concluded that
abnormalities in meiosis could account for the decreased
spermatogenesis and poor response to treatment in at least
207o of subfertile men. Treatment was largely empirical: Che
men were encouraged to wear loose fitting underwear, to
avoid excessive smoking or alcohol intake (so-called general
measures) (Hendry et al, 1973 - see volume 2); varicoceles
were treated by high ligation; patients with oligozoospermia
were given mesterolone lOOmg daily for 6-12 months, and
those with asthenozoospermia had fluoxymesterone 5mg daily
for 3-6 months (Hendry et al, 1973 - see volume 2).
Patients with azoospermia underwent scrotal exploration and
testicular biopsy, with relief of obstruction by
reconstructive surgery whenever possible (Hendry et al,
1978; Hendry 1981 - see volume 2)..
1.3.3 Prognosis
Of the 1025 men whose records were examined
(Stanwell-Smith and Hendry, 1984), 180 (1870) produced a
pregnancy while still attending the clinic at Chelsea
Hospital for Women. The proportion of men producing 
pregnancies rose with the mean sperm density on presentation
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up to 20 million per ml, and then fell amongst those with 
asthenozoospermia (Table 1).
Mean S perm
Density
(million/ml)
N u m b er
of
Men
N u m b e r
of
Pregnancies
0 208 8 (4%)
1-5 185 29 (16%)
6-10 95 25 (26%)
11-20 179 49 (27%)
>20 345 64 (19%)
Unknown 13 5
Total 1025 180
TABLE: 1 Results at CHW 1971-1978 (Stanwell-Smith and
Hendry 1984) «
Amongst 131 operated for varicocele 25.27, produced
pregnancies, whereas 9 (21.4%) of 42 with varicoceles not
operated on also produced pregnancies (mostly whilst
awaiting surgery).
Other workers have reported similar pregnancy rates of 
0-27% in the partners of men with sperm defects or 
dysfunction (Hull et al, 1985). In a collaborative study, a 
9-month course of mesterolone gave a pregnancy rate of 187o 
compared to 157> obtained with vitamin C (Scottish
Infertility Group, 1984). Tamoxifen, known to increase 
serum FSH levels in oligozoospermic men (Vermuelen and 
Comhaire, 1978) gave similarly disappointing results after 9 
months (pregnancy rate of 22% compared to 23% with vitamin 
C) (Hargreave et al, 1986).
Controversy continues to surround the role of 
varicocele in male infertility. There are many reports of 
improvement in seminal quality in around 707> of patients 
after high ligation, with pregnancies occurring in 40-507o of
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female partners (Tulloch, 1955; Charny, 1962; Scott and
Young, 1962; Hanley and Harrison, 1962; Brown et al, 1967;
Macleod, 1969; Dubin and Amelar, 1977). However, three
large series showed no difference in pregnancy rates in the
partners of those who did or did not have the varicoceles
ligated (Rodriguez-Rigau et al, 1978; Nilsson et al, 1979;
Baker et al, 1985), and this question remains open at
present. However, particularly good results have been
observed after varicocele ligation for solitary, or
functionally single left testis (Hendry, 1992a).
1.3.4 Need for specific diagnosis
It will be appreciated that the treatment for the
majority of subfertile males was empirical and the results
really rather disappointing in the period 1971-78 surveyed
above. In 1976, the author heard a paper by Kremer and
Jager indicating that autoimmunity to spermatozoa in the
male could remain unrecognised until the sperm reached the
female partner, where antibodies on the sperm surface became
attached to receptors in the cervical mucus thus impeding
their progress. The concept of "cervical hostility" was not
new, but the idea that the antibodies were in fact
auto-antibodies in the male rather than in the female where
they had always been supposed to be, was intriguing.
Detailed immunofluorescence studies amongst our infertile
couples at CHW had shown no difference in incidence of ASA
between pregnant, non-pregnant and infertile women (Wall et
al, 1975A), although ASA were found significantly more often
amongst subfertile males than amongst normal controls (Wall
et al, 1975B). Could this be a specific immunological 
disorder, occurring chiefly in Che male partners, leading to
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interference in the normal process of fertilisation in the 
female? In order to answer this question, all subfertile 
males seen by the author since 1975 were checked for ASA, 
and analysis of the findings form the basis of this thesis.
1.4 ANTIGENICITY OF SPERMATOZOA 
lo4ol Historical aspects
Landsteiner (1899) and Metchnikoff (1899) showed that 
spermatozoa were antigenic when injected into another 
species:
"La resorption des spermatozoides dans la cavite 
peritoneale est suivie de la formation dans la liquide 
du peritonie ainsi que dans le serum sanguin de ces 
animaux d'une substance qui immobilise les 
spermatozoides. II se produit done un anticorps".
(Metchnikoff, 1899) 
It is clear that production of an immobilising 
antibody by the guinea pig was recognised and recorded.
Metalnikoff (1900) extended these observations by 
showing that autoimmunisation also occurred:
"la serum du cobaye devient toxique non seulement pour 
les spermatozoides d'autres cobayes, mais ainsi pour 
ceux du cobaye inocule lui-meme"
Interestingly, Metalnikoff showed that the 
immobilising antibody was complement dependant:
^  N
"en ajoutant 10 gouttes de serum a une goutte de 
spermatozoides on les immobilise en 3-4 minutes. Elle 
perd ses proprietes toxique etant chauffee au 55°C, et 
les reacquient facillement apres l1addition du serum 
d ’un cobaye neuf".
There followed numerous attempts to induce sterility
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by injection of spermatozoa into a bewildering assortment of 
animals, documented by Katsh (1959). Baskin (1932) reported 
that women could avert pregnancy for about 1 year by 
intramuscular injection of whole human semen, and 
subsequently patented his vaccine (US Patent Number 
2,103,240). However, the results were unpredictable and 
certainly not sufficiently reliable to catch on as a 
contraceptive.
Spermatozoa can be shown to acquire an antigen during 
maturation which is absent from immature germinal cells. 
Since antibodies can be induced by immunising with 
autologous spermatozoa, it is clear that the immune system 
does not regard sperm as part of self. Sperm antigens (and 
lens antigen of the eye) are in fact examples of hidden or 
sequestered antigens, not normally accessible to the cells 
of the immune system (Weir, 1988).
lo4.2 Blood Testis Barrier
Spermatozoa are normally hidden from the immune system 
in the male by the blood-testis barrier (Johnson 1970, 1973) 
formed in the seminiferous tubules by tight junctions 
between the sertoli cells (Fawcett, 1974). Elsewhere in the 
male reproductive tract the barrier is less well formed, and 
is probably at its weakest at the rete testis (Tung et al, 
1970). In addition to the blood testis barrier, which may 
not provide a perfectly effective immunological screen, it 
is now believed that local tolerance to spermatozoal 
antigens may be induced by suppressor cells - thus local 
immuno-regulation may serve as a "back-up" system (Alexander 
and Anderson, 1987). Monoclonal antibody studies have shown 
that the majority of the mononuclear cells in the submucosa
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of the male genital tract are suppressor T lymphocytes (El 
Demiry et al, 1985).
1.4.3 Induction of immune response
Voisin et al (1951) and Freund et al (1953) showed 
that if homologous or autologous testicular tissue is 
inoculated in the guinea pig together with complete Freund's 
adjuvant, a cell-mediated immune response is provoked which 
leads to immune orchitis and ultimately aspermatogenesis. 
Mononuclear cell infiltration commences in the rete testis 
and caput epididymis by the 9th day, leading to extensive 
atrophy by 28 days. The seminiferous tubules are empty by 
48 days (Waksman, 1959; Brown et al, 1963; Brown and Glynn, 
1969; Tung et al, 1970). Apparently both circulating
antibody and delayed hypersensitivity (i.e. cellular 
immunity) are necessary to produce immune orchitis (Brown et 
al, 1967 ). Thus if incomplete Freund's adjuvant is used,
specific circulating ASA are produced but immune orchitis 
does not occur. If testicular homogenate is replaced by 
autologous epididymal spermatozoa, however, the same 
responses occur i.e. circulating antibody if incomplete 
adjuvant is used, and immune orchitis with complete Freund's 
adjuvant. Although much of this work has been done using 
guinea pigs, the phenomenon also occurs in other species and 
has been the subject of numerous experiments carried out 
with the twin objectives of defining spermatozoal/testicular 
antigens more clearly, and studying how cell mediated immune 
response is stimulated and cytotoxic lymphocyte activity is 
transmitted (see Section 4.4).
37
1.4=4 Spermatozoal antigens
During spermatogenesis, unique antigens appear at
spermatocyte stage which persist thereafter. Study of these
antigens is extremely complex, not least because other
antigens present in the seminal plasma may become absorbed
onto the surface of the spermatozoa (O'Rand, 1980; Shulman,
1987). Nevertheless, it is important to recognise that
certain surface antigens are relevant because they react
with ASA in vivo, whereas other subsurface antigens are
irrelevant because they are normally concealed, but may
become evident during fixation of spermatozoa. The chief
spermatozoal antigens are listed in Table 2, which is
derived from Hjort et al (1982). It may be seen that the
membrane antigens on the sperm surface are those detected by
agglutination and immobilisation tests, cytotoxicity, MAR
and IBT tests (i.e. those using live spermatozoa) whereas
the various subsurface antigens are those demonstrated by
IFT or ELISA on fixed spermatozoa. There is ample evidence
to demonstrate that antibodies to these two sets of antigens
are quite different, and the presence of one type of
antibody may not correlate with the existence of the other,
although both may properly be called ASA (see Section 3.1).
The first and most important study at CHW was to find out
which antibodies and which tests were clinically relevant,
and to distinguish them from those that were simple
epiphenomena. Although sperm antigens are complex, there
does not appear to be continuing justification for the view
that they still require further elucidation before treatment
can be developed for these patients, as recently concluded 
by Hamilton (1992 ) .
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ANTIGENS LOCALIZATION AND 
CHARACTERIZATION 
OF ANTIGEN
METHODS FOR 
DETECTION OF 
ANTIBODY
Membrane
antigens
Sperm Specific 
enzymes:
LDH-X (LDH-C4) 
Acrosin 
Hyaluronidase 
DNA polymerase
Nuclear
proteins
Various
subsurface
antigens
Two glycoproteins 
widely distributed 
in the membrane 
One antigen 
restricted to 
tail end piece
Post-acrosomal area
Acrosome
Acrosome
Nucleus
Protamine 1 & 2 
in sperm nucleus
Acrosome, equatorial, 
postnuclear, tail, 
tail end piece
Agglutination tests
Immobilization tests
Cytotoxicity
MAR, IBT
Cellular radio
immunobinding
techniques
Electrophoretic RIA
Enzyme
inhibition
test
IFT on swollen 
sperm heads
IFT,
immunoperoxi dase 
techniques on 
fixed spermatozoa
TABLE 2 Spermatozoal antigens
(from Hjort et al, 1982)
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1.5 INVESTIGATION OF IMMUNOLOGICAL INFERTILITY
1.5.1 Agglutination and immobilisation tests for unbound
ASA in serum and seminal plasma
(i) Gelatin Agglutination Test (GAT)
The existence of ASA had been recognised for more than 
50 years before laboratory techniques were developed with 
sufficient sensitivity to define the titre of antibody 
accurately, yet with enough specificity to be reasonably 
sure that the observed effects were indeed immunologically 
based. Kibrick et al (1952) mixed a freshly prepared
dilution of highly motile spermatozoa obtained from a
fertile donor with an equal quantity of 10% gelatin
solution, to obtain a final concentration of 20 million 
spermatozoa per ml. The gelatin increased the viscosity of 
the test solution so that at 37°C it was still perfectly 
usable, but clumps of spermatozoa agglutinated by antibody, 
once formed, were not easily broken up and indeed could be 
preserved indefinitely by simply cooling the solution. 
Equal quantities of the sperm preparation were mixed with 
test serum in serial double dilution, and incubated at 37°C 
for 2 hours. A positive result was indicated by grossly 
visible agglutinates, and the dilution before the one where 
the effect disappeared indicated the titre of antibody. 
Careful control studies indicated that non-specific 
agglutination was uncommon provided the serum was diluted to 
1:4 or more. Known positive and negative controls were 
always included.
Within 2 years, the first reports appeared recognising 
that high titres of ASA could be identified in subfertile
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human males. Rumke (1954) described 2 men with severe 
oligozoospermia. Wilson (1954) reported 2 men with normal 
sperm counts and agglutinating antibody in serum and seminal 
plasma; their female partners had poor post coital tests and 
demonstrably impaired sperm penetration of cervical mucus - 
one became pregnant promptly with donor insemination. Thus 
there appeared the first evidence that ASA occurred 
spontaneously in infertile men, and that ASA could be 
associated with either oligozoospermia or with apparently 
normal sperm counts. In the latter case the antibodies were 
associated with failure of penetration of cervical mucus 
under circumstances where other spermatozoa could apparently 
penetrate normally.
Rumke and Hellinga (1959) continued to evaluate the 
Kibrick test in a large series of men (Table 3).
Serum
of:
N u m b er
T ested
Antibody T itre  (Kibrick)
0 4-16 32-128 £256
Men with azoo- 
or oligozoospermia
102 96 1 1 4
Male Infertility 
Clinic
1913 1836 15 26 36
Husbands of 
pregnant women
416 412 4 0 0
TABLE 3 Spermagglutinins in the serum of human males 
(from Rumke and Hellinga, 1959)
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Comparing men whose women were pregnant with those attending 
a Male Infertility Clinic, it was concluded that a serum 
titre of 32 or more was likely to be the borderline below 
which the result was unlikely to be significant. Tests for 
specificity were done, and positive sera showed no cross 
reactivity with other antibodies, and sera from patients 
with other autoimmune diseases gave no reaction with 
spermatozoa. It was concluded the agglutinating factor was 
an autoantibody and was specific for spermatozoa.
Thereafter, Rumke et al (1974) tested several thousand 
serum samples from the Netherlands and Belgium, and 
investigated 254 patients found to have positive serum 
titres ranging from 4 to ,>1024. Following 137 men with 
normal sperm counts for at least 5 years indicated an 
inverse relation with the serum ASA titre (Table 4). These 
studies were of fundamental importance, showing
Serum
Titre
(Kibrick)
N u m b er
of
Patients
N u m b e r  (percen t) 
who becam e 
Fertile
4 12 5 (42)
8 II 6 (55)
16 8 4 (50)
32 14 3 (21)
64 17 4 (24)
128 27 2 (7)
256 20 3 (15)
512 17 3 (18)
£1024 II 0 (0)
Total 137 30 (22)
TABLE 4 Probability for Infertile Normospermic Men with 
different Serum ASA titres producing pregnancy 
within 5 years (from Rumke et al, 1974)
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a relationship between increasing serum titre of ASA and 
diminishing likelihood of fertility. A serum titre of less 
than 32 was probably meaningless, and it was recognised that 
a few pregnancies were produced with titres above this 
level.
(ii) Sperm Immobilisation Test (SIT)
Fjallbrant (1965, 1968a,b, 1969) studied ASA in
infertile men using both Kibrick’s test and a sperm 
immobilisation test, in which fresh guinea pig serum of 
known complement activity was mixed with inactivated patient 
serum and the test suspension of spermatozoa on a slide. 
The proportion of motile sperm was estimated by examination 
under the microscope at intervals
S perm
Agglutinin
T itre
Cervical Mucus P ene tra tion
0 1 2
4-8 1 2 4
16-32 1 2 10
64-128 5 2 2
256-512 2 1
£1024 3 1
T im e to  
S p e rm
Immobilization
Cervical Mucus P ene tra tion
0 1 2
>12 1 1 12
6-12 3 3
3-6 6 4 1
<3 hours 5
TABLE 5 Cervical mucus penetration by capi1lary-tube test 
related to serum sperm agglutinin titres and time 
to sperm immobilization (from Fjallbrant, 1968b)
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thereafter. The results were correlated with penetration of 
cervical mucus and a strong negative correlation was found, 
especially with ASA with immobilising activity (Table 5).
The interrelation between penetration ability and fertility 
was also very good (Table 6).
Cervical Mucus P ene tra tion
0 1 2
Fertile 0 6 9
Sterile 12 2 7
TABLE 6 Distribution of subjects in sterile and fertile 
groups according to degree of cervical mucus 
penetration (from Fjallbrant, 1968b)
These studies were of great importance, as they indicated 
the way that ASA were affecting spermatozoal function - that 
is, by impeding their penetration of cervical mucus, and, 
not unexpectedly, this interfered with the process of 
fertilisation.
Sperm immobilisation by ASA in the presence of 
complement had also been demonstrated in 1 case by Rumke 
(1934), before the studies by Fjallbrant outlined above. 
Isojima et al (1968) modified the sperm immobilisation test 
by repeating it in serial dilution, and defining the titre 
at which motility in the test spermatozoa had dropped to a 
certain percentage of motility in a negative control - in 
practice this is generally taken as a drop in motility to
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half or less that of the control. Husted (1975) studied the 
relationship between agglutinating and immobilising ASA and 
found a close correlation, in serum, although immobilisation 
titres were considerably lower. It was concluded that 
agglutination, immobilisation and cytotoxicity are probably 
caused by the same ASA, the type of reaction depending on 
the presence or absence of complement. However, it was also 
noted that immobilization and cytotoxicity was rarely 
observed in seminal plasma, presumably due to its 
anticomplementary activity.
(iii) Tray Agglutination Test (TAT)
Friberg (1974a) recognised that a shortcoming of the 
Kibrick technique was that only a relatively small number of 
tests could be done using the sperm from a single ejaculate, 
owing to the large quantity of reagent used in each test. A 
micro-agglutination technique was therefore developed, in 
which a single donor semen sample sufficed for 200-300 
determinations. Furthermore, since the agglutination of the 
test spermatozoa was observed through an inverted 
microscope, the type of agglutination - tail-to-tail (T-T) 
or head-to-head (H-H) - could be distinguished; it was noted 
that the former was more common in sera from men, the latter 
in sera from women. However, amongst men H-H
spermagglutinating activity was sometimes noted and further 
detailed immunological studies indicated that H-H activity 
was caused by IgM antibodies whereas T-T activity appeared 
to be due to IgG antibodies (Friberg, 1974b). The 
significance of the mode of agglutination is discussed in 
detail in Section 4.1.3. It should be noted that Friberg 
initially used the abbreviation H-T for the agglutination
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commonly seen in men, and subsequently changed it to T-T 
(Friberg, 1980a,b). The latter abbreviation is used 
throughout this thesis to avoid confusion in terminology.
Friberg (1974c) also studied the relationship between 
antibody titres in serum and seminal plasma, and showed that 
in general agglutinating antibodies were only present in 
seminal plasma when the serum titre was high (>64) and when 
T-T agglutination was present. None of the men with pure 
H-H agglutination had seminal plasma ASA activity.
(iv) Tube-Slide Agglutination Test
Franklin and Dukes (1964) incubated 0.05ml of 
standardised suspension of sperm with 0.5ml of patient's 
serum (undiluted and diluted 1:5 with isotonic saline) in 
serological tubes for 4 hours at 37°C, before examining 
samples on a slide ^ , 1 , 2  and 4 hours later for evidence of 
sperm agglutination. Two or more spermatozoa aggregated per 
high power field was considered a positive result. 
Head-to-head agglutination was most commonly observed. 
Amongst 89 women, antibody was detected in no less than 
78.97, of those with unexplained infertility, and in 11.87, of 
fertile women. This test was obviously far too sensitive, 
and the results did not correlate well with the results of 
other tests in comparative studies (see Section 1.5.2). 
Boettcher et al (1970) subsequently showed that the 
spermagglutinins found in the sera of women commonly were 
not antibodies, but were in fact due to steroids bound to 
Beta-lipoprotein. This test fell into disuse with the 
development of the Tray Agglutination Test.
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1.5.2 WHO Reference Bank
Concerned about the proliferation of tests for 
detection of ASA, and lack of standardisation of laboratory 
methods, the WHO gathered together 32 scientists
"knowledgeable and experienced specialists in the field of
sperm immunology" - to a workshop held in 1974 to define 
techniques for the detection and study of ASA. The details 
of the tests outlined above were described, and published on 
behalf of the group by Rose et al (1976). The WHO Reference 
Bank for Reproductive Immunology was set up, and 36 sera 
were distributed to 38 participating laboratories all over 
the World for testing for ASA by the defined test methods. 
Comparison of the results showed that the gelatin
agglutination test (GAT), tray agglutination test (TAT) and 
sperm immobilization tests (SIT) were reliable and
reproducible procedures (WHO Reference Bank for Reproductive 
Immunology, 1977). The relative sensitivities of these 
various tests was defined, and this is shown in Table 7. 
ASA in sera from women appeared to be nearly exclusively 
head-to-head (H-H) agglutinins, whereas sera from men 
contained predominantly agglutinins reacting with tail 
antigens (T-T) or(TT-TT).
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TYPES OF AGGLUTINATION
SENSITIVITY
OF TESTS . H - H  T - T  T T - T T
+ ++ + +
+ + +
+ + ++ + +
+  +  7
TABLE 7 Relative sensitivities of the various tests for 
detection cf A2A of different specificities (from 
Shulman 1978)
These studies, sponsored by the WHO and based in 
Aarhus, Denmark, were of fundamental importance in defining 
the technical methods for detection and quantification of 
ASA. Organised by Dr. Tage Hjort, the conclusions remain 
valid to the present time (for a recent review see Hjort, 
1987).
1,5.3 In vivo tests for ASA bound to sperm surface
The theoretical advantage of direct tests are that ASA 
bound to the patient's spermatozoa are detected and these 
are demonstrably in a position to exert a pathogenic effect.
The mixed antiglobulin reaction (MAR) was originally 
described as a direct test for detection of platelet
GAT 
TSAT 
TAT 
SIT (I)
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antibodies (Coombs et al, 1956). It was modified for use as 
an indirect test by Coombs et al (1973) to study the class 
of immunoglobulin in serum and seminal plasma from 
vasectomised and infertile men - indicating that ASA in 
serum were largely IgG, whereas in seminal plasma ASA were 
chiefly IgA. It was suggested that infertility was probably 
due to locally produced IgA antibody - a remarkably accurate 
prediction (see Sections 4.1 and 4.3).
The direct MAR test was developed as a screening test 
for ASA by Jager et al (1978). Patients spermatozoa (1 
drop) are mixed with group 0 Rh D-positive red blood cells 
sensitised with incomplete human anti-D antibody (1 drop), 
to which 1 drop of undiluted monospecific anti-human IgG 
antiserum (Behring) is added. The three drops are mixed and 
the test is ready to read in 2 minutes. Of course the red 
cells must agglutinate, but a positive reaction is indicated 
if more than 107o of the patients' spermatozoa are involved 
in mixed agglutinates. This test proved to be extremely 
useful and has been extensively evaluated (see Sections 2.2 
and 3.1). The test can also be modified to test for IgA 
antibodies. The red cells can be replaced by Latex 
particles sensitised with appropriate immunoglobulin with no 
loss of sensitivity (Sperm MAR - Hellstrom et al, 1989).
The immunobead test (IBT) was developed by Clarke et 
al (1982) and by Bronson et al (1982) and also tests for 
surface Ig on the patients' spermatozoa. The essential 
difference between IBT and MAR tests is that the 
commercially available immunobeads (BioRad, Richmond, 
California) have purified antihuman-Ig on their surface 
(anti-IgG, anti-IgM or anti-IgA), whereas the red cells in
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the MAR test have incomplete Ig bound to their surface, and 
the antihuman-Ig has to be added separately. Since seminal
plasma contains unbound immunoglobulin which would
neutralise the IBT, the spermatozoa must be carefully washed 
prior to the IBT, but this is not necessary for the MAR. 
The two procedures are compared as routine direct screening 
tests for subfertile males in section 2.2, 3.1 and 4.1.4. 
The immunobeads have also been used by others for indirect 
tests for the presence of ASA in serum or seminal plasma, 
and to define the class of Ig, and these results will be 
discussed in Section 4.1.4.
1.5.4 ASA to subsurface antigens
Once spermatozoa are fixed, subsurface antigens are 
revealed. Methanol is the usual fixative, and then 
antibodies reacting with the subsurface antigens show 
characteristic immunofluorescent patterns - staining the 
acrosome, post nuclear cap, the equatorial segment, the main 
tail piece or the tail end-piece (Hjort and Hansen, 1971).
At Chelsea Hospital for Women, we found that
immunofluorescent antibodies in sera, seminal plasma and 
cervical mucus which reacted with these antigens occurred 
with equal frequency in fertile and infertile patients, male 
and female (Harrison et al, 1976). As a general rule it
seemed best for clinical purposes to use 1ive spermatozoa as 
the substrate for ASA testing, and to use tests that had 
been thoroughly assessed. Fortunately, ASA which had 
clinical significance had been shown to have an adverse 
effect on sperm penetration of cervical mucus, (Fjallbrant 
1968b) (Table 6) and this had a close correlation with 
impaired fertility.
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1.5.5 Sperm cervical-mucus contact tests
Kremer and Jager (1976) studied the interaction 
between spermatozoa sensitized by ASA and cervical mucus, 
and showed that progressive propulsion of the sperm was 
changed into stationary, shaking movement. This phenomenon 
was also observed when normal spermatozoa came into contact 
with cervical mucus from a woman whose serum contained ASA. 
It appeared that the spermatozoa coated with ASA stuck to 
the network of long glycoprotein micelles in the normal 
ovulatory cervical mucus. Investigation of 30 couples with 
poor cervical mucus penetration due to ASA revealed that the 
antibody was in the male partner in 25, and in the female in 
5 (Kremer et al, 1978a).
The SCMC test could therefore serve as a 'test-bed' to 
see if the results of ASA testing were clinically relevant, 
and also provided an opportunity to see which partner was 
affected, so long as the test was repeated using normal 
donor sperm and normal cervical mucus as controls, thus 
forming a "crossed hostility test". Furthermore, it seemed 
that the phenomonon of cervical hostility might in fact be 
due to abnormality in the male more often than it had 
previously been suspected.
1.6 INCIDENCE OF ASA
Review of the literature to 1976 reveals a remarkable 
variety of different tests applied to a number of different 
populations. For the reasons stated above, it seems 
sensible to try to draw conclusions only from agglutination 
or immobilisation tests done on sera by recognisably 
standardised techniques. Three populations of men are of 
interest: fertile men, spontaneously infertile men, and men
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known to have testicular obstruction (e.g. vasectomised men 
or those with obstructive azoospermia). These results 
obtained from published reports up to 1976 are presented in 
Tables 8,9 and 10 respectively. It may be seen that 
agglutinating ASA were found in 2% or less of fertile men, 
3-13% of subfertile men, and 26-757, of men with known 
testicular obstruction. There therefore appeared to be good 
grounds for investigating further the relationship between 
ASA and infertility in men, with particular reference to its 
co-existence with testicular obstruction.
AUTHOR AND NUMBER NUMBER POSITIVE (%)
YEAR STUDIED AGGLUTINATION
*
Rumke & Hellinga 416 0
(1959)
Fjallbrant 500 4 (1)
(1968a)
Halim & Antoniou 100 2 (2)
(1973)
Ansbacher 106 1 (1)
(1973)
Gupta & Garg 15 0
(1975)
Gupta et al 50 1 (2 )*
(1975)
*Titre * 32
TABLE 8 Incidence of ASA in Sera of Fertile Men
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AUTHOR AND NUMBER NUMBER POSITIVE (%)
YEAR STUDIED AGGLUTINATION
Rumke & Hellinga 1913 62 (3)*
(1959)
Schwimmer et al 64 5 (8)
(1967)
Fjallbrant 400 17 (4)*
(1968a)
Hanafiah et al 124 11 (9)
(1972)
Halim & Antoniou 144 19 (13)*
(1973)
Ansbacher et al 554 27 (5)
(1973)
Gupta & Garg 70 4 (6)
(1975)
Hjort & Husted 165 16 (10)
(1975)
Schoenfeld et al 165 9 (5)
(1976)
* Titre >32 
+ Titre >64
TABLE 9 Incidence of ASA in Sera of Infertile Men
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AUTHOR AND 
YEAR
NUMBER
STUDIED
Rumke & Hellinga 
(1959)
Phadke & Padukone 
(1964)
Ansbacher
(1973)
Gupta et al
(1975)
Schoenfeld et al
(1976)
Alexander et al 
(1976)
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50*
69*
141*
45
4*
9*
87*
94t
r Epididymal obstruction 
* Vasectomised 
■f Absent vasa
NUMBER POSITIVE (%)
AGGLUTINATION IMMOBILISATION
16 (26) 
13 (26) 
39 (57) 
86 (61)
19 (28) 
56 (40)
29 (64) 
3 (75) 
6 (67)
29 (33)
30 (32)
37 (43) 
27 (29)
TABLE 10 Incidence of ASA in Sera of men with Testicular
Obstruction (Vasectomy or Obstructive Azoospermia)
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CHAPTER 2: SUBJECTS, MATERIALS AND METHODS
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2.1.1 Subjects and clinical diagnosis
The vast majority of the subjects described in this 
thesis were male partners of subfertile marriages seen, 
examined and treated by the author. The general approach to 
these patients remained the same throughout (Hendry et al, 
1973; Hendry 1975, 1979). There were, in addition, studies 
of vasectomised men before and after reversal which were 
done in collaboration with Mr. Michael Royle, Consultant 
Urologist in Brighton. All subfertile males were fully 
investigated. The history covered the age, occupation and 
religion of the patient and his female partner, the time 
they had been trying to produce a family, and the frequency 
and technical success of sexual intercourse. Present 
medical conditions, especially endocrine disorders, and any 
current drug therapy or exposure to toxic chemicals were 
reviewed. Relevant past history included tuberculosis, 
adult mumps, venereal disease, maldescended testes, and 
hernia repairs. In the social history intake of drugs, 
tobacco and alcohol were recorded.
On examination the general body build, hair 
distribution, and type of underpants worn were checked. The 
penis, foreskin, external meatus, testicular size and 
consistency, epididymes and vasa were examined with the 
patient standing in a good light, to allow a thorough search 
to be made for a possible varicocele; the prostate and 
vesicles were examined digitally per rectum with the patient 
lying on the left lateral position. Scrotal thermography 
was done to settle any doubts about the possible presence of 
a small varicocele and repeated after surgical correction 
(Jones and Hendry, 1978).
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Seminal analysis was always checked twice, 
irrespective of the findings reported in previous tests done 
elsewhere. Technical details of laboratory methods are 
described in section 2.2.
Hormone studies included measurement of plasma 
testosterone, FSH, LH and prolactin. Failure of
spermatogenesis due to gonadotrophin deficiency was uncommon 
(Greenberg et al, 1978), although it was important to 
identify such cases because they could respond well to 
replacement therapy. Much more often the cause was a 
primary defect in spermatogenesis which was recognised 
because the serum FSH level was elevated. Indeed the 
combination of azoospermia, small testes and a grossly 
elevated serum FSH level was considered to be diagnostic of 
absent or seriously impaired spermatogenesis for which there 
was no treatment (Pryor et al, 1976). Full blood count 
(with sickle status if relevant) blood urea and liver 
function tests were usually checked. Urine was tested for 
glucose, protein and evidence of infection, and any 
co-existing urological abnormality was fully investigated.
In cases of oligozoospermia or azoospermia where the 
hormone levels were normal, and there was at least one 
testicle of normal size (15ml measured by orchiometer), 
exploration of the scrotum was carried out by the author to 
find out if there was testicular obstruction (see section 
2.5) and take testicular biopsies. Spermatogenesis was 
rated from 0-10 by a mean score system (Johnsen, 1970).
Somatic chromosomes were checked in buccal smears and 
blood and meiotic chromosome studies were done on testicular 
biopsy material initially as part of a prospective study,
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and subsequently when indicated by the results of clinical 
findings, (Hendry et al, 1975 - see volume 2).
2.1.2. ASA studies, Laboratories and staff
Early work at Chelsea Hospital for Women (CHW) on 
immunological infertility was based on immunofluorescence 
studies and gave disappointing results, failing to 
distinguish between fertile and infertile populations 
(Harrison et al, 1976). Simultaneous work at the London
Hospital by Halim and co-workers (1974) appeared to indicate 
that a spermagglutination test might give better 
discrimination particularly in men. A film by Kremer and 
Jager seen by the author and subsequently published in 1976, 
drew attention to the fact that significant ASA in men 
produced alterations in sperm behaviour in cervical mucus. 
This lead directly to our first comparative studies and from 
September 1975, onwards all men attending the Male Fertility 
Clinic at CHW were tested for ASA by several different 
methods, by Miss Jitka Stedronska, who continued to work in 
the Seminology Laboratory there until 1987. ASA testing at 
St. Bartholomew’s Hospital (Barts.) has been done since 1978 
by Mrs. (now Dr.) Jaroslava Parslow who successfully 
presented her PhD thesis on autoimmunity to spermatozoa to 
the University of London in 1985. The published works on 
which this MD thesis is based are listed in Table 11, all of 
which depended on these laboratory services at CHW and 
Barts.
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SECTIONS 2.3 AND 3.1 DIAGNOSIS IN SUBFERTILE MALES
GAT and clinical findings 
GAT and X-hostility
GAT and MAR (IgG)
MAR (IgG and IgA)
TAT and MAR (IgG)
MAR and IBT (IgG & IgA) 
ELISA & TAT (IgG)
SECTIONS 2.4 AND 3.2
Hendry et al (1977)
Morgan et al (1977)
Hendry & Stedronska (1980) 
Hendry et al (1982a) 
Stedronska & Hendry (1983) 
Rajah et al (1992) 
Stedronska-Clark et al (1987)
MEDICAL TREATMENT OF SUBFERTILE MALES
Continuous Pred. 
Intermittent Methylpred. 
Intermittent Pred.
Pred. vs placebo
SECTIONS 2.5 AND 3.3
Hendry et al (1979)
Hendry et al (1981)
Hendry et al (1986)
Hendry et al (1990a)
SURGICAL TREATMENT OF TESTICULAR
OBSTRUCTION IN SUBFERTILE MALES
Surgery for testicular
obstruction Hendry (1987a,b)
Unilateral Obstruction
- diagnosis Hendry et al (1982b)
- results of treatment Hendry (1986)
Obstructive Azoospermia
(168 cases) Hendry et al (1983a)
(370 cases) Hendry et al (1990b)
Genital tract
injuries in childhood Parkhouse & Hendry (1991)
SECTIONS 2.6 AND 3.4 VASECTOMY REVERSAL
ASA before and after reversal 
1 year follow up studies 
Comparison of vasectomy 
reversal and spontaneously 
infertile men 
Failed vasectomy reversal
Royle et al (1981) 
Parslow et al (1983)
Hendry et al (1983b) 
Royle & Hendry (1985)
TABLE 11 Published ASA Work (see volume 2)
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2.2 Laboratory Methods
Standard laboratory methods recommended by the World 
Health Organization were used (WHO Laboratory Manual for the 
examination of the human semen and semen-cervical mucus 
interaction 1987; WHO Reference Bank for Reproductive 
Immunology 1977).
2.2ol Seminal Analysis
Patients were asked to abstain from sexual intercourse 
for 3 to 4 days prior to semen collection. The semen
specimens were produced in the hospital by masturbation into 
a sterile plastic container. In some cases the semen 
samples were collected at home but brought into the
laboratory within one hour. Following liquefaction, the 
semen was examined for volume, pH and viscosity. The 
motility and morphology of spermatozoa was estimated
microscopically in a drop of undiluted semen. The sperm 
count was determined in a Neubauer counting chamber after 
dilution with 17o formalin containing 5% NaHCO^. The 
specimen was considered azoospermic if there were no
spermatozoa seen in a wet film, oligozoospermic with less 
than 20 million of spermatozoa per ml, and normospermic when 
at least 20 million of spermatozoa were present in 1 ml of 
the ejaculate.
2.2.2 Post Coital Test (PCT)
PCT's were performed as close as possible to the time 
of ovulation as determined by clinical criteria (based on 
body temperature, cervical mucus changes and vaginal 
cytology). The couple were instructed to abstain from 
sexual intercourse for about 2 days prior to the day on 
which the test was to be performed. The test was performed
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preferably 6-10 hours after intercourse, but was sometimes 
done after a longer interval (up to 18-20 hours) after 
coitus. A non-lubricated syringe was inserted into the 
vagina and a sample of cervical mucus obtained with a 
tuberculin syringe (without needle) from the cervical canal. 
This was placed on a glass slide and examined under the 
microscope at 400x. The number of motile spermatozoa per 
HPF was recorded: fewer than 5 was regarded as abnormal.
Volume, consistency, Spinbarkeit, cellularity and pH of the 
cervical mucus was also recorded.
2o2.3 Cervical Mucus Penetration (Crossed Hostility)
x This in vitro ’’cervical mucus hostility” test first 
described by Miller and Kurzrok in 1932 was used to study 
the effect of spermatozoa coated with ASA on penetration of 
cervical mucus. For this purpose husband's fresh semen and 
wife's cervical mucus were obtained. In order to determine 
whether the antibodies were located on the husband's 
spermatozoa or in the wife's mucus, the test was performed 
in a cross-test system, using fresh semen and cervical mucus 
of normal donors as a control.
A drop of preovulatory cervical mucus with signs of 
good oestrogenic stimulation and a pH greater than 6.7 was 
placed on the centre of a slide and flattened by a coverslip 
to about 2cm diameter. Fresh semen was applied to the edge 
of the coverslip to draw it into contact with the edge of 
the mucus. The slide was then placed (in a moist Petri 
dish) in an incubator at 37°C and examined microscopically 
after 20 minutes. Penetration was assessed as 0= no 
penetration; 1= penetration not exceeding 2 mm into 
peripheral mucus; 2= sperm moving throughout the mucus.
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Movement within the mucus was assessed as positive if there 
was forward progression of the sperm or negative if the 
sperms were immobile or shaking. In the tube test, a 1 cm 
column of semen was placed at the bottom of a plastic 
Luckam (L.P.3) test-tube and into this was placed the quill 
with 1 cm of cervical mucus at the lower end and 
physiological saline at the upper end. The tube was put in 
the incubator at 37°C. After one hour the saline and the 
upper, middle, and lower parts of the cervical mucus were 
examined for the presence or absence of sperms and motility 
was graded. Results were expressed descriptively according 
to the level of penetration of sperms.
2.2.4 Sperm Cervical Mucus Contact (SCMC) Test
In this technique the spermatozoa in a drop of semen 
are brought into contact with cervical mucus. Changes in 
the motility pattern of spermatozoa (due to antisperm auto- 
or isoantibodies) are observed when they are inside the 
mucus.
The SCMC test was carried out as described by Kremer 
and Jager (1976) and Jager et al (1979).
A fresh semen sample of a husband was placed into a 
narrow test tube which was left in an upright position for 
30 minutes at room temperature in order to allow 
agglutinated spermatozoa to settle to the bottom. 
Approximately 0.1 ml of the semen was then withdrawn from a 
level about 0.5 cm under the fluid surface using disposable 
tuberculin syringe fitted with a very fine needle. One drop 
of the wife's preovulatory cervical mucus was placed on a
glass slide next to a drop of semen. Both drops were then
thoroughly and carefully mixed and covered with a coverslip.
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A second drop of semen was placed on the same slide as a 
motility control. After 15 minutes of incubation at 37°C in 
a moist Petri dish, the slide was examined and the 
percentage of motile spermatozoa showing quickly shaking 
movements (shaking phenomenon expressed in %S) was 
estimated. The classification of the SCMC test resuls was 
as follows: grade negative with at least 757> of
progressively motile spermatozoa, grade + with 26 to 507® of 
locally quickly shaking spermatozoa, grade + + and grade +++ 
with 51 to 7570 and with 76 to 1007o of spermatozoa exhibiting 
the shaking phenomenon, respectively. The SCMC test was 
also performed with a donor's spermatozoa and, whenever 
possible, with a donor's cervical mucus.
2.2.5 Gelatin Agglutination Test (GAT)
The GAT introduced by Kibrick and his colleagues in 
1952 was performed as described by Shulman (1975) with 
slight modifications.
Samples under investigation (serum or seminal plasma) 
were heat-inactivated by incubation at 56°C for 30 minutes 
in a water bath, to destroy complement activity that may 
otherwise cause (with the antibody) sperm immobilization. 
Samples were then serially diluted in serological test tubes 
(LP 3, Luckham), using Baker's buffer as the diluent and 
starting with dilution 1:4. Baker's buffer had the 
following composition: glucose 30.3g; Na2HP0^.I2H2O, 6.0g;
NaCl 2.0g; Kl^PO^, 0.1 g; distilled water to 1000ml. 200 pi
of each of these dilutions were transferred to small Luckham 
LP 2 test tubes, which were then stored at 37°C until 
required.
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A fresh semen specimen of good quality (i.e. sperm 
count of at least 50 million/ml, motility of at least 507®. 
good morphology and with neither agglutinates nor increased 
numbers of non-spermatozoal cells) was diluted with Baker’s 
buffer, warmed to 37°C to a final concentration of 40 
million/ml. An equal volume of 107® gelatin (Difco) in 
Baker's buffer was added to the diluted semen suspension and 
mixed gently. The gelatin medium prevented rapid
sedimentation of the spermatozoa.
200 pi volumes of semen-gelatin mixture were added to 
each of the LP 2 test tubes containing the serum or seminal 
plasma dilutions and carefully mixed using disposable 
stirring rods. The test tubes were then incubated at 37°C 
and examined after 1 hour and after 2 hours against a dark 
background in front of a strong light. In positive cases an 
agglutination was observed by the appearance of white 
floccules along with clearing of the suspending medium (fig. 
1). Sera showing the positive result at dilution 1:4 were 
studied again in the 2-fold dilution series. The antibody 
titre was defined as the hightest dilution which showed a 
positive result (precipitation), expressed as the reciprocal 
of this dilution. Control sera, both positive and negative, 
were always tested in parallel to evaluate the particular 
semen samples used in the test.
2.2.6. Tray Agglutination Test (TAT)
This microscopic test was performed according to 
Friberg (1974a) with some modifications by Hellema and Rumke 
(1976) and Jager et al (1978).
Samples (serum or seminal plasma) were inactivated as 
for GAT and diluted with Earle's balanced salt solution of
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following constitution: 10ml lOx concentrated Earle's
solution (Gibco); 3.3 ml of 307o bovine serum albumin (BSA) 
(Sigma); 3.0 ml of 7.5% NaHCO^; distilled water to 100 ml; 
pH was adjusted prior to use to 7.2 with HC1. Dilutions of 
4-, 8-, up to 128-fold were prepared in the tissue typing 
microtitre plates (Sterilin), using automatic 25 ul 
pipettes. Five pi volumes of the sample dilutions were 
transferred to the 60 ring microchambers (Medicel 
International) under paraffin oil, using a Hamilton 
micropipette with disposable tips (fig. 2).
A donor semen sample with good sperm concentration (at 
least 80 million/ml) and motility greater than 707, was 
aliquoted into narrow test; tubes (Luckham LP 2) to a depth 
of about 1 cm. An equal volume of Earle's solution 
containing 1% BSA at 37°C, was carefully layered on top of 
the semen sample. The spermatozoa penetrated the layer of 
Earle's solution after an incubation for about 1 hour at 
37°C, leaving behind any debris, non-spermatozoal cells and 
agglutinated or immotile spermatozoa. The top layer, which 
contained a high percentage of motile spermatozoa, was 
carefully removed and sperm concentration adjusted to 
between 30 and 40 million/ml (fig. 3).
One pi of the spermatozoa suspension was added to 5 pi 
drops of the diluted sample with the aid of a Hamilton 
microsyringe and mixed gently. The trays were subsequently 
incubated at 37°C and examined after 1 and 2 hours for the 
mode of agglutination (fig. 4) and the titre, using an 
inverted microscope (Olympus CK) (fig. 5). A known positive 
and negative control sera were always included in the test.
65
2.2.7 Sperm Immobilisation Test (SIT)
This test was carried out as described by Isojima et 
al (1968). Samples under investigation were pretreated by 
heating at 56°C for 30 minutes to inactivate complement. 
The test was normally carried out on undiluted serum only, 
unless GAT or TAT were positive, in which case 2-fold 
dilutions were made. Human spermatozoa of at least 707o 
motility and good forward progression were diluted to 60 x 
106 cells/ml in Baker’s buffer. Pooled fresh guinea-pig 
serum stored in small aliquots and frozen (-20° to -60°C) 
were used as the complement source. To the small tube was 
added: 0.25 ml of inactivated test serum or a control serum,
0.05 ml of complement solution and 0.025 ml of fresh human 
semen dilution. Known positive and negative sera were 
included in each test as controls. A similar mixture was 
made without the complement solution, to detect any 
non-specific sperm immobilizing activity, consisting of
0.25ml of test semen plus the semen sample. The mixtures 
were incubated at 37°C for 1 hour.
A drop of each mixture was examined on a microscope 
slide at 100 x to 250 x, studying several fields. The 
percentage of motility was measured, and a positive result 
was recorded if the sperm motility decreased to 507o or less 
of the motility in the negative control mixture. Positive 
sera were titrated from 1:4 to 1:128.
2c2=8 Mixed Antiglobulin Reaction for IgG antibodies 
(MAR-IgG)
The MAR-IgG test based on the method of Coombs et al 
(1956) was carried out as recommended by Jager and his 
co-workers (1978). The test was performed on all fresh
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semen specimens as a part of a routine seminal analysis, 
provided that the sperm concentration was greater than 1.0 
million/ml and the motility sufficient.
Sensitized red blood cells (RBC's) were prepared by 
the Blood Transfusion Laboratory according to the method of 
Chalmers et al (1959) or obtained commercially (Coombs 
Control, Baxter). Group 0, Rh positive red blood cells were 
washed three times in phosphate buffered saline (PBS), pH 
7.5. Five volumes of this suspension were mixed with 1 
volume of a strong incomplete anti-D serum and incubated at 
37°C for 30 minutes. The cells were then washed three times 
with PBS to a haematocrit of between 5 to 107>.
One drop of fresh semen was placed on a microscope 
slide with one drop of the sensitized red blood cell 
suspension and one drop of undiluted monospecific anti-human 
IgG (Gamma-chains) antiserum (Dakopatts). The three small 
drops were thoroughly mixed and covered with a coverslip. 
The reaction was observed under a microscope within 5 
minutes. The test was considered negative if at least 907«> 
of spermatozoa were freely swimming between the clumps of
agglutinated erythrocytes. The reaction was scored as + if
up to 207, of the motile spermatozoa were involved with
adhering blood cells, ++ with up to 807o of spermatozoa
incorporated into RBC's agglutinates and + + + when more than 
807> of motile spermatozoa were attached to the erythrocytes 
(fig. 6).
2.2.9 Mixed antiglobulin reaction for IgA antibodies 
(MAR-IgA) (Hendry et al, 1982)
The MAR tests were modified as follows for the 
addition of IgA testing: group 0 Rh-positive red blood cells
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were washed three times in Alsever’s solution and 
resuspended to a hematocrit of 507,. To one part of red cell 
suspension was added two parts of l-in-5 dilution of serum 
containing anti-D, which was partly IgA, although mainly IgG 
(Serum Avgh., supplied by Professor P.L. Mollison). The red 
cells and serum were incubated at 37°C for 30 minutes. The 
cells were then washed three times again in Alsever's 
solution, and resuspended to a hematocrit of between 57, and 
107>, and stored until required for use in small aliquots at 
4°C.
One drop of fresh semen was placed on a microscope 
slide with one drop of sensitized red cell suspension and 
one drop of undiluted monospecific anti-human antiserum for 
either IgG or IgA (Behring Diagnostics, SomervilLe, N.J). 
The three drops were thoroughly mixed, and the reaction was 
read within 10 minutes. No interpretation was made unless 
agglutination of the red blood cells was observed. The test 
was read as negative (0) if no motile mixed agglutinates 
were seen and freely swimming spermatozoa could be observed 
between the clumps of agglutinated red cells. If motile 
mixed agglutinates were observed, the reaction was graded as 
follows: doubtful (±), only an occasional mixed agglutinate 
seen, with less than 107o of the motile spermatozoa involved 
with adhering red blood cells (this result is interpreted as 
negative); positive (++), 107o to 907o of the motile
spermatozoa attached to the erythrocytes; strongly positive 
(+++), more than 907, of the motile spermatozoa incorporated 
into mixed agglutinates.
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2 o 2.10 Immunobead Test (IBT)
This test was carried out as recommended by Bronson et 
al (1982) and Clarke et al (1985). Anti-IgG and anti-IgA 
immunobeads (BioRad Laboratory) were reconstituted in 10ml 
of Tyrode's solution or Bulbecco's phosphate buffer saline 
(PBS) which was passed through a millipore (22 pm filter) 
before use. 0.2 ml of antilgG beads and 0.2ml of anti IgA 
beads were put into separate centrifuge tubes and made up to 
10 ml with 0.4% bovine serum albumin (BSA) buffer. In a 
centrifuge tube the required amount of semen was added and 
made up to 10ml with 0.4% BSA buffer. The amount of semen 
required was determined by sperm count and motility (table 
1 2 ).
S perm
C o n cen tra tion
(m illion/m l)
Motility
(%)
Sem en
Required
(m l)
>50 >40 0.2
20-50 >40 0.4
20-50 <40 0.8
<20 >40 1.0
<20 <40 2.5
TABLE 12 Volume of semen required for direct IB test
The three tubes were centrifuged at 500g for 5 minutes. The 
supernatant was decanted and the pellet was washed and 
resuspended in 10 ml of 0.4% BSA buffer. The washing of the 
semen was repeated and the semen pellet resuspended in 0.2 
ml of 0.4% BSA buffer. 5 pi drops of antilgG beads and anti
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IgA beads were placed at either end of the glass slide and 
approximately 5 pi of the semen suspension was added to each 
of the bead drops and mixed well with the cover slip. The 
slide was left for 10 minutes in a moist chamber and 
observed microscopically at 400x magnification. The 
percentage of motile spermatozoa attached to the immunobeads 
were scored separately in the IgG and IgA containing mixture 
(fig. 7). The test was regarded as positive if 20% or more 
of the motile spermatozoa were attached to one or more bead.
2.2.11 Enzyme Linked Immunosorbent Assay (ELISA)
Test plates coated with sperm antigen were prepared by 
ZER (ZER Science Based Industries Ltd., Jerusalem) and were 
obtained through Horwell Ltd., U.K. These kits included 
positive and negative control serum and
alkaline-phosphatase-coupled anti-human immunoglobulin. 
According to the protocol sheet accompanying the kit, we 
added various dilutions of company control reagent or our 
own set of sera known to be positive or negative by TAT to 
the assay wells. After incubation and washing, the 
anti-human immunoglobulin reagent was added, and after a 
further wash the p-nitrophenyl phosphate substrate was 
added. After 60 minutes, 3 N NaOH was added to stop the 
reaction, and colour development was measured by means of an 
ELISA plate reader. A positive result was one exceeding the 
negative control.
202.12 Immunofluorescent Test (IFT)
This test was done by the method of Hjort and Hansen 
(1971). The spermatozoa in 0.2 ml of donor semen were 
washed twice in 10ml buffered saline with centrifugation at 
680g for 5 minutes. The washed spermatozoa were resuspended
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in buffered saline, and the concentration adjusted to 10 x
£
10 /ml. Single drops of this suspension were spread on
slides and dried under a fan for 30 minutes. The dried 
spermatozoa were fixed in analytical reagent grade absolute 
methanol for 30 minutes, after which the slides were
transferred to phosphate-buffered saline PBS (pH 7.2). A
drop of serum or semen dilution was added, and the
preparation left in a moist chamber for 1 hour at room
temperature. The serum or semen was then rinsed away with
PBS and the preparation washed for 20 minutes with one
change of buffer at 10 minutes. The preparations were then 
incubated for 30 minutes with Fluorescein Isothiocyanate
(FITC) conjugated antisera and after repeated washing were 
mounted in PBS in 107o glycerol. The slides were examined
using a good fluorescent microscope equipped with
interference filters. Staining patterns were defined as 
involving acrosome, equatorial segment, post acrosomal area 
(post nuclear cap), tail mainpiece and tail end piece.
2.3 INFERTILE MALES: DIAGNOSIS OF IMMUNOLOGICAL INFERTILITY 
2.3*1 Experimental design
The first sections (2.3) are concerned with studies
done to find out which ASA tests were clinically relevant 
and meaningful. Initially, over 500 subfertile men
attending the Infertility Clinic at CHW had blood taken for 
testing for ASA by 3 different techniques (GAT, SIT and 
IFT). The results were correlated with each other and with 
clinical findings in the men and their female partners (PCT)
(2.3.2). They were also correlated with the results of 
sperm-cervical mucus contact (SCMC) and X-hostility testing
(2.3.3). The results showed that GAT was both sensitive and
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reliable, though rather cumbersome.
Miss Stedronska and then Mrs. Parslow therefore went 
to work with Dr. Jager and Dr. Kremer in Groningen for 2 
weeks to learn the details of the newer micromethod of
testing (TAT), which could be used to test seminal plasma 
routinely as well as serum. Having mastered the necessary 
technology GAT and TAT were run in parallel for some years 
before ultimately dropping GAT. Dr. Jager also demonstrated 
MAR (IgG) testing, which was evaluated carefully at CHW and 
is now used routinely to screen for ASA (2.3.4; 2.3.5).
Dr. Kremer showed that the class of antibody on the
spermatozoa was of fundamental importance. With the help of 
Professor Pat Mollison of St. Mary's Hospital, London, a new 
MAR test for IGA was devised and evaluated with serum and 
seminal plasma TAT (2.3.6). Subsequently Mrs. Parslow 
developed a sophisticated double antibody radioimmunoassay 
to quantify the class of antibody more accurately, and this 
formed the basis of her PhD thesis. These results will be 
alluded to in discussion.
Shortly before Miss Stedronska left to become Mrs.
Stedronska-Clark, she conducted with her husband Dr. David 
Clark our last study evaluating a new ELISA test (2.3.8). 
CHW closed in 1989, and since then ASA work has continued 
solely in the Williamson Laboratory at Barts,, where 
recently the direct IBT has been compared with direct MAR as 
a routine screening test for ASA in subfertile males and
prior to IVF or GIFT (2.3.7).
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2.3o2 Serum GAT, SIT, IFT, PCT and clinical findings 
(Hendry et al, 1977)
Between 1975 and 1977, sera from 591 male partners of 
infertile marriages were tested for the presence of ASA by 
GAT, SIT and IFT. All of the men submitted at least two 
specimens for seminal analysis. Those with counts of less 
than 20 m/ml, or motility less than 307o moving actively 
within 3 hours, were investigated as previously described. 
When positive antisperm antibody tests were found, both 
husband and wife were examined and repeated post-coital 
tests were done.
2.3.3 Serum GAT, SIT, IFT and X-hostility (Morgan et al, 
1977)
Forty four couples were selected for the crossed 
hostility test on the basis of the husbands' antisperm 
antibody results. In 22 couples (group I) the husbands had 
high titres (more than 1/50) of both agglutinating and 
immobilising antibodies. In 10 couples (group II) the 
husbands' sera were negative for agglutinating and 
immobilising antibodies, but positive on immunofluorescent 
testing (acrosome pattern 2, equatorial segment 1, 
postnuclear cap 2, tail 3, tail + equatorial segment 2). In 
a further 12 couples (group III) all antibody tests were 
negative in both husband and wife.
2.3.4 Serum GAT and MAR (IgG) (Hendry & Stedronska, 1980)
In 1978 and 1979, 775 semen samples from 557 male
partners in subfertile marriages were examined, and MAR IgG
testing was completed with 664 specimens from 463 patients.
In 213 patients, serum antisperm antibodies were measured in 
serial dilution by GAT and SIT. One hundred and seventy
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eight of these patients were tested on more than one 
occasion.
2.3.5 Serum TAT and MAR (IgG) (Stedronska & Hendry, 1983)
In 1980 and 1981, 1279 semen samples from 720 male
partners of infertile marriages were examined. MAR (IgG) 
testing was done in 651 patients with sufficient numbers of 
motile spermatozoa to allow interpretation of the results, 
and the fact that it was not possible in the remaining 69 
patients was noted on the seminal analysis report. In 204 
patients, antisperm antibodies were also measured by GAT, 
SIT and TAT. In 448 patients, the negative result obtained 
by MAR test was taken as sufficient to exclude the presence 
of antisperm antibodies, and no other immunological tests 
were done.
2.3.6 Serum and seminal plasma TAT, MAR (IgG and IgA) and 
X-hostility (Hendry et al, 1982a)
The presence or absence of IgA antibodies on
spermatozoa was defined by the direct MAR test in 104 semen
samples with counts of at least 1 million spermatozoa per
milliliter, provided by 51 untreated subfertile males with
positive MAR tests for IgG. In 34 cases the MAR tests for
IgA were repeated on two or more occasions. The quantity of
antisperm antibody in seminal plasma was measured in serial
dilution by GAT in all cases and by TAT in 49 cases. The
serum antibody titre was also defined in 47 cases by GAT,
TAT and SIT. In 20 couples, the patients' spermatozoa were
tested against preovulatory cervical mucus obtained from the
wife and from donors of proven fertility, comparing the
behaviour of patients' spermatozoa with those obtained from 
fertile donors by x-hostility test.
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2.3.7 MAR (IgG) and IBT (IgG and IgA) (Rajah et al, 1992)
Spermatozoa from 109 male partners of infertile 
couples were tested for surface bound ASA by MAR (IgG), and 
by direct IBT for both IgG and IgA. Sperm concentrations 
ranged from 0.6 to 282 (median 55) million per ml, overall 
sperm motility was from less than 5 to 80 (median 60) per 
cent. In addition, ASA were measured by TAT in seminal 
plasma in 26, and in serum in 34.
2o3o8 Serum TAT and ELISA (Stedronska-Clarke et al, 1987)
Eight known positive and 4 known negative sera from 
infertile and control patients were tested by ELISA and the 
results compared with those obtained by serum TAT.
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2.4 INFERTILE MALES: MEDICAL TREATMENT
2=4.1 Experimental design, patient selection and 
pretreatraent checks
Sections 2.4 and 3.2 relate to the development of 
effective medical treatment for the subfertile male with 
immunological infertiity. Drug dosage and timing required 
careful sequential evaluation in searching for a treatment 
that was effective and safe, and this had then to be tested 
against placebo in a prospective double blind trial. 
Professor Michael Besser in the Endocrinology Department at 
Barts, provided valuable help throughout these studies, and 
with his guidance a protocol was drawn up to select patients 
suitable for treatment, and to define essential medical 
checks which had to be completed before treatment started. 
Dr. Louis Hughes, Clinical Assistant at CHW, provided great 
help in seeing patients on treatment, making sure that the 
protocols were followed carefully. Miss Gill Scammell, 
Lecturer at CHW, looked after many of the female partners.
Protocol for selection of patients for medical 
treatment for antisperm antibodies:
Patients
The patients should be males who have been trying 
unsuccessfully to produce a pregnancy for at least 1 
year with:
1. Some spermatozoa in the ejaculate in at least two 
samples. (The MAR test should be positive if it 
is technically possible to do this test).
2. A positive serum GAT or TAT titre of 32 or more 
and/or a positive seminal plasma GAT or TAT titre 
of 4 or more.
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3. An abnormal PCT (less than five progressively 
motile sperms per high power field) done between 
the 12-14th day of cycle after intercourse 8-12 
hours previously.
4. An abnormal SCMC test with sperm ’shaking' on the 
12-14th day of cycle.
If these criteria are satisfied, it is reasonable to 
conclude that autoimmunity to spermatozoa in the male 
partner is a significant factor in the couple's 
infertility. Female partners should have patent tubes 
(preferably demonstrated by laparoscopy) and have been 
documented to be ovulating adequately (two 
progesterone levels on days 16, 21 or 24 above 33
nmol/L). If the female partner is not ovulating 
adequately, then she should be appropriately treated 
and no therapy given to the husband until this has 
been shown to be effective by repeating the 
measurement of the progesterone levels.
Pretreatment Work-Up
Diastolic blood pressure should be less than 90mmHg, 
and chest x-ray and liver function tests should be 
normal. The blood sugar 2 hours after food should be 
less than 8.9 mmol/L, and there should be no 
glycosuria. There should be no first-degree family 
history of diabetes - if there is, then a glucose 
tolerance test should be done and found to be normal. 
Finally, there should be no significant history of 
dyspepsia. If these criteria cannot be fulfilled, the 
patient should be referred for a detailed medical 
work-up before treatment is commenced.
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Informed Consent
Both partners should be interviewed together and the 
details of treatment explained in full. Precautions 
to be followed whilst on steroid therapy, and possible 
side effects, are detailed on an information sheet 
which is given to the couple to take away and keep. 
Mention of possible serious complications is made, and 
the final decision on whether to proceed or not is 
left to the couple. If necessary, a further 
consultation is arranged to give the couple time to 
consider their decision, and if they wish, discuss it 
with their general medical practitioner.
A copy of the Patients' Information Sheet used for the
cyclical moderate dose prednisolone regime is reproduced in
full:
INFORMATION FOR PATIENTS RECEIVING PREDNISOLONE TREATMENT
FOR ANTISPERM ANTIBODIES
1. Prednisolone treatment can lower the quantity of
antisperm antibodies in subfertile men and this may
help them to produce a pregnancy.
2. Approximately one-third (337o) of wives can expect to 
become pregnant whilst their husband is receiving 
Prednisolone treatment.
3. The normal course of treatment lasts for nine months.
4. Couples are seen after the first course of treatment
and then every three months to recheck antibody levels 
in blood and semen.
5. The usual dose of Prednisolone is four 5 mg tablets
(20mg) twice daily taken with meals, by the husband,
from day one to ten of the wife's cycle, followed by
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one tablet (5mg) in the morning on days 11 and 12.
This dose may be adjusted up or down, according to
individual response or side-effects.
6. No alcohol should be taken whilst on treatment.
7. Side-effects occur in about 20% of patients taking
Prednisolone. Many patients gain a little weight and 
develop a few spots on the face and body. Some 
experience indigestion, and this can usually be 
relieved by antacid treatment (e.g. Rennies). Some 
men become irritable and this may require patient
understanding. There is a small risk of thinning of 
the bones and rarely joint damage may occur,
especially if treatment goes on for longer than the 
recommended period.
8. It is essential that any other doctor who treats a
patient who is, or has been on Prednisolone, is 
informed of the fact. For this reason, all patients 
should carry a Steroid Card whilst on treatment and 
for one year thereafter.
9. In the event of an emergency whilst on Prednisolone
treatment, please contact your General Practitioner 
or: -
Mr. W.F. Hendry,
St. Bartholomew's Hospital, London, EC1.
(071 601 8394).
10. If pregnancy occurs, please be sure to inform your
consultant.
2.4.2 Prednisolone - continuous low dose treatment (Hendry 
et al, 1979)
Group 1 - 1 5  patients had average pre-treatment sperm
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counts of less than 20 million per ml; 4 had varicoceles 
which were ligated, and 1 had bilateral maldescended testes 
operated upon in late childhood. These patients were
treated with prednisolone 5mg three times a day for 3-12 
(average 6.1) months. Testicular biopsy specimens were
obtained under general anaesthetic from 3 patients with
severe oligozoospermia (2 of whom had varicoceles).
Group 2 - 1 4  patients with average pre-treatment sperm 
counts of more than 20 million sperms per ml received 
Prednisolone 5mg three times a day for 3-12 (average 7.1)
months.
2.4.3 Cyclical high dose methyl prednisolone (Hendry et al, 
1981)
Forty-five men, aged between 24 and 46 years (average 
31.7), were seen because of infertility lasting from 2 to 10 
years (average 5.3). Forty-two men were ’’naturally
infertile” of whom 5 had a past history of epididymitis, 4 
testicular injury, 2 venereal disease, 1 mumps orchitis, and 
2 very tight foreskins removed as adults; in all, 14 (3 3%) 
of these 42 had a history of a possible predisposing factor. 
In addition, two men had had reversal of vasectomy, and one 
had had successful epididymovasostomy.
As recommended by Shulman (1976), Methylprednisolone 
(MP), 32 mg three times a day with meals, was given to the 
husband for 7 days from days 21 to 28 of his wife's
menstrual cycle. If no serious side effects occurred, and 
if the wife did not become pregnant, the treatment was
repeated in alternate months for 6 months. Antisperm
antibody levels in serum and seminal plasma were rechecked 
as often as possible after treatment. In a few cases,
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serial antibody estimations (every 2 or 3 days for 10 days) 
were made following the third course of MP to allow fine 
adjustment of the timing of future courses of treatment. 
Ten men received up to three additional monthly courses of 
MP at times ranging from days 1 to 8 to days 3 to 12 of 
successive cycles, depending on the results of these 
additional serial antibody tests. In two patients this was 
the primary treatment given. Enquiry regarding side effects 
or pregnancy in the spouse was made at each visit, and no 
patient was lost to follow-up.
2.4<>4 Cyclical moderate dose prednisolone (Hendry et al, 
1986)
Seventy-six men 27 to 47 years of age (mean, 33 years) 
complained of spontaneous involuntary infertility for 15 
months to 21 years (mean, 4 years). In all cases initial 
semen analysis screening revealed a positive MAR test for 
IgG antibodies on spermatozoa. Sperm counts of 20 x 10^/ml 
or greater were recorded in 65 patients; sperm motility was 
40% or more in 36 patients. Serum titres of 32 or more were 
recorded by GAT or TAT in 70 patients; for the remaining 6 
patients, seminal plasma antibody titres were positive at 4 
or more. Crossed-hostility (SCMC) tests were carried out in 
41 couples. In the women, apparent ovulation was confirmed 
by observation of luteal phase serum progesterone levels of 
at least 33 nmol/L, and in 29 women this was induced by 
medication, including clomiphene citrate and gonadotropin 
therapy.
Patients were advised of the risks and possible side 
effects of treatment and cautioned to abstain from alcohol 
during therapy. They were then given soluble prednisolone,
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20mg twice daily (taken with meals), from days 1 to 10 of 
the partner’s cycle, followed by 5mg in the morning of days 
11 and 12. Serum and seminal plasma antibody levels were 
remeasured after three cycles of treatment, and the patients 
were assessed. If the antibody titres had fallen 2 or more 
dilutions, up to six more courses of treatment were given, 
bringing the total cycles of therapy up to nine. In 15 
patients in whom the titres had not fallen, the dose of 
prednisolone was increased to 40mg twice daily taken, as 
before, from days 1 to 10 of the partner’s cycles, followed 
by 5mg in the morning of days 11 and 12. The patient and 
the antibody titre were reassessed after three cycles at 
this increased dosage. The protocol permitted a final rise 
to 60mg prednisolone twice daily (the equivalent of 
methylprednisolone, 96mg daily), but this was required in 
only one patient. The protocol specified a limit of not 
more than 9 treatment cycles; however, for a variety of 
reasons, 14 men opted to continue for 12 cycles and 1 man 
went on for 17 cycles without ill effect.
2.4=5 Controlled clinical trial of prednisolone versus 
placebo (Hendry et al, 1990a)
These studies were done in collaboration with Mr. Tim 
Hargreave, Western General Hospital, Edinburgh, and Mr. John 
Pryor, St. Peter’s and Kings College Hospitals, London.
Forty-three men with ASA, who had been trying to 
produce a pregnancy for at least a year, entered the trial 
after giving informed concent. The men were stratified into 
two groups according to whether they had been trying to 
produce a pregnancy for less than 3 years (16 men) or 3 or 
more years (27 men); they were then randomised to receive
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double-blind either prednisolone (22 patients) or matching 
placebo (21 patients) for 9 months, before crossing over to 
the other treatment. The active treatment consisted of 
soluble prednisolone 20mg twice daily taken with meals on 
days 1-10 of the female partner's menstrual cycle, followed 
by 5mg in the morning of days 11 and 12. Alcohol was 
forbidden during this period. After three cycles the 
antibody levels were remeasured; if the serum or seminal 
plasma titres had dropped 2 or more dilutions the treatment 
was repeated for two more periods of 3 months to a total of 
nine cycles. If the tittes were unchanged (10 patients) the 
dose of prednisolone (or placebo) was raised to 40mg twice 
daily, taken as previously, for the remaining 6 months.
An information sheet was given to each couple 
outlining the side-effects to be expected and precautions to 
be followed with steroid treatment, together with a card 
bearing their code number so that the tablets could be
identified by the hospital pharmacy if necessary. Couples 
were seen every 3 months so that side-effects could be
discussed, and seminal analysis and antibody tests were 
repeated. The trial was approved by the appropriate 
hospital ethical committees.
2.5 INFERTILE MALES: SURGICAL TREATMENT
2.5.1 Patient selection and operative techniques
The selection of subfertile males for exploration of 
the scrotum to confirm the presence of testicular 
obstruction, and correct it whenever possible, is never very
easy, and has been the subject of a number of chapters
written by the author (Hendry, 1987 a, b). The indications 
can be described as absolute or relative, and
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contraindications are definable. These are summarised as 
follows:
Absolute indications:
(i) Vasectomy reversal.
(ii) Azoospermia with normal sized testes, palpable 
vasa and normal serum FSH levels.
(iii) Oligozoospermia (less than 20m/ml) with 
antisperm antibodies, and clinical evidence of 
unilateral testicular obstruction.
Relative indications
(i) Azoospermia or persistently severe
oligozoospermia after a previous attempt at vasectomy 
reversal.
(ii) Azoospermia with small testes and low serum FSH 
levels, prior to gonadotrophin therapy.
(iii) Azoospermia or severe oligozoospermia with 
marked disparity in the size of the testes, even with 
slightly or moderately elevated serum FSH levels.
(iv) Normal sperm count and significant titre of 
antisperm antibodies, with some evidence of unilateral 
testicular obstruction.
Contraindications
(i) Azoospermia with small testes and grossly 
elevated serum FSH levels.
(ii) Bilateral absence of the vasa deferentia. 
Surgical Technique
Under general anaesthesia, the scrotum was opened by a 
midline incision, the testes delivered and the vaginal 
spaces opened. The epididymes were examined and often 
phot<graphed. If the epididymes were empty a testicular
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biopsy was taken and nothing further was done. Provided 
that the epididymis contained distended tubules, attention 
was turned to the vasa. If they were absent nothing further 
was done. If they were present, the vas was picked up 
across the tunica vaginalis and a short longitudinal 
incision was made. The lumen was cannulated with a size 2F 
intravenous cannula (Portex) and 5ml 25% Hypaque injected 
before taking a vasogram x-ray film. The epididymis was 
then incised over the lowest part containing dilated tubules 
and side-to-side epididymovasostomy (Ep-Vas) was completed 
with a continuous suture of 6/0 Prolene and no splint (fig. 
8). If vasography showed a block in the vas, the area was 
explored through a separate incision and the block was 
either corrected by division of the vas and side-to-side 
vasovasostomy (Vas-Vas) with 6/0 Prolene (fig. 9) or the 
testicular end of the vas was anastomosed to the opposite 
vas by end-to-side technique as a transvasovasostomy 
(Trans-Vas-Vas) (fig. 10). All patients wore a scrotal 
support lined with cotton wool for 7 days.
Most patients nowadays are done as Day Cases, although 
they generally stayed in for a day or two in years gone by.
Vasectomy reversal was done by overlapped side-to-side 
anastomosis (fig. 9) with 6/0 Prolene, usually via bilateral 
oblique incisions.
2.5.2 Unilateral testicular obstruction - diagnosis (Hendry 
et al, 1982b)
Thirty-two subfertile males were questioned about 
their past medical history, examined clinically and 
investigated by seminal analysis and measurement of hormone 
levels. Serum antisperm antibodies were assayed in serial
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dilution and the mode of sperm agglutination was defined as 
head-to-head (HH), tail-to-tail (TT) or mixed by TAT. In 26 
cases the scrotum was explored and unilateral obstruction 
was confirmed.
Three patients had had bilateral epididymo-vasostomies 
some years previously: they presented with positive sperm
counts and continuing partial obstruction was suspected on 
clinical examination. Two patients refused surgical 
exploration - one had had epididymitis, the other had had a 
hernia repair twice on one side, and in both cases the 
epididymis on the affected side was distended and tender; 
they have therefore been included on clinical grounds. 
Finally, one patient had had epispadias repair as a child, 
followed by urethral stric^tjre and urinary infection. The 
stricture was dilated and the infection was eradicated but 
the scrotum was not explored and once again unilateral 
obstruction was diagnosed clinically. In 2 additional 
patients, the scrotum was explored for suspected obstruction 
but this was not confirmed; testicular biopsies were taken.
The clinical and operative findings were correlated 
with the results of seminal analysis and antibody 
estimations. The antibody results were compared with those 
found in 160 unselected spontaneously infertile males, and 
those obtained in 162 vasectomised men in an attempt to 
define criteria that would draw attention to otherwise 
unsuspected testicular obstruction.
2.5o3 Unilateral testicular obstruction: results of
treatment (Hendry, 1986)
These studies were subsequently extended to include 80 
males aged 23 to 60 years (average 33) who were referred for
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investigation of spontaneous infertility of 1 to 13 years' 
duration (average 4). No vasectomy reversal patients were 
included in this study. Nine gave a history of having 
produced children 4 to 18 years previously (average 10). 
The diagnosis of unilateral testicular obstruction was 
established in all cases by exploratory scrototomy. The 
sites of obstruction, and the causes so far as could be 
ascertained, are listed in Section 3.3.3.
In 48 patients, immediate reconstruction was done by 
epididymo-vasostomy or vaso-vasostomy. In 10 patients with 
impenetrable blocks or unilateral absence of vas, the
obstructed testis was removed at a second operation and 
replaced with a prosthesis following full discussion with 
the patient and his wife. No surgical reconstruction was 
done in 22 cases. Sixty patients have been followed for at 
least 6 months, with repeated sperm counts and measurement 
of antisperm antibodies. Amongst these, 19 patients with 
significant titres of antisperm antibodies received
prednisolone 5mg tds for 6 to 12 months and another nine
received up to 9 courses of prednisolone 20mg twice daily,
taken with meals from days 1 to 10 of the female partner's 
cycle, followed by 5mg daily on days 11 and 12.
All female partners were fully investigated by 
gynaecological colleagues to assess tubal patency and 
establish ovulation, with drug treatment if necessary.
2*5.4 Bilateral testicular obstruction - incidence of ASA 
(Hendry et al, 1983a)
In 168 azoospermic males with normal serum FSH levels, 
the site of obstruction (or exact nature of failure of 
spermatogenesis) was defined by exploration of the scrotum
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and related to known or suspected aetiological factors, and 
to the presence or absence of ASA.
These studies were subsequently extended to 370 men, 
and are described in the next section.
2.5.5 Bilateral testicular obstruction results of surgery 
and ASA (Hendry et al, 1990b)
This work formed the basis of a Hunterian Lecture at 
the Royal College of Surgeons of England. Histopathological 
features of testicular obstruction were studied in 
collaboration with Prof David Levison (now at Guy's 
Hospital, London) and Dr. M.C. Parkinson of St. Peter's 
Hospitals, London. ASA Studies were done throughout. 
Fertility after successful reconstruction in 60 men with 
obstructive azoospermia was related to presence or absence 
of ASA. No vasectomy reversal men were included in this 
section.
2.5.6 Genital tract injuries in childhood (Parkhouse & 
Hendry, 1991)
Thirty men aged 20 to 41 years presenting with
infertility were studied. All had undergone surgery or
trauma before the age of 12 years and this was demonstrated
by surgical exploration to have resulted in injury to the
vas deferens or epididymis. Twenty patients had undergone
correction of hydroceles or congenital hernias, 1 combined
with contralateral orchiopexy; 3 had had orchiopexies only
(1 unilateral and 2 bilateral), 4 had undergone rectal
surgery for imperforate anus (3) or Hirschsprung's disease
(1), 1 had undergone multiple bilateral ureteric reimplants,
1 had vasal damage due to an intra-abdominal drain following 
laparotomy in infancy, 1 had undergone cystoprostatectomy
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for rhabdomyosarcoma, and 1 had sustained a ruptured 
urethra. Results of seminal analysis and serum TAT were 
compared in those with unilateral and bilateral damage.
2.6.1 Vasectomised males before and after reversal (Royle 
et al, 1981; Parslow et al, 1983; Hendry et al, 
1983b)
These studies were done in collaboration with Mr. 
Michael Royle, Consultant Urologist in Brighton. Between 
September 1979 and December 1980, 130 vasectomised men
underwent bilateral side-to-side vasovasostomies using 6/0 
Prolene and no splints. Patients were randomised to receive 
either hydrocortisone lOOmg intramuscularly at the time of 
operation, then prednisolone lOmg twice daily by mouth for 5 
days, or no steroids. ASA were measured by GAT and TAT. 
Serum samples were taken before, 1 week and 3 months after 
operation. Seminal plasma antibodies were measured before 
and 3 months after reversal; sperm counts were checked at 3 
months, and at intervals thereafter. Since many of the 
patients lived a considerable distance from the 2 centres 
carrying out this procedure, not all follow-up specimens 
could be obtained; however, attempts were made to contact 
all patients to encourage them to send the semen samples and 
to enquire about the occurrence of pregnancy in their 
partners.
The preliminary results were reported by Royle et al 
(1981) and the final definitive analysis with at least 1 
year follow up of all possible cases by Parslow et al 
(1983).
The proportion of men with ASA in seminal plasma 
before and after vasectomy reversal was compared with an
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unselected group of 146 spontaneously infertile men and 
published briefly in Hendry et al (1983b).
2.6.2 Failed vasectomy reversal (Royle & Hendry, 1985)
In 32 patients who had vasectomy reversal which failed 
to restore their fertility, we re-explored the scrotum, 
defined the cause of the problems as far as possible, and 
carried out corrective surgery. Twenty three patients had 
no spermatozoa in the ejaculate at all, and nine had severe 
persistent oligozoospermia with sperm counts <  lOm/ml, 
generally 1 or 2m/ml. The age range of the patients was 26 
to 54 (average 39). Vasectomy had been done between 4 and 
17 years previously (average 8). One to 11 years (average 
2.5) had elapsed since the previous vasectomy reversal.
The scrotum was opened by either midline or bilateral
oblique incisions. The tunica vaginalis was opened on both
sides and the epididymes were inspected to see whether they
contained distended tubules. If no distension was seen, a
testicular biopsy was taken and nothing further was done on
that side. If, however, the epididymis showed distended
tubules, the vas was located and incised immediately on the
testicular side of the previous anastomosis. If clear or
milky fluid ran out, this was taken as evidence of
obstruction at the site of the previous anastomosis and the
anastomosis was re-done by an overlapped side-to-side
technique, using continuous 6/0 prolene. If, on the other
hand, no fluid ran out at this point, this was taken as
evidence of obstruction closer to the testicle. Patency of
the previous anastomosis was demonstrated whenever possible
by passage of a nylon splint or injection of a little saline 
through a size 2F Porges tube inserted into the vas.
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Epididymo-vasostomy was then done. The epididymis was freed 
from the body of the testicle and transected repeatedly 
until a good flow of milky fluid was obtained. End-to-side 
epididymo-vasostomy was then carried out, using a continuous 
6/0 prolene stitch. The anastomosis was done either below 
or above the previous vaso-vasostomy depending on the height 
at which the original vasectomy had been done.
2.7 AUTOIMMUNE ORCHITIS IN SUBFERTILE MALES (Hendry et al, 
1979; Hendry 1987a,b; Hendry et al, 1990b)
Testicular biopsies were taken from all azoospermic 
and most oligozoospermic males at the time of scrotal 
exploration as a matter of routine, fixed in Bouin's 
solution, stained with haematoxylin and eosin, and examined 
by Consultant Histopathologists (Dr. R.C.B. Pugh, Dr. K.M. 
Cameron, Dr. M.C. Parkinson, Dr. P. Trott, Prof. D.A.
Levison). Spermatogenesis was assessed by the score-count 
system of Johnsen (1970). Any evidence of mononuclear cell 
infiltration of seminiferous tubules was recorded
descriptively.
In 10 patients with high titres of ASA and 
uncorrectable obstruction or absence of one vas, with a 
normal testis on the opposite side, and after full
discussion with the patient and his female partner, the 
obstructed testis was removed and replaced with a
prosthesis. The removed testis and epididymis were 
subjected to detailed histopathological examination. In 
some cases, testes and epididymes were sent fresh to Prof. 
Isaacson at University College Hospital for mononuclear cell 
studies (work still in progress).
i
I
i
s
ii
91
Seven patients with azoospermia (4), severe 
oligozoospermia (less than 1 million spermatozoa per ml) (3) 
and very high serum ASA titres (>512); with no evidence of 
obstruction on scrotal exploration and evidence of 
reasonably normal spermatogenesis on testicular biopsy, were 
treated with prednisolone 5mg TDS for 6-12 months on a 
presumptive diagnosis of autoimmune orchitis, although in 
only 4 cases was there histological evidence of mononuclear 
cell infiltration of seminiferous tubules.
Sperm concentration and serum and seminal plasma ASA 
titres were followed 1-2 monthly for the duration of the 
prednisolone treatment and whenever possible for a month or 
2 after stopping treatment.
CHAPTER 3: RESULTS
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3.1 LABORATORY RESULTS
3.1.1 Continuous Appreciation of Results
Since 1975, every subfertile male seen by the author 
has had ASA checked as a matter of routine, by at least 2 
different techniques. Initially serum GAT and SIT were 
used, then TAT replaced GAT, and routine testing of seminal 
plasma became feasible; as the value of the MAR-IgG test 
became established, direct MAR-IgG supplemented by serum and 
seminal plasma TAT became the standard form of testing. By 
always using at least 2 tests, a constant check was 
maintained on reliability of the tests, and any disparity 
was immediately discussed with the laboratory concerned. 
The results that followed were worked out at intervals 
during this 15 year period and were used to guide clinical 
practice.
3.1o2 Serum GAT, SIT, IFT, PCT and clinical findings - see
2.3.2 (Hendry et al, 1977)
Incidence and Correlation between Tests
Agglutinating or immobilising antibodies were found in 
68 of 591 men (11.5%). The correlation bewteen the presence 
or absence of immobilising antibodies and the titre of 
agglutinating antibodies is shown in Table 13. 
Immobilisation was always produced by sera with positive 
agglutination titres of more than 64. Antibodies were 
detected by immunofluorescent testing in 139 of 448 patients 
(31%). Although these antibodies were found more commonly 
with increasing titre of agglutinating antibodies (Table 
14), the overall correlation was poor.
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TABLE 13
TABLE 14
GAT
T itre
N u m b er  
of Patien ts
S p e rm  Immobilisation T e s t
Negative Doubtful Positive
0 1 1
4-16 17 9 4 4
32-64 9 4 1 4
>128 41 41
Correlation between the Presence or Absence of 
Immobilising Antibodies and Titres of 
Agglutinating Antibodies.
GAT
Titre
N u m b er  
of Patients
IFT
Positive
0 1 0
4-16 17 6 (35%)
32-64 9 4 (45%)
>128 41 23 (56%)
Correlation between the Presence of 
Immunofluorescent Antibodies and Titre of 
Agglutinating Antibodies
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Analysis of 50 Patients with Agglutinating Antibodies (Titre 
*3 2 )
The 50 patients (8.5%) with agglutinating antibodies 
in a titre of 32 or more were the subject of further 
detailed analysis.
(a) Clinical
The average duration of sterility was 6.3 years (range 2-18 
years) and only 2 of 50 had ever produced a pregnancy in the
past. Twenty patients (407®) gave a past history of
genito-urinary infection (9), testicular swelling (3), 
injury (2) or ectopia (2), vasectomy (3) or haemospermia
(1). Four patients had eczema.
(b) Seminal Analysis
Twenty seven patients had sperm counts of more than 20 m/ml, 
and in 18 of these the motility was greater than 307®. 
Eleven patients had oligozoospermia and 5 of these had a
varicocele. All specimens showed agglutination of sperms 
and marked variability in the sperm counts was a noticeable 
feature. Twelve patients had azoospermia, which was 
obstructive in 7.
(c) Seminal Culture
Seventeen of 31 patients (557®) with antisperm antibodies had 
positive seminal cultures (Staphylococcus coagulase positive 
8, Escherichia coli 8, Streptococcus group A, 1), compared 
with only 5 of 32 unselected patients (157®) without 
antisperm antibodies. None of the patients with positive 
cultures had any symptoms of genito-urinary infection.
(d) Findings in their Wives
Three patients had wives with blocked tubes which were 
treated surgically. Post-coital tests were never normal.
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Of 31 couples in whom the result was known and the husband 
had sperms in the ejaculate, many "dead" sperms were seen in 
4, a few "dead" sperms in 12, and no sperms were seen at all 
in 15. Cervical ’’hostility" was observed in all 8 couples 
in whom it was sought.
3.1.3 Serum GAT, SIT, I FT and X-hostility (see 2.3.3)
(Morgan et al, 1977)
The results are summarised in Table 15. Good
correlation was found between the slide and tube methods of 
determining cervical hostility. High titres of both 
immobilising and agglutinating antibodies were present in 
all the husbands’ sera in group I, but in only 8 was
immunofluorescent testing also positive (acrosome 3, 
equatorial 2, post nuclear cap 1, tail and equatorial 2).
In 21 of the couples in group I the husbands' sperms 
were unable to invade cervical mucus, either their wives' or 
a donor’s, despite a seminal analysis which was reasonably 
adequate. The shaking phenomenon was clearly seen to trap 
the sperms in the cervical mucus when previously they had 
been swimming vigorously in the seminal plasma. In 1 case 
(a vasectomy reversal patient - see 3.4) a few sperms were 
found moving slowly in the central part of the mucus, and in 
another 2 couples the wife's mucus was of poor quality and 
resisted invasion by donor sperms. In 2 couples in group 
II, the husbands sperms did not penetrate the wife's mucus 
effectively. The results of the crossed hostility test 
indicated that in 1 couple this was due to poor sperm 
motility, and in another couple this was due to poor quality 
mucus. Similarly, in group III, poor mucus penetration was 
observed in 3 couples, and on testing it was found that this
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was due to poor sperm motility in 1 couple and poor quality 
mucus in the other 2 couples. The shaking phenomenon was 
not seen for any couple in groups II and III. Adequate 
sperm penetration was always seen when sperms were set 
against donor mucus.
H usband 's
Antibody
S ta tus
N u m b er
of
Couples
Cervical Hostility
Husband 
+ Wife
Husband 
+ D onor
D onor 
+ Wife
D onor 
+ D onor
GAT + SIT 
positive
22 21 21 2 0
IFT positive 10 2 1 1 0
Negative 12 3 1 2 0
TABLE 15 Results of Crossed Hostility Testing in 44
Infertile Couples related to Antibody Results in the 
Husbands
As a result of the poor correlation between IFT and 
the other ASA tests, and the lack of correlation with 
impaired sperm penetration of cervical mucus, IFT was 
discontinued.
3.1.4 Semen GAT and MAR (IgG) (see 2*3^4) (Hendry & 
Stedronska, 1980)
Reproducible results were found in 172 (97%) of 178 
patients who were tested more than once (Table 16)
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Result of 
Repeat 
MAR Test
RESULT OF FIRST MAR TEST
Negative Doubtful Positive
Strongly
Positive
Negative 136 13 3
Doubtful 7 1 2
Positive 1 1
Strongly
Positive 1 13
TABLE 16 Comparison between results of first and second 
MAR (IgG) test in 178 patients 
The results of the MAR tests related to the results of 
serum gelatin agglutination tests are shown in Table 17: 
there was a very good overall correlation (V> = 178; p
*0.001), taking the positive and strongly positive together 
and comparing them with the combined doubtful and negative 
results. Twenty-nine (85%) of 34 patients with antisperm 
antibodies had a positive MAR test, whilst negative results 
were obtained with 174 (9 7%) of 179 patients without
antibodies. In contrast, spontaneous sperm clumping was 
commonly observed irrespective of the serum sperm 
agglutination test results.
Serum
Antisperm
Antibody
Test
RESULT OF MAR TEST
Negative Doubtful Positive
Strongly
Positive
Negative 
(179 patients) 151 23 2
3
Positive 
(34 patients) 3 2 3 26
TABLE 17 Results of MAR (IgG) tests related to results of 
serum GAT
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The relation between the MAR test results and serum 
GAT titre is shown in Table 18.
Both patients with strongly positive MAR tests and 
serum titres of antisperm antibodies of less than 32 
impregnated their wives without further treatment. The 
other three patients with serum antibody titres below this 
level had negative or doubtful MAR tests. Twenty-seven 
(93%) of 29 patients with antisperm antibody titres of more 
than 32 had positive MAR tests. Three patients had strongly 
positive MAR tests without serum sperm agglutinins; one had 
had reversal of vasectomy, one had ulcerative colitis and 
one had dermatitis herpetiformis. Four patients with 
positive serum antisperm antibody tests had negative MAR 
tests; good sperm penetration of cervical mucus was noted in 
three cases on sperm-cervical mucus contact testing. The 
other patient had a history of dysuria followed by the 
development of angulation of the penis, resembling that seen 
in Peyronie's disease. Two additional patients had
transiently negative MAR tests following high dose 
prednisolone treatment, which subsequently reverted to 
positive.
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Serum
Spermagglutination
Titre
RESULT OF MAR TEST
Negative Doubtful Positive
Strongly
Positive
Negative I 2 3
1/4 1 1*
1/8 1
1/16 1 1*
1/32 3
1/64 1 3
1/128 7
1/256 1 9
1/512 1 3
>  1/1028 1
TABLE 18 Results of MAR (IgG) test related to serum GAT 
in 37 patients with positive results in one or 
other test. ** Produced pregnancy without treatment.
3,1.5 Serum TAT and MAR (IgG) (see 2,3,5) (Stedronska & 
Hendry, 1985)
The overall results are shown in Table 19. The test 
was not possible in 69 patients (9.5%) due to low motility 
(14 cases), low count (25 cases), or azoospermia (30 cases).
In 484 patients with sperm counts that would have been 
passed as normal by our usual criteria (greater than 20 
million spermatozoa per millilitre, with 407, motility within 
3 hours of production), the presence of IgG antisperm 
antibodies was detected by MAR testing in 48 (10%),
Likewise, such antibodies were detected in 18 (23%) of 78
patients with low sperm motility (less than 407,) and 19 
(157>) of 128 with low sperm counts (less than 20 million per 
millilitre). Overall, IgG antisperm antibodies were 
detected in 85 (127o) and excluded in 566 (78.57,) of the 720 
male partners of these infertile marriageso
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Average sperm 
count
Number 
of patients
MAR (IgG) Test
Positive Negative Not possible
Normal 484 48
(10%)
436
Low motility 
(< 40%)
78 18
(23%)
46 14
(18%)
Low count 
(< 20 m/ml)
128 19
(15%)
84 25
(19.5%)
Azoospermia 30 - - 30
Total 720 85
(12%)
566
(78.5%)
69
(9.5%)
TABLE 19 MAR (IgG) test on 1279 Semen Samples in 720 Male
Partners of Infertile Marriages (1980 to 1981)
The results of the serum TAT in 85 men with positive 
or doubtful MAR test results are shown in Table 20. In all 
cases with serum TAT titres of 32 or more, the MAR test was 
positive or strongly positive ; all doubtful results were 
obtained with TAT titres of 16 or less and, hence were of 
doubtful clinical significance.
Serum 
TAT titre
MAR (IgG) TEST
Negative Doubtful Positive
Strongly
positive
Not done 2 5 2
Negative 2 6
4 1 1
8 1 3 3
16 2 4 5
32 4
64 1 13
128 1 13
256 8
512 1 4
>  1024 3
Total 8 22 55.
TABLE 20 Serum TAT titres in 85 Men with Positive MAR 
(IgG) tests (1980 to 1981)
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The overall correlation between serum TAT and MAR test 
results is shown in Table 21. Negative serum TAT was found 
in 94 patients with negative or doubtful MAR tests. 
Statistical analysis (Table 22) confirmed a highly 
significant correlation between serum antisperm antibodies 
(TAT) result and MAR test (taking negative/doubtful together 
and comparing with positive/strongly positive: X2 = 127; p 
<0 .001).
MAR (IgG) TEST
Serum Not Strongly
TAT titre possible Negative Doubtful Positive positive
Not done 34 448 27 5 2
Negative 28 86 8 7
4 1 1 1
8 1 1 3 3
16 2 2 4 5
32 2 4
64 1 1 13
128 1 13
256 8
512 1 4
>  1024 3
Total 69 534 39 23 55
TABLE 21 Serum TAT Titres in 720 men who had routine MAR 
(IgG) tests (1980 to 1981)
Serum
TAT
MAR (IgG) TEST
Negative/
Doubtful
Positive/
Strongly
positive
Negative 94 7
Positive 4 64
TABLE 22 Serum TAT and MAR (IgG) Results (1980 to 1981)
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As a result of these studies, MAR (IgG) testing was 
done as a routine therafter on all semen samples from male 
partners of infertile marriages referred to the author.
3d.6 Serum and seminal plasma TAT, MAR (IgG & IGA (see 
2.3.6) (Hendry et al, 1982a)
The MAR (IgA) test was applicable to all except one of the 
semen samples suitable for IgG testing, although the 
reaction with IgA was slower and less easy to read than the 
IgG reaction; furthermore, the spermatozoa tended to lose 
motility about 10 minutes after addition of the anti-IgA, 
and so the reading had to be completed by this time. In the 
one exceptional case, the spermatozoa were caught in large 
clumps, and a satisfactory conclusion could not be reached 
in the IgA test. The results of the MAR (IgA) test appeared 
to be reasonably consistent (Table 23).
FIRST
m a r  IgA
TEST
REPEAT
TE
o/±
MAR IgA
1ST
++/+++
0/± 17 2
++/+++ 2 *3
TABLE 23 Correlation between results of first and second 
MAR (IgA) test in 34 subfertile men
In 34 patients who had two or more tests, the first 
and second results were comparable in 30 instances (taking
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negative and doubtful together and comparing them with
o
positive and strongly positive, we found \  = 22.61, p
<0.001). The MAR (IgA) test were negative or doubtful in 42 
(44%) of 94 samples with positive or strongly positive MAR 
tests for IgG (Table 24).
MAR (IgG) MAR (IgA)
0/± ++/+++
0/± 8 2
+ +/+ + + 42 52
TABLE 24 Correlation between results of MAR tests for IgG 
and IgA in 104 samples from subfertile men
The results of the MAR (IgA) tests are shown 
correlated with the presence of seminal plasma antibodies, 
defined by TAT in Table 25a and by GAT in Table 25b.
SEMINAL PLASMA MAR IgA TEST
TAT 0 It ++/+++
N e g a t iv e 20 3
P o s i t iv e 8 18
( t i t r e  >4)
TABLE 25a Results of MAR (IgA) tests related to seminal 
plasma TAT of 49 patients
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SEMINAL PLASMA
G A T
m a r  lg
0/ +
A TEST 
++/+++
Negative 18 8
Positive 
( t i t re  >4)
9 16
TABLE 25b Results of MAR (IgA) tests related to seminal 
plasma GAT in 51 patients
There was a good correlation with the results of both tests, 
which was more significant with TAT (X^ = 15.732, P <0.001) 
than with GAT (X^ = 5.649, 0.02>P 0.01). This was largely 
due to the increase in the number of patients with positive 
MAR (IgA) tests who were found to have seminal plasma 
antibodies with the more sensitive TAT test.
The 20 patients who had sperm-cervical mucus 
penetration tests done are summarized in Tables 26a,b. It 
may be seen that good penetration of cervical mucus was only 
seen in the absence of antisperm antibodies from the seminal 
plasma and with a negative or dubious MAR (IgA) test. In 
contrast, good and poor penetration of mucus was seen with 
positive serum antibody tests and with positive MAR (IgG) 
tests. However, in three cases with dubious MAR (IgA) 
tests, penetration of cervical mucus was poor, and two of 
these patients had antisperm antibodies in seminal plasma. 
Overall, there was evidently a strong association between 
the results of the MAR (IgA) test and the ability of 
spermatozoa to penetrate cercical mucus. The probability of 
results shown in Table 26b having been obtained by chance is
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calculated to be 1 in 277 by Fisher’s exact method for 2 x 2  
tables. On the other hand, there is evidently no 
correlation between the results of MAR (IgG) test and 
cervical mucus penetration.
S P E R M / C E R V I C A L NUMBER SERUM MAR T e s t
MUCUS P E N E T R A T I O N * OF A N T I B O D Y  T I T R E S l y u
H u s b a n d D o n o r P A T I E N T S CAT S IT T A T o / ± ++ / +++
1- 2 + 15 32 -  512 0 -  128 16 -  20*48 15
2 ± 2 + 5 16 -  128 0 - 8 8 -  128 5
TABLE 26a Results of SCMC tests comparing husbands' and 
fertile, donors' spermatozoa, related to 
antisperm antibodies in serum and results of 
the MAR (IgG) test
S P E R M / C E F  
MUCUS PEr 
H u s b a n d
tVICA L
^ E T R A T I O N *
D o n o r
NUMBER
OF
P A T I E N T S
SEMINAL
A N T I B O D I E S  
C A T  P o s i t i v e
PLASMA
(+ T I T R E S )  
T A T  P o s i t i v e
MAR
Ic
0 1 ±
T e s t
3a
++ / +++
1- 2+ 15 6 / 1 2  ( 4 - 1 6 )  
2 / 3  ( 8 - 1 6 )
9 / 1 0  ( 4 - 2 5 6 )  
2 / 3  ( 8 - 6 4 ) 3
12
2 ± 2 + 5 0 / 4 0 / 5 5
TABLE 26b Results of SCMC tests comparing husbands' and 
fertile donors' spermatozoa related to
antisperm antibodies in seminal plasma and 
results of the MAR (IgA) test
Unfortunately, the special serum (Avgh) containing
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anti-D that was both IgA and IgG was in short supply, and 
this test was ultimately discontinued.
3olo7 IBT (IgG and IgA) and MAR (IgG) (see 2,3.7) Rajah et 
al, 1992
Both MAR and IBT tests were possible in 103 of 109
patients; in the remainder azoospermia, severe 
oligozoospermia or asthenozoospermia prevented completion of 
the test. There was a highly significant correlation
between MAR (IgG) and IBT(IgG) (Table 27) (K.2 = 74.7; p
*0.001). There was also a highly significant correlation 
between serum TAT and IBT (IgG) (X? = 17,6; p <0.001).
However, there were 5 men who had positive serum tests for 
ASA (mostly producing head-to-head agglutination) which were 
not associated with detectable surface bound antibody on 
their spermatozoa as shown by either MAR or IBT.
MAR
(IgG)
IBT (IgG)
Negative Positive
Negative . 73 2 75
Positive 4 24 28
77 26 103
TABLE 27 Correlation between MAR (IgG) and IBT (IgG)
There was highly significant correlation between IBT (IgA)
and seminal plasma TAT (X = 7.8; p<0.01) although there
were 5 men who had positive IBT and negative TAT (Table 28).
The correlation between IBT (IgG) and seminal plasma TAT was
less good although it still reached statistical significance
%
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o
(Y. = 4.2; p<0.05). There was no significant correlation
between MAR (IgG) and seminal plasma TAT = 2.9; p 0.05).
The MAR test took 3 minutes to do, compared to the IBT 
which took 30 minutes on average. Reagents for MAR (IgG) 
cost approximately one-third of the cost of reagents for IBT 
(IgG and IgA).
Seminal
Plasma
TAT
IBT (IgA)
Negative Positive
Negative 7 5 12
Positive 1 13 14
8 18 26
TABLE 28 Correlation between seminal plasma TAT and IBT 
(IgA)
3.1.8 Serum TAT and ELISA (see 2.3.8) (Stedronska-CIarke et 
al, 1987)
The optical density reading generated by the company 
positive control serum ranged from 0.90 to 0.98 OD with a 
negative control background of 0.04 to 0.10. Our patient 
sera known to be positive by TAT testing gave low-level 
reactivity (0.1-0.14) with positive (above background) 
readings usually requiring a 1/16 concentration. The titre 
given by ELISA was lower than that given by TAT even when 
the same criteria were used to define the end-point. These 
data are summarized in Table 29. We found that a number of 
TAT-negative control sera that had been provided by healthy 
men of normal fertility and seminal analysis nevertheless
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gave a positive result in the ELISA. These data are 
summarized in Table 30. If one assumes that TAT to be the 
"gold standard” for detection of antisperm antibodies, then 
the ELISA used in this study gave a false-negative detection 
rate of 5/8 (637o) and a false-positive rate of 3/4 (75%).
S eru m TAT ELISA
1 32 16
2 64 32
3 512 0,16
4 2048 16,32
5 2048 16,128
TABLE 29 Comparison of ASA titre by ELISA and TAT methods
EL SA
TAT Positive Negative
Positive 3 5
Negative 3 1
Table 30 Positive and Negative Test Results: TAT vs ELISA
As a result of this small study, no futher use was 
made of ELISA testing, and TAT continued to be our "gold 
standard”.
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3.2 MEDICAL TREATMENT
3.2.1 Comparison of effectiveness and side effects
The results described below were obtained in 
sequential studies done over 12 years. Long term low dose 
prednisolone (5mg TDS for 6-12 months) produced few side 
effects apart from some weight gain and a tendency to moon 
face. Although semen quality often improved strikingly, few 
pregnancies resulted. The intermittent high dose regimen 
described by Shulman (1976) appeared to offer better 
results, and indeed some spectacular successes were 
obtained; unfortunately one patient then developed aseptic 
necrosis of the hips and this treatment was abandoned. The 
moderate dose intermittent regimen was developed and 
introduced at Barts, in collaboration with Prof. Michael 
Besser. Side effects were few and transient, and results 
were as good as those obtained with Shulman1 s regime. It 
was therefore submitted to double blind prospective 
controlled trial comparing its effectiveness with placebo.
3.2.2 Continuous low-dose prednisolone (see 2.4.2) (Hendry 
et al, 1979
Group 1 (Patients with oligozoospermia) - Average
sperm-counts and antisperm antibody titres before treatment 
are shown in table 31(a), and these may be compared with the 
results during long-term prednisolone treatment (table 
31(b). Sperm counts rose to consistently normal levels in 
10 (67%) of the 15 patients, and serum antisperm antibody
levels declined, but never fell to less than 32. Two of the 
wives became pregnant (antibody titres 1024 and 128)
and 2 further wives became pregnant with AIH and sperm 
washing. In 1 patient with high titres of antibodies
Ill
(1024), the sperm count, which was less than 1 million per ml 
before treatment, rose to near normal levels on long term 
prednisolone, and then declined to less than 1 million per 
ml again when prednisolone was stopped (fig. 11).
GAT
T itre
Average Initial S perm  C ounts  (millions/ml)
<5 6-10 11-20 >20
32 1
64 1
*128 (3) (1) 2(1)
256 1
512 1
>1024 3
Total 8 2 5
TABLE 31(a) Average sperm counts and GAT titres in 15
oligozoospermic men before treatment with prednisolone 
(figures in brackets not assayed >128 ).
GAT
Titre
Average Sperm  C ounts  on T r e a tm e n t  
(millions/ml)
<5 6-10 11-20 >20
32 1 2
64 2
*128 (1) (2) 1 2(1)
256 1
512 1
>1024 1
Total 2 2 1 10
TABLE 31(b) Average sperm counts and GAT tites in 15
oligozoospermic men during treatment (Figures in brackets 
not assayed >128).
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Group 2 (Patients with normal sperm counts) - Sperm counts 
were well maintained in this group, and pronounced variation 
in seminal analysis in 6 cases became consistently normal. 
Antisperm antibody titres declined slightly but never 
dropped below 32. Two pregnancies were produced (antibody 
titres both 1 in 64); one further pregnancy occurred after 
AIH with sperm washing.
Histological examination of the 3 testicular biopsy 
specimens showed that spermatogenesis was proceeding 
satisfactorily in most of the tubules, although local areas 
of atrophy were also present (mean scores 6.7 to 8.4} out of 
10). However, in 1 case there were localised lymphocytic 
and plasma-cell infiltrates adjacent to and extending into 
seminiferous tubules, which showed pronounced reduction of 
spermatogenesis; this patient had a very high GAT titre of 
1024 (for details see section 3.5).
3.2.3 Cyclical high-dose methylprednisolone (MP) (see 
2.4.3) (Hendry et al, 1981)
Twenty-eight patients completed three or more courses 
of MP, 11 received two courses, and 6 had only one course. 
Fourteen wives (317.) became pregnant in the cycle following 
treatment of the husband: 2 after one course, 6 after the
second course, and 6 after the third or subsequent courses. 
Eleven pregnancies occurred after treatment was given from 
days 21 to 28, and 3 after treatment was given to 10 men 
from days 1 to 7 or later. One miscarriage occurred.
Sperm counts following treatment are shown in Table 
32; counts of 20 million per millilitre or above were 
obtained by 39 (877.) of the 45 men, compared with 29 (647.) 
before treatment.
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A V ER A GE  SPERM C O U N T S  
( mi l l io n s  p e r  ml)
0 - 1 0 11 -  20 21 -  40 >41 U n k n o w n
B e f o r e  t r e a t m e n t 14 4 4 25
A f t e r  t r e a t m e n t 5 9 30 1
TABLE 32 Distribution of average sperm counts of 45 
patients before and after treatment with 
Methylprednisolone
The GAT results before and after treatment are shown 
in Fig.. 12:th?re is no evidence that the titres fell more 
profoundly in men whose wives became pregnant, compared with 
those who did not. The SIT titres in 33 men tested in one 
laboratory (CHW) before and after treatment are shown in 
Fig. 13; production of pregnancy appeared to be associated 
with a fall in sperm immobilization titres to zero or near 
zero; however, a similar fall was obtained in many men whose 
wives did not become pregnant. Seminal plasma antibody 
testing was introduced in the latter part of this study, and 
it is difficult to draw firm conclusions as yet; however, 
serial testing showed that the steroid treatment caused the 
antisperm antibodies to disappear from seminal plasma in six 
patients, two of whose wives became pregnant (Table 33).
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S e m i n a l  p l a s m a  a n t i b o d i e s  p r e s e n t  ( G A T  )
B e f o r e  t r e a t m e n t A f t e r  t r e a t m e n t
Wife p r e g n a n t 4 / 7 2 / 7
Wife n o t  p r e g n a n t 16 / 24 12 /  25
TABLE 33 Relationship between presence or absence of 
seminal plasma antibodies (by GAT) before and 
after treatment, and occurrence of pregnancy in 
the spouse.
An example ot serial sperm counts, MAR test results, 
and antibody levels in serum and seminal plasma is shown in 
Table 34 in one patient who received MP from days 1 to 7 in 
three successive cycles. The rise in sperm counts and fall 
in serum GAT and SIT titres that accompanied MP therapy can 
be observed; the MAR test for IgA became negative as the 
seminal plasma antibodies disappeared; however, the MAR test 
for IgG stayed positive.
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ANTISPERM ANTIBODIES
SEMINAL
SPERM COUNT MAR TEST SERUM PLASMA
TREATMENT DATE m /m l % motility IgG IgA GAT SIT GAT SIT
3 0 /1 0 /7 9 4 25 ♦  ♦ ♦
2 9 /1 1 /7 9 11 25
8 /1 /8 0 3 50 ♦  ♦ ♦ 128 8 16 —
M.P. ♦ (? )
1 4 /3 /8 0 54 40 ♦  ♦ ♦ ♦ 256 8 8 —
M .P. ®
1 0 /4 /8 0 66 40 - 32 1 —
M .P. ®
2 0 /5 /8 0 145 40 • 16
TABLE 34 Serial counts, MAR test and ASA titres following 
three courses of MP given in successive months 
from day 1 to day 7 of the wife's menstrual cycle.
Table 35 shows serial sperm counts and MAR test (IgG) 
results for a period of 3 weeks before and after the third 
course of MP in a man whose initial serum GAT titre was 256 
and had fallen to 16 prior to this treatment. The MAR test 
became negative on the third post treatment day at which 
time good sperm penetration of donor cervical mucus was 
observed.
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TIME IN RELATION SPERM COUNT MAR
TO 7 - DAY COURSE (IgG)
OF M.P.* m /m l % Motility
Before 16 40 + ++
A fter :
Day 1 171 50 ♦
3 43 50 -
7 33 50 ♦
9 24 40 ♦
15 36 50 ■f
20 65 50 +
TABLE 35 Serial sperm counts and MAR (IgG) test results for 
a period of 3 weeks before and after a 7 day course of MP.
Altogether 54 patients were treated with MP (including 
9 patients described previously who had one course of MP 
that was not synchronized with the wife’s cycle (Hendry et 
al, 1979)). Three (6%) experienced such severe side effects 
that treatment was discontinued; one had marked dyspepsia,
and treatment was suspended until he had had a course of
cimetidine; he subsequently tolerated two further courses of 
MP, taking one tablet of cimetidine 1 hour before each dose 
of MP. One patient had a small hematemesis, and no further 
treatment was given. One patient developed transient pain 
in the hips lasting for a few days and refused further 
treatment. In addition, 14 (26%) other patients experienced 
less severe side effects: transient pain in the hips (3),
dyspepsia (1), headaches (1), flashing lights (2), tinitus 
(1), aggressive behaviour usually directed against the wife 
(3), or marked blotchy face and acne (3). In general, men
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who were fit and worked in physically demanding occupations 
suffered fewer side effects and responded less well than men 
who were unfit and had sedentary occupations.
One year after treatment one patient developed 
bilateral aseptic necrosis of the hips. This treatment was 
therefore abandoned, and this complication was documented in 
the world literature (Hendry, 1982).
3.2.4 Cyclical moderate dose prednisolone (see 2.4.4) 
(Hendry et al, 1986)
Of the 76 men treated, 25 (3 3%) reported that their 
partners became pregnant during a treatment cycle. A 
life-table analysis of monthly conceptions is shown in Table 
36; it takes into account 20 patients who left the study 
before completion of nine courses of treatment and 2 men who 
had not completed treatment at the time of analysis. The 
cumulative pregnancy rate is compared with that of the 
normal population and that of a group of unselected 
subfertile men in Figure 14. There is a linear relationship 
between cycles of therapy and cumulative pregnancy rate. 
One woman became pregnant at 12 months, but no further 
pregnancies were recorded after additional treatment 
therafter.
We compared the successful group and the remainder. 
The age ranges of the two groups were similar. There was a 
preponderance of successful patients among those who had 
been trying to produce a pregnancy for less than 2 years 
(fig. 15). Serum and seminal plasma TAT titres before and 
after treatment are shown in Figures 16,17, respectively; 
there were no significant differences between successful and 
unsuccessful patients in either absolute levels or change in
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antibody titres. The results of seminal analysis before and 
after treatment were available for 50 men: there were no
N um ber 
of Cycles
N u m ber 
of P atien ts
N um ber of 
Pregnancies
Lost to  
Follow up
Pregnancy
Rate/M onth
C um ulative 
Probability 
o f Pregnancy
1 76 4 0.054 0.054
2 72 4 0.057 0.108
3 68 5 3 0.078 0.178
4 60 2 3 0.034 0.206
5 55 0 1 0.206
6 54 4 9 0.084 0.273
7 41 2 2 0.051 0.310
8 37 1 4 0.029 0.330
9 32 2 0.065 0.374
TABLE 36 Cumulative pregnancy rate
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significant differences in sperm counts or motility before
treatment or in sperm counts after treatment. However,
sperm motility after treatment was significantly better in
the successful group, compared with the unsuccessful group ( 
2
X = 7.9; P < 0.02). Abnormalities of ovulation required 
treatment in 11 (44%) of 25 women who eventually conceived, 
compared with 18 (357®) of 51 who did not.
No major complications occurred with this regimen. 
However, 40 patients (53%) reported transient side effects, 
including folliculitis (18), weight gain (10), headache 
(10), sweats or flushes (8), dyspepsia (7), musculoskeletal 
pain (7), and/or mood changes (10). There was no difference 
in the incidence of side effects between successfully and 
unsuccessfully treated patients.
Since this regimen appeared to be equally as effective 
as the high dose MP regimen (3.2.3) but better tolerated and 
free of major complications, it was submitted to double 
blind prospective controlled trial against placebo.
3.2.5 Controlled clinical trial of cyclical moderate dose 
prednisolone versus placebo (see 2.4.5) (Hendry et 
al, 1990a)
Twenty seven patients completed the full 18 months of 
treatment or the partner conceived and treatment was 
stopped. Six completed only 9 months of treatment and then 
declined to continue (4 prednisolone, 2 placebo). Four had 
to stop treatment owing to the severity of side-effects (1 
prednisolone, 3 placebo), and 6 dropped out of the trial 
after taking fewer than nine courses of treatment (3 
prednisolone, 3 placebo).
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Nine pregnancies occurred during prednisolone 
treatment (1 on the higher dose), 1 during placebo 
treatment, and 1 was produced by a man allocated placebo but 
who had not started treatment. Analysis of results by 
treatment allocated with no exclusions gave significantly 
better results with prednisolone (pregnancies 9 of 33 
allocated prednisolone versus 2 of 27 allocated placebo; p 
<0.05, Fisher's exact test). Analysis by treatment received 
also showed a significant benefit from prednisolone 
(pregnancies in 9 of 29 who received prednisolone versus 1 
of 20 who received placebo; p< 0.05, Fisher's exact test). 
The results are plotted against time in Fig. 18. Three 
pregnancies occurred among 16 couples who had tried for less 
than 3 years, and 8 among the 27 who had tried for 3 or more 
years.
There was no significant effects of prednisolone or 
placebo on seminal analysis (see table 37). There was no 
consistent change in levels of antibody to sperm in serum on 
placebo or prednisolone. In contrast, there was a 
significant fall in antibody levels in seminal plasma after 
prednisolone treatment ( p<0.05, Wilcoxon's signed rank sum 
test), though not after placebo (Fig. 19). In most of the 
men who produced pregnancies seminal plasma antibody 
disappeared.
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Seminal SPERM COUIM1’ (m/ml) MOTILITY (%)
analysis 0 - 1 0 1 1 -2 0 20+ < 1 0 2 0 -3 0 40+
Before 7 9 26 7 15 19
Placebo 1 11 11 5 6 11
Prednisolone 2 9 17 2 9 17
TABLE 37 Distribution of seminal analyses before and after 
prednisolone and placebo treatment
Mild side-effects, including acne, weight gain, dyspepsia, 
and irritability, were experienced by 18 (607o) of 30
patients taking prednisolone and by 3 (19%) of 26 taking
placebo.
Serious side-effects necessitating withdrawal from the 
trial occurred in 3 patients taking placebo; there was 1 
case each of tachycardia with hypertension, irritability, 
and indigestion, and diminished libido with impotence. Only 
1 patient taking prednisolone had side-effects necessitating 
withdrawal-glaucoma with migraine and irritability. In 
general, however, the treatment was well tolerated; 
irritability caused the most trouble, leading to strain in 
the marital relationship in some couples.
3.3 SURGICAL TREATMENT OF INFERTILE MALES 
3.3ol Morbidity and complications
Virtually all the patients described in this section
were operated on by the author and followed up personally as
far as possible. With modern anaesthetic techniques post 
operative discomfort is minimised and most go home the same
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day. Complications were rare, largely due to obsessional 
care about haemostasis within the scrotum. Wound healing 
was usually completed within 7 days, and the use of 
subcutaneous closure of the dartos layer and subcuticular 
skin closure with Vicryl meant that there were no stitches 
to be removed. Wound infection was exceptionally rare.
3.3.2 Unilateral testicular obstruction - diagnosis (see 
2.3.2) (Hendry et al, 1982a)
The details of the sites of obstruction, sperm counts, 
antisperm antibody results and treatments for the 32 
patients are given in Table 38.
Clinical findings
The past medical history gave useful and relevant 
information in 27 cases (8470), but the findings at operation 
were not always as expected from the history. In 7 patients 
who had had a hernia repair, the obstruction was found in 
the groin in 5, where the vas was caught in fibrosis or had 
been divided; however, in one case epididymal obstruction 
was found and the vas was patent, while in another case 
there was no evidence of obstruction on exploration. In 
another example of post-operative occlusion, the vas had 
been divided just inside the internal inguinal ring at 
laparotomy in childhood. Four patients had had large parts 
of their epididymes excised during previous removal of 
epididymal cysts. Four others had suffered severe injuries 
- one in a fall-astride rupture of urethra, one having stood 
on a mine, both being complicated by recurrent urinary 
infections; the third patient had damaged one testicle in a 
building site injury, and the fourth during army exercises. 
Six patients admitted to previous venereal disease, 2 with
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epididymitis. One had had a strange tropical infection, 
possibly sand-fly fever. Three had had epididymovasostomies 
in the past.
In 3 cases with no relevant past history, useful 
observations were made on clinical examination. Unilateral 
absence of the vas was found in 2 cases. The tail of the 
epididymis in one man was so distended that he had noticed 
it himself and pointed it out. Similar distension was noted 
in several other patients. Unilateral obstruction was an 
unsuspected finding at scrotal exploration, done at the time 
of testicular biopsy, in 2 cases with inexplicably low sperm 
counts.
Seminal analysis
The average pre-treatment sperm counts were more than 
20 million per ml in 15, between 10 and 20 million per ml in 
2, and less than 10 million per ml in 15 cases. Significant 
abnormalities were present in the contralateral, 
non-obstructed testes in 5 of the patients with counts of 
less than 10 million per ml - 3 had had orchiopexies and 2 
had large varicoceles; correction of the obstruction 
produced normal sperm counts and pregnancies in the wives of 
3 of these men. In 7 of these severely oligozoospermic 
cases the cause of the low sperm count was unclear since 
spermatogenesis in the unobstructed testis was normal.
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PATIENTS SITE OF OBSTRUCTION SPERM
COUNT
M/ML
ANTISPERM ANTIBODIES 
TAT MODE OF 
TITRE AGGLUTINATION
1 Hernia repair 38 128 HH
2 Epididymis-tail 1 128 HH
3 Previous ep-vas 8 128 HH
4 Epididymis & vas 4 64 HH
5* Epididymis-tail 3 16 HH
6* Epididymis-tail 4 16 HH
7* Epispadias repair 97 16 HH
8 Epidiymis-tail 18 2048 HH/TT
9 Absent vas 38 512 HH/TT
10 Hernia repair 46 512 HH/TT
11 Epididymis-tail 30 512 HH/TT
12 Epididymis-tail 47 512 HH/TT
13 Previous ep-vas 2 265 HH/TT
14 Ruptured urethra 28 128 HH/TT
15 Ejaculatory duct <1 64 HH/TT
16 Epididymis-tail 1 64 HH/TT
17 Previous ep-vas 89 64 HH/TT
18 Previous ep-cyst 22 64 HH/TT
19 Ejaculatory duct 23 64 HH/TT
20 Hernia repair 105 32 HH/TT
21 Hernia repair 15 8 HH/TT
22* Previous laparotomy 4 512 TT
23 Hernia repair 1 64 TT
24 Absent vas 35 64 TT
25 Previous ep-cyst 29 32 TT
26 Previous ep-cyst 44 16 TT
27 Epididymis-tail 29 0 —
28 Epididymis-tail 2 0 —
29* Epididymis-tail <1 0 —
30* Epididymis-tail 2 0 —
31 Epididymis-head 0.8 0 —
32 Previous ep-cyst 1.5 0 —
* Wives became pregnant
TABLE 38 Details of 32 patients with unilateral testicular 
obstruction
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Antisperm antibodies
Twenty six (81%) of the 32 patients had antisperm 
antibodies detectable in serum - the titres are shown in 
Table 38. Twenty-one (81%) of the 26 men with antibodies 
showed evidence of HH agglutination in pure or mixed form. 
This incidence in unilaterally obstructed males is 
significantly higher than that found in 162 bilaterally 
obstructed (vasectomised) males (X = 6.16; P<0.02) and both 
groups showed evidence of HH agglutination highly 
significantly more often than did the 160 naturally 
subfertile males ( P<0.001, see Table 39).
G roup N u m ber
of
Patien ts
S erum  TAT: N u m b er 
(and p er cen t) w ith 
HH o r Mixed A gglutination
Unilaterally 
obstructed  males
26 21 (81%)
Bilaterally obstructed 
(vasectomised) males
162 89 (55%)
Spontaneously 
Infertile males
160 38 (24%)
TABLE 39 Differing incidence of HH or mixed agglutination 
in subfertile males according to presence or absence of 
testicular obstruction
In retrospective analysis of the 160 unselected 
naturally infertile males (Table 40) definite evidence of 
obstruction (surgically proven, unilateral or bilateral) was
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found highly significantly more often in men with evidence 
of HH agglutination in pure or mixed form (37%.) than in 
those with TT agglutination (10%) = 1 5 . 5 3 ;  P< 0 . 0 0 1 ) .
When all cases with a past history of hernia repair, 
testicular operation or injury, epididymo-orchitis or other 
significant infection, or with epididymal cysts on 
examination - any of whom might have had obstruction - are 
included, the incidence of definite or possible obstruction 
is still significantly higher in those with HH or mixed 
agglutination (50%) than in those with TT agglutination 
(327.) (X2 = 4 . 0 7 7 ;  P«0.05).
Four patients with pure HH agglutination on TAT had 
evidence of other autoimmune diseases with antibodies that 
may have been cross-reacting with the spermatozoa. One had 
diabetes with islet cell antibodies, one had thyrotoxicosis 
with thyroid microsomal and thyroglobulin antibodies, and 
one had an unusual painless parotid swelling with gastric 
parietal cell antibodies. The other patient, with thyroid 
microsomal antibodies, underwent scrotal exploration - there 
was no evidence of obstruction, but testicular biopsy showed 
focal round cell infiltration of seminiferous tubules.
Overall, it appeared that a cause for the antisperm 
antibodies could be defined in 47%> of the 38 patients with 
HH agglutination, whereas the cause remained obscure in 90% 
of those with TT agglutination. In 160 naturally infertile 
males with antisperm antibodies, unilateral testicular 
obstruction was demonstrated surgically in 12 cases ( 7 .5%) ,  
but could have been present in a further 32 (207>).
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Mode of 
A gglutination
Definite T esticu lar 
O bstruc tion
Possible T esticu lar O bstruc tion
Epididymal
Cyst
Previous
B ilateral U nilateral H ern ia
R epair
Epididymo
O rchitis
Injury,
O peration ,
Infection
HH/mixed 7 7 1 2 2
(38 cases) (3'7%)
TT/TT-TT 7 5 2 6 10 9
(122 cases) (10%)
1
TABLE 40 Incidence of definite and possible testicular 
obstruction in 160 spontaneously subfertile males 
with ASA related to mode of agglutination in TAT
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3,3.3 Unilateral testicular obstruction - results of 
treatment (see 2,5.3) (Hendry, 1986)
The commonest site for unilateral obstruction was the 
tail of the epididymis, which usually followed previous 
genital or urinary infection. The findings at scrotal 
exploration were clear cut and easy to recognise (Fig. 20). 
The next most common group was vasal blocks usually due to 
previous groin surgery, but sometimes post infective (Fig. 
21). The sites of obstruction and probable causes so far as 
could be ascertained are shown in Table 41.
Post-
infective
Surgery/
injury Congenital
Cause
unknown
Upper
epididymis 5 6
Tail of 
epididymis 25 6 9
Vas deferens 8 12 4
Ejaculatory
duct 1 2 1 1
Total 34 25 5 16
TABLE 41 Sites and probable causes of unilateral 
obstruction in 80 subfertile males 
The surgical methods of reconstruction used are listed 
in Table 42. In 10 patients with irreparable blocks the 
obstructed testis was removed and replaced with a 
prosthesis, after full discussion with the patient and his 
female partner.
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Site
Surgical treatm ent
Ep-vas Vas-vas Orchidectom y None
Upper
epididymis 5 6
Tail of 
epididymis 34 1 5
Vas
diferens 9 9 6
Ejaculatory
duct 5
Total 39 9 10 22
TABLE 42 Surgical treatment in 80 subfertile males with 
unilateral testicular obstruction
Seminal analysis, serum FSH and testicular biopsies
The average pre-treatment sperm counts are shown in 
Table 43. Forty patients (507o) presented with severe 
oligozoospermia (<5 million/ml) and in 22 ( 2 7 . 5%) the initial 
sperm count was less than 1 million/ml. The serum FSH 
levels were normal in all except one of these patients and 
testicular biopsies showed adequate spermatogenesis (Johnsen 
score-count 8.0 or more) in the obstructed testis in all 
patients except for the one with the elevated serum FSH, 
whose score-count was only 5 . 9 .  Biopsy of the contralateral 
testis was done in only two cases and both were normal at 
9 .1 and 9 . 2 .
Moderate oligozoospermia was seen in 19 patients and 
testicular biopsies showed adequate spermatogenesis in all 
except two, who had Johnsen counts of 7.8 and 5.9. Normal 
sperm counts of 20 million/ml or more were recorded in only 
21 patients, all of whom had normal testicular biopsies.
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Serum
TAT N
Initial sperm count M/ml
< 5 6 - 2 0 > 2 0
0 19 13 5 1
4 3 1 1 1
8
16 8 5 1 2
32 12 5 3 4
64 11 6 1 4
128 6 3 2 1
256 4 1 2 1
512 6 3 3
< 1024 11 3 4 4
Total 80 40 19 21
TABLE 43 Distribution of average initial sperm counts 
(million/ml) related to serum ASA titres
Antisperm antibodies
The serum TAT results are also shown in Table 43. It 
may be seen that there is no correlation between antisperm 
antibody titres and average initial sperm counts. 
Altogether, 61 patients (76%) had antisperm antibodies, 
amongst whom 17 (21%) had very high titres of 512 or more. 
The mode of agglutination was recorded in 54 patients, 
amongst whom head-to-head (H-H) agglutination was observed 
in pure or mixed form in 36 (66%). The relationship between 
serum and seminal plasma antibody titres is shown in Fig. 
22: 22 of 34 patients studied (65%) had antibodies in
seminal plasma, often in very high titres.
Response to treatment
Analysis of the pregnancies produced by the 60 
patients with adequate follow-up is shown in Tables 44 
a,b,c. Table 44a shows that the highest success rate was 
observed amongst those starting with the lowest sperm count:
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12 of 30 (407o) with initial sperm counts £ 5 million/ml,
including eight who started with counts <1 million/ml. 
Vaso-vasostomy appeared to be the most satisfactory surgical 
procedure, although it should be noted that four pregnancies 
were produced with prednisolone treatment even though the 
testicular obstruction was unrelieved. Most of the 
pregnancies produced were associated with improvement in the 
sperm output after treatment (Table 44b). The pregnancy 
rate was not influenced by the level of antisperm antibodies 
until very high titres were reached (* 1024) (Table 44c), 
however, it should be remembered that many of these patients 
received prednisolone treatment for the antisperm 
antibodies.
Surgical Initial sperm count M/ml
treatm ent < 5 6 - 2 0 > 2 0 Totals
Ep-vas 7/18 1/10 2/5 10/33 (30%)
Vas-vas 2/5 1/1 3/6 (50%)
Orchidectomy 1/2 0/2 1/6 2/10 (20%)
None (steroids) 2/5 1/2 1/4 4/11 (36%)
Totals 12/30
(40%)
2/14
(14%)
5/16
(31%)
19/60
(32%)
TABLE 44a Pregnancies produced/number treated in 60 
patients with adequate follow-up related to 
initial sperm counts and surgical treatment
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Post treatm ent 
sperm count M/ml
Initial sperm count M/ml
< 5 6 - 2 0 > 2 0
Not known 2/2 1/1 1/1
< 5 2/13 0/1 0/1
6 - 2 0 6/10 0/4 0/1
> 2 0 2/5 1/8 4/13
TABLE 44b Pre-treatment and post-treatment average sperm 
count results
Post treatm ent 
sperm count M/ml
Serum TAT
< 3 2 6 4 -5 1 6 > 1024
Not known 4/4 — —
< 5 1/9 1/6 —
6 - 2 0 2/6 3/4 1/5
> 20 3/11 4/10 0/5
Totals 10/30
(30%)
8/20
(40%)
1/10
(10%)
TABLE 44c Post-treatment sperm counts and serum ASA titres 
(many patients received prednisolone therapy)
Orchiectomy
In 10 patients with high titres of antisperm
antibodies and incorrectable obstruction or unilateral
absence of the vas, the obstructed testis was removed and 
replaced with a prosthesis. Histological examination of
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these testes revealed focal mononuclear cell infiltrates and 
sperm granulomas in the epididymis, and sometimes amongst 
the seminiferous tubules (see Section 3.5).
After orchiectomy, striking falls were observed in 
serum and seminal plasma ASA titres which continued to fall 
with subsequent prednisolone therapy (Figs. 23 & 24). Two 
men subsequently produced pregnancies.
3.3o4 Bilateral testicular obstruction - incidence of ASA 
(see 2.5.4) (Hendry et al, 1983)
Many of the results of this study were extended and 
are described in more detail in the next section. However, 
two statistically significant observations were made in this 
study which were subsequently shown to be important. The 
patients are shown grouped according to the site of 
obstruction in Fig. 25. This is related to their domicile 
in Table 45. It may be seen
Site of 
O bstruction
N um ber 
of Patien ts
N u m b er (%) C om ing 
from  A broad
Empty epididymes 25 9 (36%)
Caput epididymis 48 6 (12.5%)
Cauda epididymis 34 19 (56%)
Absent vas
bilateral 29 8 (28%)
unilateral 8 2 (25%)
Blocked vas 23 12 (52%)
Ejaculatory duct 1
T otal 168 56 (33%)
TABLE 45 Site of bilateral testicular obstruction related 
to domicile
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that over half (56%) of the patients with blocks at the 
cauda epididymis came from abroad, whereas most (87.5%) of 
those with spermatozoa confined to the caput epididymis 
lived in the British Isles. This difference is highly 
significant (X.^  = 17.67; P<0.001) and will be considered
further in the next section.
Serum antisperm antibodies
The number of patients in each category with positive 
serum antisperm antibody tests is shown in Table 46.
G ro u p N u m b e r S e r u m  T A T
o f  C a se s P o s itiv e  (%)
Empty epididymes
(impaired spermatogenesis) 22 3 (13.6)
Bilateral absent vasa 29 6 (20.7)
Caput epididymis 48 14 (29.2)
99 23 (23.2)
Empty epididymes
(normal spermatogenesis) 3 3
Unilateral absent vas 8 4 (50)
Cauda epididymis 34 18 (52.9)
Vasal block 23 10 (43.5)
Ejaculatory duct 1
69 35 (50.7)
TABLE 46 Incidence of serum ASA related to site of 
obstruction in men with bilateral testicular 
obstruction
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Statistical analysis showed that ASA occurred 
significantly more often with blocks at the cauda epididymis
(52.97.) than with those at the caput epididymis (29.2%) (Y^
= 4.7; P*0.05) and also significantly more often than in men
o
with congenital bilateral absent vasa (20.7%) (X = 6.9, P 
*0.01).
3.3.5 Bilateral testicular obstruction - results of surgery 
and ASA (see Section 2.5.5) (Hendry et al, 1990b)
The operative findings in 370 cases are shown in Fig. 
26. Epididymovasostomy gave good results with postinfective 
caudal blocks (patency 527., pregnancy 387.), while 
postinfective vasal blocks were better corrected by total 
anatomical reconstruction (patency 737,. pregnancy 277.) than 
by transvasovasostomy (patency 97,, no pregnancies). Poor 
results were obtained with capital blocks (patency 127o, 
pregnancy 37.) , in which substantial lipid accumulation was 
demonstrated in the ductuli efferentes; three-quarters of 
these patients had sinusitis, bronchitis or bronchiectasis 
(Young's syndrome). There is circumstantial evidence to 
suggest that this syndrome may be a late complication of 
mercury intoxication in childhood (Pink Disease).
The incidence of ASA in the various groups is shown in 
Table 47. This confirmed that ASA occurred significantly 
more often with caudal than with capital epididymal blocks, 
and with blocked compared to absent vasa. Eighty-two 
(77.47.) of 106 patients with capital epididymal blocks had 
chronic sinusitis, bronchitis or bronchiectasis (Young's 
syndrome) whereas only 9 (8.57,) had a past history of
genital infection. In contrast, a history of epididymitis, 
urethritis or smallpox was given by 38 (54.37,) of 70 with
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caudal epididymal blocks, and only 1 had chronic bronchitis
o
(different from those with capital blocks, X  = 87.2, p
<0.001). The most common cause of vasal blocks was previous 
genital or urinary infection (16 cases) and there was a 
history of tuberculosis in 7, of which 3 were active 
(significantly different from capital blocks (X - 69.8, p 
<0.001; no significant difference from caudal epididymal 
blocks). It can be concluded from the data on Table 47 that 
postinflammatory blocks are most likely to be associated 
with development of ASA.
Site of problem Number Serum GAT or TAT positive (%)
Epididymis
Caput 106 29 (27.4)
Cauda 69 36 (52.2)
Vas deferens
Absent — bilateral 67 11 (16.4)
— unilateral 19 6 (31.6)
Blocked 40 19 (47.5)
Ejaculatory duct 14 1 (7.1)
Totals 369 112 (30.4)
TABLE 47 Incidence of serum ASA in 369 men with obstructive 
azoospermia related to site of obstruction
The relationship between presence or absence of ASA 
and production of pregnancy by 66 men whose obstruction was 
corrected (as evidenced by postoperative sperm counts of 10 
million per ml or more) is shown in Table 48. It can be 
seen that pregnancy is significantly more likely to occur if 
the man has not produced ASA (by Fishers Exact Test p<0.05).
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Pregnancy
produced
Serum GAT or TAT 
Positive Negative
Yes 11 20 31
No 22 13 35
33 33 66
TABLE 48 Relationship between serum ASA and production of 
pregnancy after correction of obstructive
azoospermia (sperm counts* 10 million per ml)
Unfortunately, the groups most suitable for surgical
correction (postinflammatory caudal epididymal and vasal 
blocks) are those most likely to be associated with ASA 
production.
3,3.6 Genital tract injuries in childhood (see 2.5.6) 
(Parkhouse & Hendry, 1991)
The 17 patients with unilateral testicular obstruction 
had sperm counts ranging from 1 to 89 x 10 / ml, with 11 
having counts below 20 x 10^/ ml. All had serum antibodies
to spermatozoa, with titres 1:128 in 12 cases (70%). The
13 patients with bilateral testicular obstruction all had 
azoospermia, but only 6 (4670) had serum antibodies and none 
of the 6 had antibody titres >128. Antibody titres of the 
patients with bilateral obstruction were compared with the 
antibody titres of patients with unilateral obstruction 
(Fig. 27) and the difference between the 2 groups was 
significant at the 1% level (Wilcoxon's rank sum test).
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Following corrective surgery and prednisolone 
treatment for the antibodies, where appropriate, 5/17 
patients with unilateral blocks and 1/11 with bilateral 
blocks successfully produced pregnancies.
3.4* 1 Vasectomy reversal: laboratory results (see 2<.6»1)
(Royle et al, 1981; Parslow et al, 1983; Hendry et al 1983b)
The interval between operation and follow-up was over 
one year in all 130 patients. Antisperm antibody results 
have been analyzed for all patients, but occurrence of 
pregnancies in their partners has been studied only in those 
who were actively trying to produce a pregnancy.
The results of TAT and GAT in serum coincided within 2 
titres in 222 (92%) of 242 tests. In 20, the TAT was 2 or 
more titres higher than GAT: in 17 of these cases, there was 
a significant element of head-to-head agglutination, which 
is only detected by TAT testing. Since head-to-head 
agglutination is fairly common after vasectomy, though rare 
in naturally subfertile males, the results of the TAT have 
been used in this analysis.
The antisperm antibody results in serum and seminal 
plasma before vasectomy reversal are shown in Table 49. A 
positive result was obtained in the sera of 95 ( 797o) of 121 
men tested. Seminal plasma antibodies were found in only 8 
(9 . 570) of 85 men tested, all of whom had serum titres of 512 
or more. Overall, 41 (347o) of 121 men tested had serum
titres of 512 or more. The corresponding figures 3 months 
or more after reversal are also shown in Table 49: 78
patients had seminal plasma tested, of whom 23 (29.57o) had 
antibodies, which appeared at serum titres of 64 and higher.
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S erum  
TA T T itre
N u m b er
o f
P atien ts
Sem inal P lasm a TA T T itre
No.
te s ted 0 4 8 16 32 £64
Not done 9 4 4
0 26 15 15
4 5 2 2
8 5 4 4
16 4 2 2
32 7 7 7
64 II 9 9
128 6 3 3
256 16 II II
512 23 15 12 1 1 1
£1024 18 13 8 2 1 1 1
3 2 2 1
Tptal 130 85 77 8/85 (9.5%)
Not done 15 12 II 1
0 8 5 5
4 2 2 2
8 6 5 5
16 5 5 5
32 4 4 4
64 12 10 9 1
128 II 10 5 3 1 1
256 10 8 4 2 1 1
512 9 7 2 1 2 1 1
£1024 12 10 3 1 1 4 1
2 9 7 2 3
Total 130 78 55 23/78 (29.5%)
Before
Reversal
After
Reversal
TABLE 49 Semen and seminal plasma TAT titres in 130 men (a) 
before and (b) 3 months after vasectomy reversal
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These results are shown graphically in Fig. 28, and 
compared with the findings in 146 unselected spontaneously 
infertile males studied at the same time.
3.4.2 Fertility after vasectomy reversal (see 2.6.1) 
(Parslow et al, 1983; Royle et al, 1981)
Ninety patients were operated upon by Mr. Michael 
Royle in Brighton, and 40 were done at St. Bartholomew's 
Hospital in London. The results of follow up sperm counts 
and pregnancies in the partners of those wanting children 
are shown in Table 50(a). Excluded are those lost to follow 
up. The pregnancy rates for the 2 hospitals were similar at 
447, and 45%.
Total
no.
Inform ation
available
SPERM COUNT ? PREGNANCY
0 <  20 >  20 m/ml Trying Success
Brighton 90 69 4 24 41 63 28
(44%)
Barts 40 35 3 9 23 29 13
(45%)
TABLE 50(a) Sperm counts and incidence of pregnancies (a) 
related to hospital
There was no benefit from per-operative steroids. 
Pregnancy rates of 527, and 537, were achieved by those men 
with preoperative serum titres in the range 0 to 16 and 32 
to 256, respectively (Table 50b). Significantly fewer 
pregnancies (257,) were produced once the serum titre reached 
512 or more (Table 51) (I2 = 5.88; p<0.02).
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Serum 
TAT titre
Total
no.
Information
available
SPERM COUNT ? PREGNANCY
0 < 2 0 >  20 m/ml Trying Success
<  16 40 32 5 7 20 29 15
(52%)
32—256 40 36 1 14 21 32 17
(53%)
>  512 41 31 2 9 20 28 7
(25%)
TABLE 50(b) Related to serum TAT titres
Serum TAT 
titre
Pregnancy
No Yes
0 - 2 5 6 29 32
512 -  1024+ 21 7
TABLE 51 Serum TAT titres and pregnancy rates
The number of patients with seminal plasma antibodies 
is relatively small, but it can be seen from Table 52 that 
the pregnancy rate remained at 44% with seminal plasma 
antibody titres of up to 16. Only one pregnancy was 
produced by the 4 men with titres of 32 or more.
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Seminal plasma 
TAT titre
Total
no.
Information
available
SPERM COUNT ? PREGNANCY
0 < 2 0 >  20 m/ml Trying Success
0 55 51 3 15 33 45 20
(44%)
4 2 2 1 1 2 1 \
8 9 8 1 2 5 7 3 > (44%)
16 7 7 4 3 7 3 )
>  32 5 5 1 2 2 4 1
(25%)
TABLE 52 Sperm counts and incidence of pregnancies related 
to seminal plasma TAT titres
A few patients exhibited an unusual course, and 2 are 
worthy of brief description. The first (Fig. 29) had no 
detectable antibodies before or immediately after reversal 
without steroids, and a good sperm count was obtained: 
however, antisperm antibodies then appeared in both serum 
and seminal plasma, and as the titre rose, so the sperm 
count fell, to nearly zero, and temporary and incomplete 
correction of this fall was obtained with a 6-month course 
of prednisolone (5mg three times daily). The second patient 
(Fig. 30) started with a serum titre of 512 and a seminal 
plasma titre of 8: after reversal without steroids, a good 
count was obtained, the serum antibodies dropped, the seminal 
plasma antibodies disappeared, and the wife twice became 
pregnant.
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3.4,3 Findings in failed vasectomy reversal (see 2.6.2) 
(Royle & Hendry, 1985)
The findings in 23 patients who were azoospermic prior 
to reconstructive surgery are shown in Table 53(a). In the 
first category were 12 patients in whom the anastomosis of 
the vasa had become blocked. Following repeat
vaso-vasostomy by the technique described, spermatozoa were 
restored to the ejaculate in 10 patients: the wife of a
further patient became pregnant before a sperm count had 
been done. Of eight patients followed up for 6 months or 
more, five (62%) impregnated their female partners.
In the second category (patients with epididymal 
blocks which were treated by epididymo-vasostomy), three of 
four patients regained satisfactory sperm counts and two 
wives became pregnant.
In the third group, comprising patients with very high 
antisperm antibody titres of 1024 or more, appropriate 
surgery and prednisolone treatment led to reasonable sperm 
counts in six patients (^20 m/ml in 3), but none of the 
wives became pregnant.
The overall pregnancy rate for this group was 3770.
Category Treatm ent No.
Follow-up sperm counts
Pregnancies*0 < 2 0 > 2 0
1 Blocked vas Redo
vas-vas
12 1 3 7 5/8 (62%)
2 Epididymal 
block
Ep-vas 4 1 3 2/4  (50%)
3 Antisperm 
antibodies 
(>1024)
Surgery + 
prednisolone
7 1 3 3 0/7
TABLE 53 (a) Results obtained by reoperation after previous
failed attempt at vasectomy reversal
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Nine men with persistently poor sperm counts following 
previous vasectomy reversal were explored and the results 
are shown in Table 53(b). A blockage was found in the vas 
on one side, although at least partial patency had obviously 
been restored on the other side. The cases fell into the 
same categories as before, except that in eight of the nine 
cases only one side remained blocked. Corrective surgery 
resulted in improved sperm counts and one pregnancy has been 
obtained. In this particular case the patient had a rather 
poor testicle on one side which had been successfully 
reconnected, but was putting out less than 1 million 
spermatozoa per ml. Following reconnection of the
contralateral normal testicle, the sperm count returned to 
normal and his wife has recently been delivered of a normal 
baby.
Category Treatm ent No.
Follow-up sperm counts
0 < 20 >20
1 Blocked vas Redo
vas-vas
5 1 4 *
2 Epididymal 
block
Ep-vas 2 2
3 Antisperm 
antibodies 
0 1 0 2 4 )
Surgery + 
prednisolone
2 1
4 Testicular 
failure
None y2
TABLE 53(b) In 9 oligozoospermic patients
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3.5 AUTO-IMMUNE ORCHITIS IN SUBFERTILE MALES (see 2.7) 
(Hendry et al, 1979; Hendry, 1987; Hendry et al, 1990b)
3.5.1 Histological findings
Focal infiltration of lymphocytes and plasma-cells 
extending into the inside of a seminiferous tubule (Fig. 31) 
(i.e. beyond the blood-testis barrier) in a man with severe 
oligozoospermia and high serum titre of ASA (>1024) was 
first noticed by Dr. R.C.B. Pugh, and reported and 
illustrated in Hendry et al (1979). In discussion, the 
possibility was raised that this might be a manifestation of 
autoimmune orchitis. Subsequent observations indicated that 
this finding was very rare, extremely patchy in 
distribution, and sometimes seen in men without ASA. It 
could not, therefore, be regarded as diagnostic of 
autoimmune orchitis. Furthermore, clinical observation 
indicated that severely oligozoospermic or even azoospermic 
men with high titres of ASA (£512) could respond well to 
prednisolone with normalisation of sperm concentration 
without this change on testicular biopsy (see below 3.5.2).
Studies of the testis and epididymis in 10 men with
unilateral uncorrectable obstruction or absence of the vas
showed patchy mononuclear cell infiltration of epididymal
tubules (Fig. 32) and in one case, prominent infiltration of
rete testis (Fig. 33). These changes were recorded by Dr.
M.Co Parkinson and illustrated in Hendry et al (1990b), with
the comment that they may support a diagnosis of autoimmune
orchitis, although attention was drawn in discussion to
their very patchy distribution. They had, however, not been
recorded before 1979 as evidence of autoimmune orchitis 
occurring spontaneously in man.
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3o5o2 Response to treatment (see 2,7)
Four azoospermic and 3 severely oligozoospermic men 
showed marked improvement in sperm concentration whilst 
receiving prednisolone 5mg T.D.S. The data shown in Fig. 11 
were from Hendry et al (1979) and were used to illustrate 
the marked beneficial effect of steroid therapy. The best 
examples, are shown in Figs. 34 and 35, men with no 
demonstrable mononuclear cell infiltrate on testicular 
biopsies, but a pronounced response to prednisolone therapy 
leading to production of 2 pregnancies. This response to 
therapy was taken as presumptive evidence of autoimmune 
orchitis (Hendry et al, 1990b).
CHAPTER 4: DISCUSSION
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4.1 LABORATORY METHODS 
4.1*1 Which tests to use?
The first and most important question regarding ASA in 
male subfertility was "do they matter?" In September 1976, 
at the end of the first year of routine serum testing for 
ASA in subfertile males at CHW, we found over one-third 
positive for IFT, and around 107o positive for agglutinating 
and immobilising antibodies by GAT and SIT. Clearly the 
first priority was to see which tests correlated with each 
other, and it quickly became apparent (Table 13) that there 
was a very good agreement between GAT and SIT, if a serum 
titre of 32 or more by GAT was accepted as significant, as 
suggested by Rumke et al (1974) (see Table 4 p 41). Husted 
(1975) had found a similar correlation. On the other hand, 
there was no relationship whatsoever with the results of IFT 
testing (Table 14). However, this finding by itself was not 
sufficent to condemn the latter tests, although such a high 
proportion of men with immunological infertility seemed 
unlikely. Another test was needed to put the antibody test 
against, preferably a test showing a fundamental defect in 
the processes known to be necessary for fertilisation. 
Failure of sperm penetration of cervical mucus was not a new 
phenomenon - "cervical hostility" had been recognised for 
many years, and, as the name implied, was generally taken to 
indicate that the mucus was "rejecting" the man's 
spermatozoa. Condom treatment was often recommended, to 
keep the spermatozoa away from the mucus for 6 months, to 
allow the "hostility" to subside. Results had needless to 
say, been poor and unpredictable. Kremer and Jager (1976) 
drew attention to the fact that autoantibodies in the man,
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as well as isoantibodies in the woman, led to failure of
penetration of the mucus. Once this fact had dawned on us,
it was possible to show by crossed hostility testing that
the spermatozoa from most men with ASA could penetrate
neither mucus from their female partner nor that from a
donor, whereas their partner's mucus accepted donor sperm
readily. Clearly the concept of "cervical hostility" was
outdated and in need of revision, but equally importantly,
this test gave us the opportunity to find out which ASA
tests were associated with significant impairment of sperm
function in cervical mucus, and which were not. It quickly
became apparent that & em err GAT and SIT gave results that
r-
correlated well, though the correlation was not perfect.
The association between the presence of ASA in the 
male and failure of sperm penetration of cervical mucus in 
the female, which was known to impair fertiity (Fjallbrant 
1968b - see Table 6 p 43), clearly needed further study. 
Accordingly, a symposium on Immunological Infertility was 
arranged and held at the Institute of Urology on 11th 
February 1978. The proceedings were subsequently published 
as a book entitled "Spermatozoa, Antibodies and Infertility" 
(Cohen & Hendry, 1978). Many new facts were learned from 
the 11 invited speakers and some insight was gained into the 
complex problems of reproductive immunology. Rumke (1978) 
provided a clear description of the autoantigenicity of 
spermatozoa, and drew attention to some differences between 
spontaneously infertile and vasectomised men, pointing out 
that seminal plasma antibodies are rarely seen in the latter 
population. Shulman (1978) provided a critical evaluation 
of the available tests and drew attention to some important
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principles on diagnostic application of ASA tests, including
advice that at least 2 different test methods should be used
in each patient; that undiluted semen should never be used,
that known positive and negative controls should always be
included, and that there should be no hesitation in
discarding test results if the donor semen was poor, or did
not behave as expected with control sera. Kremer et al
(1978) developed the hypothesis that ASA present on the
spermatozoa or in cervical mucus caused cross linking
between the spermatozoa and receptors on the glycoprotein
micelles in the cervical mucus, leading to characteristic
non-progressive shaking or jerking movement of the
spermatozoa. Furthermore, they indicated that this
phenomenon was only observed when the spermatozoa were
coated with IgA, either by itself or in combination with
IgG, but not with sperm coated with IgG alone. The presence
of IgA on the sperm correlated with the presence of seminal
plasma ASA as shown by TAT; Rumke (1978) proposed that this
autoantibody was probably locally produced in the genital
tract. Hjort et al (1978) had used F(ab)2 fragments to
block the immobilising effect of some but not all sera.
Finally, Shulman (1978) reviewed the results of treatment up
to that time, and speculated on possible future
developments. These, and other valuable contributions on
spermatozoal biology and the properties of cervical mucus,
provided the scientific foundations for the work that was to
be done in our departments in the next 12 years. In
particular the fundamental importance of measuring ASA in
seminal plasma as well as serum was recognised, coupled with 
the significance of the class of antibody bound to the
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spermatozoa.
4 0102 Agglutination and immobilisation tests
Statistical confirmation of the relevance of TAT in 
the evaluation of male subfertility came from the careful 
studies of Hargreave (1982, 1983) and Hargreave et al (1980, 
1984) (supervisor of this thesis) who measured serum and 
seminal plasma TAT titres in 645 men attending the 
infertility clinic and compared them with 151 men requesting 
vasectomy, who all claimed fatherhood of 2 or more children, 
and at the time of testing had at least one child under the 
age of 2 years.
TAT
T itre
Fertile Men* Infertile Men*
Serum Seminal
PLasma
S erum Seminal
P lasm a
0 137 52 518 310
4 2 2 5
8 8 25 22
16 3 19 4
32 1 20 14
64 15 10
128 10 6
256 13 3
512 9 1
1024 4 1
£2048 II 2
Total 151 52 645 378
*(p<0.0l by Wilcoxon Rank Sum Test) 
(Hargreave, 1983)
TABLE 54 Comparison of TAT titres in serum and seminal 
plasma between fertile and infertile men (from 
Hargreave 1983)
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It may be seen from Table 54 that no serum titres over 
32, and no positive seminal plasma titres were seen amongst 
the fertile men. The serum TAT results provided
confirmation of a serum titre of 32 as a reasonable lower 
working limit of significance as suggested by Rumke et al 
(1974), and the seminal plasma TAT results confirmed the 
fundamental importance of testing both serum and seminal 
plasma. Hargreave (1982) found that SIT was only positive 
in association with agglutinating activity, and found both 
tests positive in 7.5% of infertile husbands - remarkably 
similar to our own findings (Table 13).
Further confirmation of the validity of GAT, TAT and 
SIT was provided by the WHO's Task Force on Immunobgical 
Methods In Fertility Regulation (Hjort and Griffin, 1985). 
Semen samples from 26 fertile and 82 infertile males were 
collected and distributed to 18 investigating laboratories, 
where sera were tested by a variety of tests including GAT, 
TAT, SIT, sperm cytotoxicity (SCT), passive 
haemagglutination (PHA) and immunobead binding (Bronson et 
al, 1985), and various ELISA methods (Mettler et al, 1985). 
GAT and TAT gave 7 and 127> positive results respectively in 
infertile males, and negative results for fertile males from 
all except one laboratory. SIT correlated well with TAT and 
GAT in all except one laboratory. Indirect immunobead 
testing (IBT) correlated well with GAT, TAT and SIT, but SCT 
and PHA did not; however, IBT gave the highest incidence of 
ASA (217> positive for sperm reactive IgG) in the infertile 
male group, and may have included some false positive 
results. Shulman et al (1985) also reported good overall 
correlation between indirect IBT and GAT, whilst noting that
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a number of sera were IBT positive with low and probably 
insignificant GAT titres. Returning to the WHO study, ELISA 
testing gave a high frequency of positive results in all 
groups, including fertile controls (Mettler et al, 1985).
Winnett and Suominen (1982) compared 8 techniques of
ASA testing, including TAT, GAT, SIT, IFT, and others, and
concluded by recommending TAT. Parslow (1985) in her PhD
Thesis, showed that both GAT and TAT produce reprodiceable
results (within 1 or 2 dilutions) when repeated with the
same control sera and fresh semen from the same donor on
many different occasions, and with a battery of sera using
TAT was
different donor spermatozoa, ^more sensitive, particularly 
with head-to-head (H-H) agglutination. However, no test is 
perfect: Jager et al ( 1987)  reported finding serum TAT
titres between 16 and 128 ,  and seminal plasma titres between 
128 and 2048 in a fertile man whose baby shared his 
haplotype on tissue typing. Although IgA and IgG were 
detected by MAR and IBT on almost all motile spermatozoa, 
only 407o showed the shaking phenomenon on SCMC testing, the 
remainder showing excellent penetration of cervical mucus. 
This rare man appeared to be the exception who proved the 
rule that the results of ASA testing should always be 
checked by sperm-cervical mucus penetration testing before 
recommending treatment.
4.1»3 Mode of Agglutination
TAT is more sensitive than GAT, since the small clumps 
produced by head-to-head (H-H) agglutination can be seen 
under the microscope, but are not visible macroscopically; 
the large clumps produced by tail-to-tail (T-T) 
agglutination, on the other hand, are easily seen by both
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techniques. This was reflected in the results obtained with 
our vasectomy reversal men (see 3.4.1, page 138), when GAT and 
TAT coincided within 2 titres in 92%, although in 20 TAT was 
2 or more titres higher than GAT, and in 17 of these there 
was prominent H-H agglutination. The significance of the 
mode of agglutination remains obscure. Friberg (1974a) 
developed TAT, and recognised that H-H agglutination was 
most common in women, whereas T-T agglutination was more 
common in men (Friberg, 1874b). Fractionation and
absorption investigations indicated that H-H agglutination 
was caused by IgM antibodies, whereas T-T agglutination was 
usually caused by IgG antibodies in serum (Friberg, 1974c) 
and IgA antibodies in semLnal plasma (Friberg, I974d). T-T 
agglutinating antibodies were found in seminal plasma with 
serum titres £ 64, but none of the men with pure H-H 
agglutinating antibodies had antibodies in the seminal fluid 
(Friberg, 1974e). These conclusions were all subsequently 
confirmed by Friberg (1980a), although it was noted that the 
total immunoglobulin concentration in serum and seminal 
plasma were similar in fertile men and in infertile men 
with H-H or T-T sperm agglutinating antibodies (Friberg, 
1980b). Post-coital tests in the female partners were poor 
if the man had moderate or high titres of T-T agglutinating 
antibodies, but were normal if the man had H-H agglutinating 
antibodies, or low titres of T-T agglutinins (Friberg, 
1981). Spermagglutination in the ejaculate was much more 
marked with T-T agglutinating antibodies (Friberg and 
Tilly-Friberg, 1977). In azoospermic men, the development 
of ASA only occurred if there was complete spermatogenesis 
(i.e. did not occur with Sertoli-cell-only syndrome or
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maturation arrest at or before spermatid level) (Friberg and 
Kjessler, 1975). Friberg and Fritjofsson (1979) described 
10 infertile men with ASA and a history of inguinal 
herniorrhaphy - exploration showed occlusion of the vas 
deferens at the site of hernia repair in 5, and 3 others had
small spermatoceles. . Only 1 of these 8 men had H-H
agglutinating antibodies. The findings are at variance with 
our own observations, which indicated that H-H or mixed
agglutination was found significantly more often with 
unilateral (817.) or bilateral (55%) testicular obstruction 
than in spontaneously infertile males of whom only 24%
showed such agglutination (Tables 38 and 39, pages 124). 
Girgis et al, 1979 studied 50 cases of azoospermia, 32 of
whom had testicular obstruction: 13 (407.) had ASA, of whom 9 
(70%) had H-H or mixed agglutination - results more in 
accordance with our own observations.
4.1.4 Direct MAR and IBT
The mixed antiglobulin reaction was first applied to 
spermatozoa by Coombs et al (1973) as an indirect test to 
define the class of antibody in semen and seminal plasma 
from infertile men with ASA, and compare them with normal 
and vasectomised men. Sera were found to be positive for
IgG, but not for IgA, in most of the infertile and many of 
the vasectomised men, but in only 1 of the normal men. 
Although there was some difficulty in reading the results, 
definite evidence of IgA class of ASA was found in 6 of the 
7 samples of seminal plasma from the infertile men, but not 
in the normal controls, even in the man with ASA in serum.
A direct test was possible in 1 infertile man, the only one 
from whom a fresh semen sample could be obtained, and both
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IgG and IgA antibody were found adhering to his spermatozoa; 
similar tests from a normal man were negative. With 
remarkable foresight, the authors concluded that the 
infertility in these men might have been due to locally 
produced IgA antibody, rather than through transmission of 
IgA from serum. A direct erythrocyte-platelet antiglobulin 
reaction had been originally described by Coombs et al 
( 1 9 5 6 ) ,  and Jager et al ( 1978)  modified this test for use 
applied directly to fresh semen, so that it could be 
incorporated into routine seminal analysis as a screening 
test for IgG on the spermatozoa. There was excellent 
correlation with the presence of circulating ASA and with 
impairment of sperm penetration of cervical mucus. Our 
studies at CHW (see 3 . 1 . 4  and 3 . 1 . 5 )  amply confirmed these 
observations. This test, applicable to over 907<> of semen 
samples produced by the male partners of infertile 
marriages, demonstrated surface-bound IgG on the spermatozoa 
of 127o, and excluded the presence of ASA in almost 807o. It 
was, however, very sensitive, and gave strongly positive 
resutls even with low serum titres of circulating antibody 
shown by GAT or TAT, in men who were subsequently shown to 
be fertile (see Table 18 . plOO). It was therefore just a 
screening test, and it was emphasised that serum and seminal 
plasma titres of ASA should also be defined if the MAR was 
positive, and the importance of checking serum TAT in 
patients in whom MAR was technically impossible was 
emphasised (e.g. in men with azoospermia or severe 
oligozoospermia). The MAR is now included as a routine with 
seminal analysis in most up-to-date laboratories.
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As an alternative, many laboratories use direct IBT 
with washed patients' spermatozoa to screen for ASA. This 
test is also exquisitely sensitive (Adeghe et al, 1986), and 
it is not surprising that low or moderate levels of sperm 
surface-bound ASA detected by this technique have no 
intrinsic prognostic value for subsequent fertility (Barrett 
et al, 1992). Clearly this is just a screening test, and 
full evaluation of a particular patients' ASA status should 
include measurement of serum and seminal plasma unbound ASA 
by TAT.
Jager et al (1980) also used the MAR with cells coated 
with IgG or IgA (obtained from colostrum) to define the 
class of antibody bound to the spermatozoa of infertile men 
with ASA. The results showed that the percentage of motile 
spermatozoa with IgA bound to their surface showed no direct 
relation to the unbound ASA activity in serum and seminal
plasma, but was roughly proportional to the percentage of
spermatozoa exhibiting the shaking phenomenon on SCMC
testing. Subsequently Jager et al (1981) showed that the Fc 
part of the antibody became attached to receptors in the
cervical mucus. We used Group 0 Rh positive RBC's 
sensitised with serum containing anti-D which was partly IgA 
although mainly IgG to study the same question, and reached 
largely the same conclusions as Jager et al (1980).
Successful sperm penetration of cervical mucus was not 
seen when MAR (IgA) was positive or strongly positive, 
although it was seen in patients with significant serum 
titres of ASA (though negative for seminal plasma ASA) who 
had negative or doubtful MAR (IgA) (see Tables 26 a & b,plQ6). 
ASA after vasectomy reversal are always a difficult problem
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(see below section 4.4), but it is germaine to mention here 
that Meinertz et al (1990) used MAR to define the percentage 
of spermatozoa with IgG or IgA bound to the sperm membrane 
and found that the conception rate fell from 867® in a 
subgroup with a pure IgG response, to 437® when IgA was
present on the sperm as well, to 227® when 1007® of sperm were
covered with IgA, and ultimately to zero when there was IgA 
on all the sperm and a strong immune response as shown by a
serum TAT titre of 256 or more. Meinertz et al (1991) used
a similar MAR technique to show that motile spermatozoa 
emerging from the epididymis in men undergoing vasectomy 
reversal had both transuded and locally produced ASA bound 
to their surface, and that follow up semen samples 4-12 
months later showed identical results. In this regard, 
Patrizio et al (1992) have shown by indirect IBT studies 
that ASA binding was the same using either sperm emerging 
from the testes of men with absent vasa or normally 
ejaculated sperm, and hence concluded that sperm acquired 
the surface antigens detected by IBT within the testes, 
prior to transit through the epididymis. Before this, it 
had been thought that ASA mostly entered the semen from the 
prostate at the time of ejaculation, conclusions derived 
from split-ejaculate studies of the total immunoglobulin 
content of whole semen (Rumke, 1974). This question has 
important therapeutic implications, which will be considered 
in more detail in the next section.
As an alternative to red blood cells, latex particles 
coated with immunoglobulin have been used for MAR (Comhaire 
et al, 1988), and satisfactory sensitivity and specificity 
was observed by McClure et al (1989).
158
The MAR test differs from the IBT in that the 
indicator red blood cells are covered with incomplete 
antibody (mostly IgG) which are mixed with unwashed 
spermatozoa, and the reaction is completed by the addition 
of antihuman Ig; if there is antibody on the spermatozoa, 
mixed agglutinates are formed which are easily recognised. 
The immunobeads, on the other hand, are coated with class 
specific antihuman Ig, which would react non-specifically 
with unbound Ig in seminal plasma; it is therefore necessary 
to wash the spermatozoa thoroughly before carrying out this 
test. The latter test is, as a result, more time consuming 
and laborious. However, there is an excellent correlation 
between MAR and IBT (IgG), and since the former test is 
cheaper and quicker it is probably preferable for routine 
screening.
A positive MAR-test result necessitates definition of 
the class of antibody present on the spermatozoa since this 
determines the effect of the ASA on sperm penetration of 
cervical mucus and hence the effect on fertility. The IBT 
(IgA) correlated well with seminal plasma antibody measured 
by TAT, although there were some patients in whom all the 
antibody was bound to the spermatozoa, leaving no unbound Ig 
to be detected by TAT. The IBT (IgA) thus adds further 
useful information in defining not only the class of 
antibody, but also what percentage of the spermatozoa are 
affected. There is evidence that once this exceeds 50%, 
there is likely to be impairment of cervical mucus 
penetration (Bronson et al, 1984). Over 807,, a significant 
decline in ovum fertilization is probable on attempting in 
vitro fertilization (see 4.5.1).
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IBT have also been used extensively as an indirect 
test for ASA in serum and seminal plasma, even though 
Bronson et al (1984) showed that residual ASA in seminal
plasma detected by this technique were not representative of 
the cell-bound Ig present on the spermatozoa. Some strange 
results have been obtained with class specific IBT used 
indirectly. Thus, Matson et al (1988, 1989) found that poor 
post coital tests, and impaired fertility were only found 
when both IgG and IgA ASA were present, but there was no 
impairment with either class of antibody alone. These
results are so contrary to those of Kremer et al (see 4.1.6) 
and of our studies (see above) that false positive results 
were probably a problem caused by use of undiluted serum, 
and failure to define the dilution at which the effect 
disappeared. All in all, the indirect IBT test seems to 
give less than satisfactory results that correlate poorly 
with those reported from elsewhere.
A specific radiolabelled antiglobulin test, using live 
spermatozoa as the substrate has been used by Haas et al, 
(1980, 1981, 1982, 1983) to quantify the amount and class of 
antibody on spermatozoa, and a similar double-antibody 
technique was used by Parslow et al (1985) to compare the
class of antibody on spontaneously infertile men and those 
following vasectomy reversal (see below, section 4.4).
4.1.5 IFT and ELISA
Our experience with IFT and ELISA showed poor 
correlation with GAT and TAT respectively (see 3.1.2 and
3.1.8), probably because the former tests use fixed 
spermatozoa, thus revealing subsurface antigens which have 
little relevance to impairment of fertility and hence to
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clinical practice. Similar conclusions were reached by 
Mettler et al (1985) (see above).
Many of the problems associated with ASA work in human 
infertility have resulted from the plethora of tests that 
have sprung up, each investigator designing a new method of 
quantifying or defining the antibody, and few taking the 
trouble to compare the results with those obtained by GAT 
and TAT, old fashioned and non-specific, perhaps, but 
none-the-less tests that have stood the test of time, and as 
indicated in this section, have been shown again and again 
to be reliable and reproducible. When combined with MAR or 
IBT to define the presence and class of bound antibody, they 
provide a reliable laboratory base on which to base clinical 
work in subfertile men.
4ol.6 PCT and SCMC testing
The post coital test provides an insight into the 
behaviour of spermatozoa in the female, and was never found 
to be normal in the partners of our 50 men with significant 
serum titres of antibody (section 3.1.2). Kremer et al 
(1978b) studied 32 infertile couples with 'unexplained' poor 
post coital tests and found ASA in 30: in 25 the antibodies 
were in the male, in 5 in the female partner. The PCT has a 
marked prognostic value, the time to conception being 
inversely related to the number of motile spermseen: thus,
Hull et al (1982) showed a fivefold greater chance of 
conception associated with a positive compared to a negative 
PCT; after 2 years the cumulative conception rates were 8470 
and 167o respectively. Subsequently, Glazener and Hull 
(1987 ) showed that amongst many causes of poor PCT, ASA in 
semen showed by TAT or MAR was highly significantly
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associated with failure of sperm to invade despite 
colonisation of clefts in the mucus.
Of course, definition of the cause of the poor PCT 
requires SCMC testing, using donor sperm and donor mucus to 
define the partner with the problem. We preferred to define 
the depth of sperm penetration in our crossed hostility test 
by the technique originally described by Miller and Kurzrok 
in 1932, rather than define the percentage of sperm showing 
the shaking phenomenon in the SCMC test described by Kremer 
and Jager (1976), but the information derived from the test 
was the same. Care must, however, be taken to ensure that 
poor sperm motility or forward progression does not give 
false positive results: Menge and Beitner (1989) carried out 
multivariate analysis i n  734 couples and showed significant 
independant effects of sperm concentration, motility, 
forward progression and ASA on sperm-cervical mucus 
penetration. Nonetheless, Franken et al (1988) found the 
SCMC test a reliable monitor of treatment, and found that 
improvement in SCMC characteristics correlated well with 
ultimate production of pregnancy.
Sperm-cervical mucus contact thus forms the point of 
interaction between male and female partners where the 
effects of ASA in either partner become manifest, and 
without significant reaction at this point, it is very 
unlikely that there is ft-signif icant immunological aspect to 
the couples infertility. This observation was fundamental 
to the initiation and development of medical treatment that 
was used in subfertile males in the ensuing 15 years, to be 
described in the next section.
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4,2 MEDICAL TREATMENT
4.2.1 Case selection and pretreatment work-up
Subfertile males were selected for medical treatment 
on the basis of positive ASA tests in serum and/or seminal 
plasma at titres generally accepted as significant, with 
clearly demonstrated evidence of impaired sperm function on 
SCMC testing, as compared to normal control spermatozoa. An 
abnormal PCT was an essential prerequisite. It was realised 
that the ASA could be associated with moderate or severe 
impairment of sperm concentration and motility (also 
recognised by Rumke, 1981), which could improve or even
normalise with treatment. In practice, it was difficult to 
know when oligozoospermia could be due to unilateral 
testicular obstruction with associated ASA, and when it was 
due to a primary effect of the ASA. If there were 
reasonable grounds for suspecting obstruction or if the man 
was azoospermic, the scrotum was explored before starting 
medical treatment. Otherwise, medical treatment proceeded 
so long as there were some spermatozoa in the ejaculate 
(obviously a positive MAR was expected if it was technically 
possible to do the test). Care was taken to make sure that 
the female partner had patent tubes, and was ovulating 
normally; failure of donor sperm to penetrate her mucus 
adequately on x-hostility test was always investigated and 
treated by gynaecological colleagues. Standard pretreatment 
medical checks are listed in section 2.4.1.
4.2.2 Which medical regimen?
In man, production of circulating antibodies is 
usually only slightly affected by corticosteroid 
administration: however, manifestations of cell-mediated
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immunity can be suppressed by prolonged treatment (Claman, 
1972). The success of the long term low dose prednisolone 
in improving the sperm counts but with relatively few
pregnancies in the female partners may reflect its greater 
effectiveness in suppressing the cell mediated component of
the antibody-dependant reaction - perhaps clearing the
blockage to sperm flow, but leaving the antibody bound to
the spermatozoa. This concept is developed further in
Section 4.5.
Intermittent high-dose methylprednisolone (MP) was 
recommended by Shulman ( 1976)  as a more effective method of 
reducing circulating antibody titres. A significant
decrease in IgG had been observed in 867o, and IgA in 43%, of
17 normal adults 2 -4  weeks after MP 96 mg/day for 5 days 
(Butler and Rossen, 1 9 7 3 ) .  Timing of treatment was 
therefore important, which lead Shulman to recommend that 
the MP should be given to the man from day 2 1 -2 8  of the 
female partner's menstrual cycle. A practical problem was 
that it was entirely possible that the man's wife could be 
pregnant at the time, possibly after a preceding course of 
treatment; this lead us to change the regimen to give the 
drug from day 1-7  of alternate cycles. There was no
evidence of reduction in pregnancy rate as a result (see
3 . 2 . 3 ) .  The results of this study arecompared with those 
reported from elsewhere, and
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A u th o r 
(and year)
C orticostero id  
(daily dose)
P regnancies / 
P atien ts T re a ted
Side Effects 
M ajor M inor
No % % %
Hendry et al (1981) Methylpred. (96mg) 14/45 31 6 26
De Almeida & Dexamethasone 3/14 21 0 Some
Jouannet(1981) (2mg)
Hargreave & Methylpred. (96mg) 5/13 38 ? 1 63
Elton (1982) Betamethasone (2mg) 6/7 85
Shulman Methylpred (96mg) 31/71 44 2 16
& Shulman (1982)
Hendry et al Prednisolone 25/76 33 0 53
(1986) (40/80mg)
Alexander e t al Prednisolone (60mg) 7/19 37 0 Some
(1983) Control 3/25 12 0 Some
Fredricsson Prednisolone 6/16 38 0 Some
(1988) (48/96mg)
TABLE 55 Reported results of intermittent corticosteroid 
therapy for male infertility due to ASA
with the results of the cyclical moderate dose regimen (see
3.2.4) in Table 55. It may be seen that approximately 
one-third of the female partners became pregnant 
irrespective of the exact drug and dosage used (with the 
exception of Hargreave's betamethasone regime, where numbers 
are too small to draw valid conclusions.
The problem was the side-effects. The 31 year old man 
whose results are shown in Table 33 as a classic example of 
falling ASA titres in serum, disappearance of ASA from 
seminal plasma coincident with disappearance of IgA from his 
spermatozoa, along with a spectacular improvement in sperm 
concentration and motility, occurring with 3 courses of MP, 
failed to impregnate his wife and developed bilateral 
aseptic necrosis of the hip joints one year later. This 
required bilateral hip replacement and lead to litigation on 
the grounds that he was not warned of this possible side
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effect. The prednisolone regime was therefore modified with 
the help and guidance of Prof. M. Besser at St. 
Bartholomew's Hospital. The cyclical moderate dose regimen 
(see 3.2.4) which was developed in its place proved to be 
just as effective and mercifully free of serious side 
effects. Ultimately it was submitted to double blind 
controlled clinical trial, when it was shown to be 
significantly more effective than placebo (see 3.2.5). 
Interestingly, 3 patients taking placebo, and only 1 taking 
prednisolone, had to be withdrawn from Che trLal because of 
side effects - an indication of the worry, tension and 
anxiety surrounding treatment of this sort. All patients
were given a copy of the Information Sheet reproduced in
\
Section 2.4.1, and advised not to proceed unless they were 
prepared to face up to the possibility of serious 
side-effects. The large proportion that opted to proceed is 
evidence of the great motivation of couples in search of a 
solution to their infertility problem.
Serial observations showed a significant fall in ASA 
levels in seminal plasma with prednisolone treatment (figure 
19, p 120) indicating that this was the probable mode of 
action of the drug. This was also observed by Fredricsson 
(1988). Nonetheless, it was not possible in any of the 3 
studies to distinguish from the antibody titres alone which 
men would succeed in producing a pregnancy from those that 
would not, although success appeared to be associated with a 
fall in SIT to zero (figure 13), with disappearance of 
seminal plasma ASA (see 3.2.5), and sperm motility after 
treatment was significantly better in the successful 
compared to the unsuccessful (see 3.2.4). It is possible to
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envision a dynamic struggle between sperm pushing forward 
under their own motility, being held back by the seminal 
plasma ASA, and treatment perhaps altering the balance in 
favour of the former.
Three other controlled trials of prednisolone have 
been reported, which failed to show benefit for the
active treatment. However in all these trials the active 
drug was only given for 3 cycles, not long enough to
distinguish any effect from that of the placebo (de Almeida 
et al, 1985; Haas and Manganiello, 1987; Bals-Pratsch et al,
1992). Indeed, there was no difference at 3 months in our
own study (see Fig. 18, pi 2Q).
An alternative immunosuppressive regimen using 
cyclosporin A for 6 months with a dose of 5 to 10 mg/Kg/day 
was used by Bouloux et al (1986) at St. Bartholomew's
Hospital. Seminal plasma and serum ASA fell in 3 of 9 
subjects on treatment and 3 successful pregnancies occurred. 
However, conceptions were unrelated to falls in ASA titres. 
Treatment was carefully monitored and well tolerated by all 
patients.
4o2.3 Other treatment options 
Artificial insemination and sperm washing
Kremer et al (1978c) recommended intrauterine AIH to '
get beyond the barrier created by cervical mucus, and they
obtained three pregnancies in 15 women whose husbands had
spermagglutinin titres of 32 or more. Artifical
insemination can be combined with sperm washing, using
either phosphate-buffered saline (Halim et al, 1974) or
sterile 47> human serum albumin (Shulman et al 1978). We 
treated 30 couples with this technique for 1-13 (average
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4-5) cycles with production of only three pregnancies. 
Analysis showed that in all three cases where the wife 
became pregnant, the husband had previously received steroid 
therapy, and no other pregnancies occurred. There are good 
grounds for doubting whether antibodies (especially IgA) can 
be removed from spermatozoa by simply washing them (Adeghe 
1987), although Boettcher et al (1982) reported a pregnancy 
following AIH using sperm ejaculated into fresh Tyrode's 
tissue culture medium and immediately washed and separated. 
A similar approach has been studied by Lenzi et al (1988) 
who found no reduction in surface bound ASA after washing 
and swim-up. Nevertheless, there are continuing reports of 
success with carefully timed intrauterine AIH with washed 
spermatozoa Trom men with ASA with pregnancy rates from 2170 
(Galle et al, 1990) to 737> (Windt et al, 1989).
Increasingly ingenious methods of separation of 
antibody-free spermatozoa from the rest are being studied, 
including supplementing the medium with 10-507o fetal cord 
serum, which reduced a positive direct MAR to negative, only 
to return to positive in media without the FCS (Hinting et 
al, 1989), to immunobinding to polystyrene Petri dishes 
coated with antihuman Ig, thus increasing the number of 
motile antibody-free spermatozoa (Jevlin et al, 1989) to 
magnetic separation with supermagnetic polymer microspheres 
coated with anti Ig (Dynabeads) (Foresta et al, 1990). 
Passage of diluted ejaculate through a column of Sephadex 
G.200 dextran beads produced physical separation of 
antibody-free from antibody-laden sperm and resulted in good 
sperm velocity and improved sperm function as measured by 
hamster egg penetration testing (Kiser et al, 1987).
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However, the question of ASA and their effects on sperm egg 
fusion, and the place of in vitro fertilization as a 
treatment option will be considered separately in Section 
4 . 6 .
Antibiotics 7
Prostatitis was noted in 377o of 43 men with antisperm 
antibodies by Fjallbrant and Obrant ( 1 9 6 8 ) .  We found that 
557, of 31 patients with antibodies had positive semen 
cultures, compared to only 157o of 32 unselected patients 
without such antibodies (see 3 . 1 . 2 ,  p 93 ) . Fjallbrant and 
Nilsson ( 1977)  reported eight cases with more than 20 white 
blood cells per HPF in expressed prostatic secretion, who 
were treated with long-term antibiotics: in fLvc cases, the
antibody titres dropped, cervical mucus penetration improved
t
and the wives became pregnant. In our experience with 290 
patients, however, pregnancies occurred with equal frequency 
with or without positive semen cultures, irrespective of 
whether the organisms were treated with antibiotics or not 
(unpublished observations). Furthermore, electron
microscopic studies in 57 patients with large numbers of 
cells in the ejaculate showed that in 607, the leucocytes 
contained spermatozoa, and in only 287, were bacteria seen 
within the cells (Hughes et al, 1 9 8 1 ) .  Nevertheless, 
prostatitis can be associated with antisperm antibodies, and 
a positive culture in expressed prostatic secreations should 
probably be treated by long-term low-dose antibiotics before 
and during prednisolone therapy. In the author's
experience, however, this is not often necessary.
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4.3 SURGICAL TREATMENT
4 03.1 Immunological response to testicular obstruction
In their first large study of infertile men, Rumke and
Hellinga (1959) noted that occlusion in the vas deferens or
epididymis lead to formation of ASA more frequently than was
observed in the others (see Tables 9 & 10, p52 ). This was
attributed to post obstructive extravasation of spermatozoa
into the interstitium, lymphatics and even the capillaries
as a result of the occlusion - a finding that was
subsequently confirmed experimentally by vasectomy in rams
and boars (Ball and Setchell in 1983), and clinically in
man, by finding spermatozoa in an abdominal lymph node one
year after vasectomy (Ball et al, 1982). Although patchy
local obstructive changes are commonly observed in the
epididymis at autopsy, especially in the ductuli efferentes
(Ball and Mitchinson, 1984) relatively few and certainly not
more than half (Rumke, 1972) develop ASA, suggesting that
there is normally a degree of local tolerance to
extravasated spermatozoa. Complete obstruction to the
outflow, however, seems to produce antigenic overload with
stimulation of ASA production in some (though not all)
individuals (Rumke, 1968). Rumke (1965) reviewed the past
histories of 64 patients with ASA, and found possibly
relevant information such as previous genital infection,
surgery or injury in just over half: our findings were
similar in 407o of 50 men with significant titres of ASA (see
3.1.2, p93). On physical examination, Rumke (1965) found
abnormalities suggesting that one or both efferent ducts
were obstructed in about half: we found definite obstruction 
in 16% and possible obstruction in a further 207, of 160
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unselected spontaneously infertile males (Table 39, p25).
Rumke and Titus (1970) studied the association between 
testicular obstruction and ASA formation by subcutaneous 
injection of sperm, unilateral vasectomy and vasoligation in 
rats. A brisk ASA response was dependant upon the injection 
of adequate numbers of sperm, and was observed more often 
after vasectomy than vasoligation, presumably because more 
sperm were extravasated. Antibody titres fell significantly 
after removal of the obstructed testis in all animals. 
Kessler et al (1985) used inbred DBA/IJ mice, which are 
known to be high antibody formers: unilateral vasectomy
consistently induced an ASA response and significantly 
reduced fertility, whereas sham operation or unilateral 
orchiectomy did not.
Bilateral testicular obstruction inevitably causes 
sterility as a result of the ensuing azoospermia, and the 
individual may or may not form ASA depending on his 
immunological responsiveness and the cause of the blockage 
(see below). With unilateral obstruction, on the other 
hand, sperm output may be maintained from the unobstructed 
testis and impairment of fertiity will depend on whether ASA 
are formed or not. This was graphically illustrated by our 
study of 30 men who had genital tract injuries in childhood: 
ASA titres were significantly higher in those with 
unilateral obstruction (Fig. 27, pi 37) suggesting that there 
are probably a number of men with unilateral obstruction who 
retain their fertiity because they did not produce ASA. 
These and other factors need to be considered in more detail 
if the true significance of testicular obstruction with ASA 
formation in male subfertility, and the obverse, that is,
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the relevance of ASA on the results of surgical treatment of 
unilateral and bilateral testicular blockage, are to be 
understood more clearly.
4.3.2 Unilateral testicular obstruction
It is difficult to diagnose testicular obstruction, 
especially if only one side is blocked. There are usually 
no local symptoms and the findings on examination may be 
indefinite. The first study (3.3.2) was therefore directed 
towards defining diagnostic indications for scrotal 
exploration since there is no satisfactory non-invasive test 
for testicular obstruction. The clinical history is often 
helpful - previous epididymitis or a hernia repair in 
infancy or childhood should alert suspicion. On
examination, characteristic distension of the tail of the 
epididymis on the affected side, with a little tenderness, 
may be the only clue. Strangely, some testicular asymmetry 
may present, and the obstructed testis is often the larger. 
Studies into the reasons for this are continuing, but it 
remains a baffling observation to the present day. It is 
important, however, as the obstructed testis may have 
perfectly normal spermatogenesis while the contralateral, 
unobstructed one may have quite severe atrophic changes. 
The finding of ASA on routine testing always raises the 
possibility of obstruction, especially if H-H agglutination 
is reported. Once again, the reason for this association 
remains obscure (see 4.1.3, above) but the information 
serves as a useful diagnostic pointer.
In the second, larger study (3.3.3) it was noted with
some surprise that half of the patients with unilateral 
obstruction had severe oligozoospermia despite apparently
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normal spermatogenesis as shown by testicular biopsy in 
almost all the obstructed testes. Three-quarters had ASA, 
often in high titres, but there was no obvious correlation 
between the sperm concentration and the ASA titre (Table 43, 
p 130) . Many (657o) had ASA in seminal plasma as well as 
serum, often in very high titre (see Fig. 22, pl30 ) 
indicating that these men belonged firmly in the grouping of 
spontaneously infertile as opposed to vasectomy reversal men 
few of whom have seminal plasma antibody even after reversal 
(see fig. 28, pl40) . This difference is discussed in more 
detail below (4.4).
Confirmation of the diagnosis of unilateral 
obstruction and surgical correction required exploration of 
the scrotum. The diagnosis was usually fairly clear, but 
deciding what to do was not always so obvious. If there was 
a block at the tail of the epididymis, epididymo-vasostomy 
was straightforward, and has a patency rate of around 50% 
(see below). In men with severe oligozoospermia the results 
were excellent: 7 of 18 subsequently impregnanted their
wives, and overall 10 of 33 in this group were successful. 
Reconnection of a normal testis in a man with a low sperm 
output clearly does good. With vasal blocks, often the 
results of stripping out the vas. with the hernia sac during 
repair in infancy or childhood, primary repair may be 
impossible. Should the surgeon attempt to graft the remnant 
of the vas onto the other side (transvasovasostomy) thus 
endangering the patency of the normal vas and risking 
production of azoospermia, or should such a testis be 
removed? In practice, it was found best to take biopsies 
and sew up, then discuss the situation with the patient and
173
wife, and return for definitive surgery another day. With 
severe or moderate oligozoospermia and normal biopsies, 
clearly nothing was to be lost by attempting reconstruction. 
With normal sperm concentration and high ASA titres, on the 
other hand, removal of the obstructed testis makes sense, 
and the scrotum is by then sufficiently well healed to 
receive a prosthesis in its place.
Following orchidectomy profound falls in antibody
titre occurred, a phenomenon that was first described in man
by Bandhauer in 1966. The fall.was particularly marked in
seminal plasma (see figs. 23 & 24, pl32). Detailed study of
these men, and their testes are continuing. Should surgical 
or
correction orchidectomy precede prednisolone therapy? This 
question is considered elsewhere (4.2.1), and in general it 
seems to make sense to correct any anatomical abnormality 
first, before subjecting the patient to a prolonged course 
of medical treatment that cannot be repeated if it fails.
It is remarkable how often the diagnosis of unilateral 
testicular obstruction is missed, or, if it is thought of it 
is dismissed as unimportant. "Only one cylinder is needed 
to fire on" is a remark commonly heard, even from medical 
colleagues. Authorities as eminent as Bedford (1976) and 
Silber (1986) have concluded that "unilateral blockage does 
not interfere with fertility". There is now ample evidence 
to indicate that sometimes it does, and when it does, it 
represents a real chance for therapeutic improvement in a 
man's fertility. Fortunately, the impact of disease 
affecting one testicle on the function of the contralateral 
organ is now receiving increasing attention(Tarter & Kogan, 
1988).
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4 03.3 Bilateral testicular obstruction (excluding vasectomy 
reversal)
The most striking finding in the early analysis of
patients with obstructive azoospermia (see 3.3.4) confirmed
by the later figures (3.3.5) was the marked and significant
differences in the incidence of ASA in the different groups,
depending on the site and aetiology of the blocks. The
lowest incidence was recorded with congenital absence of the
vasa - only 167, had ASA in the final analysis. This low
incidence has recently been confirmed by Patrizio et al
(1989), who found only 117> positive, compared to 7l7o in men
with failed vasectomy reversal. These findings are,
however, much lower than those previously recorded by Amelar
et al ( 1975), who found significant titres of ASA in 18
(627o) of 29 men with absent vasa t. Certainly, our studies
showed that serum ASA occurred significantly less often with
congenital absence of the vasa than with postinflammatory
blocks in the vas or at the tail of the epididymis, roughly
half of whom developed ASA. This is not surprising, since
the inflammatory process that lead to the block would
probably have altered the local mononuclear cell population,
and set the scene for immunological response to the sperm.
Although Hargreave et al (1984) found no increase in the
overall incidence of ASA in men attending a clinic for
sexually transmitted diseases compared to the normal
population, serum ASA developed in male beagle dogs injected
with Brucella canis: sperm agglutinins, chiefly IgA, were
found in seminal plasma of chronically infected but not
normal control dogs (George & Carmichael, 1984). Testicular 
atrophy eventually developed after more than 4 months
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associated with development of cutaneous delayed-type 
hypersensitivity reactions when tested with soluble canine 
testicular extracts (see section 4.4). We have observed 
development of high titres of ASA in a man after an attack 
of non-specific urethritis, apparently immunised at the time 
of the acute inflammation (Shahmanesh et al, 1986, see vol. 
2). If a block developed during the healing phase, ASA 
production would naturally be perpetuated.
The incidence of ASA in men with blocks in the caput 
epididymis was significantly less, at 27%. Many of these 
men had co-existing sinusitis, bronchitis or bronchiectasis, 
a syndrome first described by Young in 1970. 
Histopathologically, the obstruction appears to be due to 
failure of spermatozoa to flow through the ductuli 
efferentes (which have a ciliated epithelium similar to the 
nasal and respiratory passages). The onset is gradual 
(Jequier et al, 1983) and there is little extravasation of 
spermatozoa in the interstitium. Rare in men born since 
1955, when mercury containing teething powders were 
withdrawn, it seems that this peculiarly English (and 
Australian) condition may be a late manifestation of Pink 
Disease (mercury intoxication in childhood) (Hendry et al, 
1990b).
The results of epididymo-vasostomy were best in the 
post inflammatory caudal blocks, similar to those obtained 
with vasovasostomy for postinfective vasal blocks (see 
3.3.5). There was however, a considerable shortfall between 
patency and pregnancy rates, which may also be observed in 
other reported series (Table 56). The high incidence of ASA 
in these patients.
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1 1 
| AUTHOR |
1 1
YEAR
1 1 
| NUMBER | 
| OF CASES| 
1_________ 1
1
PATENCY|
(%> 1 
________ 1
I
PREGNANCY|
(%> 1 
___________1
1 1 
| Dubin & | 1984
1 1 
1 69 |
1
20 |
1
10 |
| Amelar | 
1 |
| 46* j 
I 1
39 | 
1
13 i 
1
1 1 
| Jequier | 
I |
1985
1 1 
1 24 | 
I 1
I
12.5 | 
|
4 1 
j1 1 
| Fogdestam | 
j et al | 
1 I
1986
1 I 
1 41* |
1 I 
1 1
85 |
1
1
37 j
1
11 1 
| Schoysman & f 
j Bedford j
1986
1 1 
| 565 |
1 1 
I 1
1
1
j
18 j
1
11 1 
| Lee | 1987
1 1 
1 97 | 31 |
1
12 |
i i
I I
| 158* j
| I
37 | 
I
20 j
1 1 
| Thomas |
i i
| Silber |
1987
1989b
1 1 
| 50* |
1 1 
1 1
1
66 | 
1 
1
42 |
l
1
| Corpus | | 139* | 78 | 56 |
j Caput |
i i
1 51* j 
1 1
73 j 
1
31 | 
1
TABLE 56 Recent results of epididymo-vasostomy 
(* = microsurgical technique)
and the observed statistically significant reduction in 
pregnancy rate with which the presence of ASA is associated 
(Table 48, pl37) , indicates that the immunological sequelae 
of the block may be responsible for some of the failures of 
surgical treatment. Nevertheless, Phadke and Padukone 
pointed out as long ago as 1964 :hat pregnancies can be 
produced after surgical correction by successful 
epididymo-vasostbmies even in the presence of circulating 
ASA. Our results support this observation, though 
statistically pregnancy is less likely with positive serum 
ASA, and there may be a case for adjuvant prednisolone 
treatment in cases where patency has been achieved but 
pregnancy does not occur.
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4»3.4 Vasectomy reversal
Patients presenting for vasectomy reversal appeared to 
offer a golden opportunity to study the effects of ASA on 
spermatozoa, since most were previously fertile, and it was 
known that 60-807, had ASA following the vasectomy 
(Ansbacher, 1973: Hellema and Rumke, 1978: Rose and Lucas, 
1979). With the help of Mr. M.G. Royle in Brighton, we 
quickly recruited 130 such cases, and studied their ASA 
before and after the reversal procedure, and followed their 
sperm counts and subsequent fertiity. It was known that 
many would be fertile, from the work of Silber (1977, 1978), 
but the effects of ASA were poorly understoood. Ansbacher 
(1977) showed that ASA levels persisted after vasectomy, 
rose transiently after the reversal procedure, and then fell 
to preanastomosis levels by 1 year. Sullivan and Howe 
(1977 ) found ASA in the serum of 487o of men whose wives were 
pregnant, and 947, of those whose women were not pregnant. 
We found ASA in the sera of 797,, and in seminal plasma of 
9 o 5 To before, and 29.57, after the reversal procedure. This 
was still considerably fewer, for each serum titre, than we 
were finding in spontaneously infertile men (fig. 28, pl40) . 
Overall, 447, impregnated their wives, and we could show no 
statistically significant fall off in fertility until very 
high serum titres (£512) were reached, and even then 257, 
were apparently fertile. Furthermore, a small number of men 
appeared to be fertile with seminal plasma ASA titres as 
high as 16. These results were quite different from those 
we were used to seeing in spontaneously infertile males.
Linnet et al (1981) published results of a similar 
study at the same time as our first publication (Royle et
ai, 1981) and showed a highly significant association 
between presence or absence of seminal plasma antibody and 
fertility. This was clearly at variance with our 1 year 
follow up results published by Parslow et al (1983), 
mentioned above, and we speculated in discussion whether the 
difference might be due to the class of antibody. This was 
the subject of Dr. Parslow1s PhD Thesis, which was 
successfully presented to the University of London in 1985, 
and reported by Parslow et al (1985). Using a sophisticated 
radio-labelled double antibody technique, the class of 
antibody on spermatozoa from vasectomy reversal and 
spontaneously infertile men was defined and quantified, and 
it was clearly shown that failure of penetration of cervical 
mucus was dependant on the class of antibody, IgA being much 
more powerful in this effect than IgG. Most spontaneously 
infertile men had the former, and most vasectomy reversal 
men had the latter. The confirmation of these conclusions 
in a much larger series published in 1990 by Meinertz and 
colleagues (including Linnet) has been described in section
4.1.4 (pagel54), and provides satisfying reassurance of the 
results of our earlier studies.
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| AUTHOR |
1 1 
1 _______________ 1
YEAR | NUMBER
| OF CASES 
_ 1_____________
PATENCY
(%)
PREGNANCY |
(%) I 
______________ 1
1 1 
| LEG & |
1
1 41 90
1
46 |
| m c l a u g h l i n |
i i
1980 j 26*
I
96 54 | 
1i 1 
| FALLON et al |
I I
1981
1
| 36 
1
74 57 | 
I1 1 
| FITZPATRICK |
I I
1978 1 I4
I
90
1
64 | 
1
1 1 
| MIDDLETON | 
| et al | 
1 1
1987
1
| 73
1
|
81
1
49 |
1
|1 1 
| AMELAR & |
| DUBIN | 
I I
1979
1
| 26
1
I
88
1
53 |
1
I1 1 
| KESSLER & |
| FREIHA | 
1 |
1981
1
I 83
1
1
92
1
45 |
1
|1 1 
| URQUHART-HAY | 
1 1
1981
1
| 50
I
84 52 | 
11 1 
| COS et al | 
I 1
1983
1
| 87*
I
75
1
46 |
I1 1 
| SOONAWALLA | 1984
1
| 194 81
1
44 |
j & LAL 
1 |
| 339*
I
89 63 j
I1 1 
| BECKER | 
| et al | 
I 1
1991
1
| 1012*
1
1
86
1
52 |
1
11 1 
| SILBER | 
1 1
1989a
1
| 282*+ 
I
91
1
81 | 
11 1 
| MEINERTZ | 
| et al j
1990
1
| 145 
1
90
1
53 |
* microsurgical technique
+ excluding 44 patients with no sperm in vas fluid
TABLE 57 Some recent results of vasectomy reversal
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Our surgical results with vasectomy reversal are 
rather similar to those described from elsewhere (Table 57) 
but failures continue to occur from time to time. Further 
collaboration with Mr. M.G. Royle in Brighton allowed us to 
define 3 main causes of failure: (i) fibrosis at the site
of anastomosis requiring redo ’vaso-vasostomy, which gave 
very satisfactory results, as previously described by Silber 
(1977); (ii) failure of flow due to epididymal tubule blow 
out, presumably due to back pressure, also described by 
Silber (1979), and readily corrected by epididymo-vasostomy; 
and (iii) very high ASA response (>1024) for whom further 
surgery and adjuvant prednisolone therapy had little or 
nothing to offer. We commented in 1985 that this group 
continued to present a significant therapeutic challenge, 
and this remains the position, although persisting 
unilateral obstruction should be excluded by surgical 
exploration in men with a less than perfect result.
The present day success rate of vasectomy reversal has 
recently been reported by Belker et al (1991), the results 
of 1469 microsurgical procedures. The pregnancy rates were 
closely related to the interval between vasectomy and 
reversal, falling from 767, if the interval was less than 3 
years, to 5370 between 3 and 8 years, to 447> between 9 and 14 
years, to 307, after more than 15 years. The results can be 
quoted to patients asking for advice on whether to proceed 
with reversal, and they can be fine-tuned with the results 
of the preoperative serum ASA results, giving a rather less 
good prognosis if the titre is 512 or more. However, it 
should be remembered that antibody levels can fall after the 
reversal (fig. 30), or even appear when there were no ASA
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before, apparently provoked by the procedure itself (fig. 
29pl42).Even under the worst circumstances, however, this 
procedure carries a success rate that is as good as that 
achieved by modern high technology methods such as in vitro 
fertilisation or gamete intrafallopian transfer, and the 
surgeon should not hesitate to reconstruct the vasa if this 
is what the couple wish.
4.4 AUTOIMMUNE ORCHITIS
The patchy mononuclear cell infiltrate observed in a 
few testicular biopsies (see 3.5.1 pl45), and the marked
improvement in sperm output obtained with long term low dose 
prednisolone in severely oligozoospermic or even azoospermic 
men with very high ASA titres (see 3.5.2 pl46) , raised the 
possibility of autoimmune orchitis. This condition has been 
much studied and well documented in different species of 
experimental animals (an excellent review by Kosuda and 
Bigazzi in 1987 runs to 249 references), but it has not been 
identified as a disease entity occurring spontaneously in 
man (Hjort, 1977), although Mancini et al (1965) provoked 
immune responses in men awaiting castration for prostatic 
carcinoma by injection of human testicular material. Patchy 
lesions consisting of congestion, oedema and sloughing of 
germinal cells were seen in the testis, along with positive 
skin tests indicating delayed hypersensitivity; circulating 
antibodies were detected by complement fixation and other 
tests. Although the results of animal experiments vary from 
species to species, and from breed to breed it does appear 
that both circulating antibody and delayed hypersensitivity 
are needed to produce this lesion (Brown et al, 1967), which 
is usually provoked by injection of either testicular
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homogerate or spermatozoal antigens with complete Freund's 
adjuvant (see 1.4.3, p36).
Spermatozoal antigens are usually hidden by the 
blood-testis barrier (Johnson, 1973), but modern 
immunological theory suggests that this is supplemented by a 
degree of local immune tolerance provided by suppressor T 
lymphocytes which line the male genital tract (El Demiry et 
al, 1985). Evidence in favour of this hypothesis is two
fold. First, spontaneous occurrence of immune orchitis has 
been observed in mice after neonatal thymectomy, which
presumably removed the source of the suppressor cells; the
*
incidence and severity of the orchitis was increased' by 
unilateral vasectomy (Taguchi and Nishizuka, 1981). 
Secondly, pretreatment with testicular antigen in incomplete 
Freund's adjuvant in guinea pigs markedly reduced the 
incidence and severity of immune orchitis when the animals 
were subsequently challenged with antigen in complete 
Freund's adjuvant. The pretreatment rendered T lymphocytes 
temporarily specifically unresponsive as judged by in vitro 
lymphocyte proliferative response, whereas ASA formation was 
not affected. Cyclophosphamide pretreatment abolished the 
protective effect suggesting that the tolerance was mediated 
by the CY-sensitive suppressor T-cells (Hojo and Hiramine, 
1982). Thus "physiologic" autoimmunity can become
"pernicious" if the local tolerance mechanisms are disturbed 
(Cohen, 1984). Further evidence for this is the spontaneous 
occurrence of autoimmune orchitis in certain breeds of 
animals, including dark mink (Tung et al, 1984), beagles 
(Fritz et al, 1976) and tail-less mice (Dooher et al, 1981). 
Examples have also been seen occurring spontaneously in
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related dogs used for breeding which became sterile (Allen & 
Longstaffe, 1982; Allen & Patel, 1982). In all of these 
examples, the histological findings were similar to those 
described in experimental immune orchitis (see 1.4.3, p 36 , 
that is focal mononuclear cell infiltration around and 
inside seminiferous tubules where spermatogenesis was 
diminished or absent. Ultimately the animals became sterile 
with aspermatogenesis.
Although these changes have been observed very rarely 
in our subfertile men with severe oligozoospermia or 
azoospermia and very high ASA titres (see Figs. 31-33, pl45) 
the changes have been very focal, and altogether absent in 
some men who responded well to prednisolone therapy (for 
example, see Figure 35, pl46) . Indeed, a recent project set 
up to study the nature of these mononuclear cells has made 
no progress at all due to the paucity of the number of cells 
available to study (Prof. Tsaacson, personal communication). 
There is, however, another mechanism of hypersensitivity 
that might be producing subtle changes with the passage of 
time in these testes in the absence of cellular 
infiltration. Although sperm production appears to continue 
normally in man (Bagshaw et al, 1980) marked depression of 
spermatogenesis has been noted after vasectomy in 
guineapigs, even if it was only done on one side (Alexander, 
1973). The histological and skin-test changes were similar 
to those seen in autoimmune orchitis provoked by injection 
of spermatozoa and complete Freund's adjuvant. Bigazzi et 
al (1976) showed that vasectomised rabbits with high levels 
of ASA developed an orchitis with granular deposits of IgG 
and C3 in the basement membrane of the seminiferous tubules
184
associated with thickening of the basement membrane, 
accumulation of macrophages and polymorphs, and destruction 
of the basal lamina, Sertoli and spermatogenic cells. 
Formation of sperm antigen-antibody complexes at the 
basement membrane was presumed to be the underlying 
pathological process. Heavy granular deposits of IgG and C3 
were also found in the basal lamina of the seminiferous 
tubules of dogs (Allen and Patel, 1982) and dark mink with 
autoimmune orchits (Tung et al,1984). Similar depositis of 
IgG and C3 have been observed in testicular biopsies from 
subfertile men (Salomon et al, 1982) resembling the immune 
deposits seen in glomerulonephritis (Salomon and Hedinger, 
1982). In one case these changes appeared to have followed 
previous epididymectomy, and were associated with mild 
atrophic changes in both the affected and the contralateral 
testes. In a clearly illustrated review of the histological 
and immunoelectron microscopic changes Salomon and Hedinger 
(1987) staged the changes, relating the immunological and 
morphological changes, and concluded that this provided 
evidence of immune complex orchitis as a disease entity in 
man. Similar changes have been described by Lehman et al
(1987), and by Harrison et al (1981), who proposed that this 
might be the mechanism of contralateral damage observed 
after testicular torsion. We also observed evidence of 
degenerative changes, which we called sympathetic 
orchiopathia, after experimental testicular injury in rats 
(Wallace et al, 1982). However, from our point of view this 
proposed mechanism of testicular damage must remain 
speculative at present in the absence of any positive 
pathological evidence.
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The first description of the response to 
corticosteroids of this condition in man was provided by 
Bassili and El-Alfi in 1970. Thirteen agoozpermic and 5 
oligozoospermic men had positive lymphoid blastoid 
transformation tests in response to seminal antigens, 11 
controls were negative. The patients were given
prednisolone 40mg per day for 2 weeks, then the dose was
gradually reduced over the next 9 weeks. Four showed a good
response, all starting with sperm counts of less than 1 
million per ml, and one reached 40 million per ml, when his 
wife became pregnant. This response is very similar to that 
shown by our patients (see section 3.5.2) and suggests that 
we are observing the same phenomenon. It is important,
clinically, to think of this condition which can be 
recognised by the co-existence of high serum ASA titres, 
empty epididymes on surgical exploration and reasonably
normal testicular biopsies (with or without focal 
mononuclear cell infiltrate). It is obviously important not 
to damage the epididymis or vas in such cases, by 
unnecessary epididymovasostomy, and it is the author's 
practice not to do vasography in such cases until the 
testicular histology and ASA results are available. 
Certainly there seems to be a condition resembling 
autoimmune orchitis which occurs spontaneously in man, but 
it remains difficult to characterise, and it may be that it 
will turn out to be due more to a combination of high 
circulating  ^antibodies with toxic-complex (type2ar3) 
autoimmune reaction than to classical cell mediated (type 4) 
reaction that we have been seeking rather vainly up to the 
present time. Studies are continuing in this area both in
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azoospermic and severely oligozoospermic men with high ASA 
titres and no evidence of obstruction (primary autoimmune 
orchitis) and in men with similar changes secondary to 
unilateral or bilateral testicular obstruction.
4.5 IN VITRO FERTILISATION
4.5ol The effects of ASA on sperm-egg fusion
Soon after the development of the zona-free hamster 
egg system for assessment of fertilizing capacity of human 
or other species of spermatozoa by Yanagimachi et al (1976), 
reports began to appear indicating that treatment of human 
sperm with antisera containing ASA caused a significant 
decrease in ova penetrated compared to normal sera. Since 
Fab preparation of antisera exhibited a similar inhibutory 
effect, it was concluded that the blocking effect was due to 
the antibodies (Menge & Black, 1979). Tzartos (1979) showed 
that the ASA inhibited passage through the zona pellucida, 
as well as sperm-egg fusion in zona-free hamster eggs and 
proposed that the ASA were blocking or masking specific 
receptors on the sperm surface. These observations were 
quickly confirmed by many other workers, mostly using the 
human sperm- zona free hamster egg preparation (Alexander, 
1984; Brannen-Brock & Hall, 1985; Menge et al, 1984) but 
also with boar sperm (Smith et al, 1983) and with a sea 
urchin sperm-egg preparation (Saling et al, 1982). Some 
workers noted variability in the effect of ASA, however, and 
Bronson et al (1981, 1989) even noted enhancement of
sperm-egg penetration on some occasions. This observation 
was confirmed in a carefully conducted study by Aitken et al
(1988), in which we were able to collaborate by providing
# \
sera and seminal plasma from known ASA-positive patients:
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the antibodies could either suppress or stimulate sperm-egg 
fusion, the proportion showing stimulation being higher in 
the vasectomy reversal compared to the infertile population.
Monoclonal antibody studies showed that only a small 
number of sperm-specific antibodies caused significant 
inhibition of fertilization in mice apparently by blocking 
the acrosome reaction and sperm binding to the zona 
pellucida (Saling & Lakoski, 1985; Lee et al, 1986).
Monoclonal antibodies that cross reacted with human sperm 
similarly showed inhibition of penetration of zona-free 
hamster eggs (O'Rand & Irons, 1984) and human oocytes (Moore 
et al, 1987). The latter observation was obviously 
important, as some variation in the effects of monoclonal 
antibodies on sperm function had boon shown depending on 
whether zona-free hamster eggs or homologous eggs were used 
for study (Primakoff & Hyatt, 1986).
A problem with interpretation of the results of these 
studies arose with the plethora of methods used to measure 
the presence or absence of ASA, exactly the same problem 
that has bedevilled fertility work in general. In reviewing 
the studies summarised above, those of Menge et al (1984) 
and Aitken et al (1988), using standard agglutination and 
immobilisation tests, both showed that the effects of ASA on 
sperm-egg fusion as assessed by the zona-free hamster egg 
penetration test were very variable but generally 
inhibitory. Observations on human sperm-egg fusion done at 
the time of in vitro fertilisation have given rather 
confusing results. Clarke et al (1985) showed that ASA in 
men, especially of IgA class reduced the proportion of eggs 
fertilised if more than 807o of sperm were affected, as shown
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by direct IBT. Junk et al (1986) and Matson et al (1988)
using an indirect IBT concluded that both IgG and IgA were 
needed to produce significant reduction in fertilization, 
whereas either class alone did not produce any effect. In 
fact, these differences are probably technical, and Clarke 
et al (1988) certainly showed a highly significant reduction 
in fertilisation of supernumerary human oocytes when human 
sperm were treated with sera from women with ASA - an effect 
that could be reduced by immunoabsorption of the IgG
fraction of the serum. Similar conclusions were formed by
Kamada et al (1985) and Tsukui et al (1986). Tsukui (1988) 
showed with electron microscopy studies that the number of 
acrosome reacted sperm was significantly reduced by 
treatment with ASA positive serum. Mandelbaum et al (1987), 
on the other hand, used an indirect IBT for IgA, IgG and IgM 
on serum, seminal plasma, and follicular fluid from 40 
couples undergoing in vitro fertilisation and concluded that 
ASA in men had no effect on fertilisation, whereas they did 
in women. Once again technical problems with the indirect
IBT, perhaps due to its sensitivity, appeared to cause 
confusion. Be that as it may, the concensus obtained from 
reviewing the studies summarised above appears to be that 
ASA can interfere to some extent with sperm-egg fusion, but 
that the effect is variable and by no means absolute, and 
that once the egg is fertilised there is little evidence 
that subsequent development is adversely affected.
4.5.2 Results of IVF in patients with ASA
The first reports of pregnancies occurring 
successfully after in vitro fertilisation of ova in couples 
with a significant ASA problem appeared in 1984-1986.
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Yovich et al (1984) described fertilisation of 15 of 20 ova 
from all of 5 women with ASA shown by GAT and SIT, 2 of whom 
became pregnant. Naaktegeboren et al (1985) described 
successful in vitro fertilisation from a man with ASA after 
methyl prednisolone treatment had failed. Devroey et al 
(1986) described a man with a serum titre of 64 on TAT, 
whose partner had persistently poor PCT's; 6 eggs 
fertilised, 3 were returned by laparoscopic zygote 
intrafallopian transfer and twin pregnancy resulted. 
Fertilization rate is generally poor when sperm quality is 
poor (Van Vem et al, 1985), but the proport: Lon can be 
improved when the man has ASA by increasing the number of 
motile sperm added to the ovum (Hamilton et al, 1989), 
washing the sperm in Earle's solution (Hinting et al, 1989) 
collecting the sperm in medium with 107> serum and using a 
swim-up procedure to improve the number of motile sperm (Van 
der Merwe et al, 1990; Elder et al, 1990). Nevertheless, 
fertilization docs seem to depend on the percentage of sperm 
covered with antibody, and success is uncommon when more 
than 70% of sperm are affected (de Almeida et al, 1989).
Sperm binding to the zona pellucida is reduced in the 
majority of unsuccessful attempts; however, if fertilisation 
does occur, pregnancy appears to proceed normally.
This conclusion coincides with our experience at St. 
Bartholomew's Hospital where work is in progress looking at
the effects of ASA in subfertile men on the results of in
/
vitro fertilisation (Rajah et al, unpublished observations).
Egg fertilisation and pregnancies after in vitro 
fertilisation have been studied, comparing 11 couples (group 
1) where the man had antibodies to spermatozoa with 20
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couples (Group 2) where the man had no such antibodies. In 
Group 1, 21 (45%) of 47 eggs fertilised, compared to 93
(737.) of 128 eggs in Group 2. In Group 1, 5 women had 3 
fertilised eggs transferred and 2 (407.) became pregnant. In 
Group 2, 18 women had 3 fertilised eggs transferred and
there were 6 pregnancies (337.).
Antibodies t o .spermatozoa thus appeared to reduce the 
egg fertilisation rate, but not the pregnancy rate once ovum 
fertilisation had occurred. These results provided some 
support for the view that IVF offers an additional treatment 
option to the infertile couple where the man has ASA 
(Barlow, 1988; Alexander, 1990).
4.6 CONCLUSIONS (Hendry, 1992 b)
Spermatozoa are clearly highly antigenic to the man 
who produces them, probably because spermatogenesis does not 
commence until puberty when the immune system is mature, and 
since their chromosomal make-up is totally altered during 
meiosis. Normally, they are hidden by the blood-testis 
barrier (Johnson, 1973), probably supplemented by a degree 
of local immune tolerance (el Demiry et al, 1985). ASA may 
arise as a primary local phenomenon, perhaps initiated by 
genital inflammation such as non-specific urethritis 
(Shahmanesh et al, 1986), and it is known that certain 
individuals with particular genotypes are especially 
susceptible (Law et al, 1979). Alternatively, they may be 
secondary provoked by obstruction to the testicular outflow 
tracts: the spermatozoa are directed to the lymphatics
leaving the testis (Ball and Setchell, 1983) which drain to 
the abdominal lymph nodes (Ball et al, 1982), where systemic 
antibody production is stimulated. If both testes are
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blocked, for example after vasectomy, the man will be 
azoospermic and the diagnosis obvious. Analysis of large 
numbers of vasectomised men indicates that the strength of 
the antibody response to this particular stimulus depends on
the individual's immunological responsiveness (Rose & Lucas,
\
1979). If, however, only one testis is obstructed, the 
sperm output from the other testis may be normal but
fertility can be impaired by antibody production which is 
sustained by the spermatozoa reabsorbed from the blocked 
testis (Kessler et al, 1985) - this diagnosis may be much
more elusive. It is important to distinguish between 
primary and secondary causes of antibody production for 2 
reasons: first because the class of antibody produced may be 
significantly different, and secondly because surgical
treatment may be necessary in men with testicular
obstruction.
ASA are most readily detected bound to the patient's 
own spermatozoa, using as a marker either sensitised red 
blood cells in the direct MAR test or, after washing 
thoroughly to get rid of unbound immunoglobulin in
seminal plasma, by direct IBT. Whilst the former test has
the advantage of being quick, reliable and easy to read, it 
is generally only useful for detection of IgG, whereas with 
class specific IB, the class of antibody on the spermatozoa 
can be defined. The MAR test is thus an excellent screening 
test, but positive results should be studied further with IB 
tests. The amount of unbound antibody should be measured in 
serum and seminal plasma by TAT - this has replaced the 
older macroscopic GAT. A number of new tests have been 
developed based on ELISA, IFT or radioimmuno- assay using
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fixed spermatozoa as substrate - the results correlate 
poorly with those obtained by the classical agglutination 
tests and with impairment of fertility, probably due to 
exposure of subsurface antigens during fixation - these 
tests are best avoided in clinical practice.
ASA interfere with fertility in a number of ways. 
First, they cause impairment of spermatozoal penetration of 
cervical mucus; it appears that the Fc part of the antibody 
becomes attached to receptors in the mucus (Jager et al, 
1981) - this is reflected in poor post-coital tests (PCT), 
and may be seen on SCMC testing. This may be mistaken for 
’’cervical hostility" unless the test is also done with donor 
spermatozoa and donor cervical mucus as a crossed hostility 
test. This phcnomonon is produced by IgA on the 
spermatozoa, but not by IgG. This is why primary locally 
produced ASA (mostly IgA) is more harmful than secondary, 
systemic ASA which is mainly IgG. Thus for a given serum 
titre of ASA, a spontaneously infertile male will probably 
have a much higher seminal plasma titre than a man after 
vasectomy reversal. Fertility after vasectomy reversal may 
be normal if the ASA titres are low and the class purely 
IgG, but if becomes progressively impaired as serum titres 
increase and the percentage of spermatozoa affected by IgA 
rises (Meinertz et al, 1990).
ASA may interfere with sperm motility and with
sperm-egg fusion and the presence of antibody should always
be sought in patients with asthenozoospermia, especially if
in vitro fertilisation (IVF) is contemplated. Furthermore,
oligozoospermia or even azoospermia may be observed in men 
with very high titres of antibody, apparently due to a form
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of cell-mediated or immune - complex immune orchitis. It 
follows that serum and seminal plasma should be checked for 
ASA by TAT in all patients in whom direct MAR or IBT may be 
impossible due to insufficient numbers of active 
spermatozoa.
Once the presence of ASA has been detected in a 
subfertile male, and titres defined, the testicles should be 
examined carefully to see if there is evidence of 
obstruction: a history of epididymitis or of hernia repair 
in childhood may provide a clue, and indicate which side 
might be affected. In cases of doubt, the testicles should 
be explored, the epididymes examined with magnification to 
search for distended tubules, and vasography may be done to 
exclude vasal or ejaculatory duct obstruction; a testicular 
biopsy is usually taken and spermatogenesis assessed by an 
objective score system. If obstruction is present it should 
be corrected by epididymo- or vaso-vasostomy as required. 
In some cases with irreparable lesions - for example, 
absence of a great length of vas - the obstructed testicle 
may be best removed and replaced with a prosthesis. This 
may be followed by a profound fall in antibody production, 
especially noticeable by a drop in seminal plasma TAT titre.
Once the anatomical situation has been defined, and 
corrected surgically if necessary, medical treatment can 
follow. After careful medical work up, and after ensuring 
that the female partner has been fully investigated and any 
co-existing defects corrected, the couple should be given 
the opportunity to choose between steroid therapy for the 
male, or going directly for IVF or gamete intrafallopian 
transfer (GIFT). The advantages, disadvantages, possible
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side effects and costs are outlined and the couple 
encouraged to take time to make their choice and take 
further advice if they wish to. Of course, the sperm 
quality, especially motility, may make it easier to choose - 
if poor, steroid therapy may well improve it; if good, they 
may prefer to go straight for’ an assisted fertilisation 
technique; of these IVF is usually preferable in the first 
instance, to see whether the spermatozoa are capable of 
fertilising the ova. If not, then adjuvant medical therapy 
is clearly required.
In selecting the most appropriate drug treatment, the 
physician should take into account the sperm count and 
motility and the patients' general health. If the sperm 
concentration is normal, cyclical prednisolone is the 
treatment of choice, in a dose of 20mg twice daily given 
with meals to the man from the first to the tenth day of the 
female partners cycle, then 5mg daily on days 11 and 12. 
Alcohol is expressly forbidden during these days. After 9 
cycles, one-third of the female partners can expect to 
become pregnant, significantly more than were produced by 
men taking placebo in the double-blind crossover trial. 
Sperm motility usually improves markedly and supplementary 
IVF or GIFT may be recommended if pregnancy does not occur 
spontaneously. In men with high antibody titres and severe 
oligozoospermia or even azoospermia, in whom obstruction has 
been excluded by exploration, considerable improvement in 
sperm output can be obtained with prednisolone 5mg thrice 
daily for 6 months - possibly due to suppression of the 
immune orchitis. In men who cannot take prednisolone, 
cyclosporin provides an alternative drug which has been
shown to be effective in this setting (Bouloux et al, 1986).
Side effects with prednisolone in the dose regimens 
outlined above are generally mild and transient. However, 
all patients must be warned about side effects to be 
expected, and complications that can occur with 
prednisolone, and the usual precautions are observed. Two 
instances of aseptic necrosis of hip have been reported, 
both using methylprednisolone 96mg daily for' 7 days 
effectively three times the dose recommended above (Shulman 
& Shulman, 1982; Hendry, 1982 b). This regimen has now been 
abandoned, and aseptic necrosis has not been seen or 
reported since then.
Antibodies to spermatozoa can be found in 8-127. of the 
male partners of infertile marriages but are relatively 
uncommon in the female partners (Kremer et al, 1978). The 
presence of these antibodies should not be missed, since 
their presence may alert the surgeon to the existence of 
surgically correctable obstruction, and since effective 
medical therapy gives the physician an opportunity to 
produce a real improvement in the man's reproductive 
potential. Furthermore, enhancement of spermatozoal
performance by treating the antibodies will greatly improve 
the gynaecologist's chances of success with assisted 
reproduction techniques.
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FIGURE 3: TAT - swim-up procedure to obtain motile sperm
preparation.
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FIGURE 6: MAR - clumps of erythrocytes with attached
spermatozoa.
FIGURE 7: IBT - spermatozoa with attached IB.
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FIGURE 12: Serum GAT titres before and after MP.
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FIGURE 13: Serum SIT titres before and after MP.
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FIGURE 16: Serum TAT titres before and after moderate dose
prednisolone treatment.
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FIGURE 17: Seminal plasma TAT titres before and after moderate
dose prednisolone treatment.
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FIGURE 19: Seminal plasma TAT titres for patients receiving
prednisolone and placebo.
SEMINAL PLASMA TA T  T IT R E S
PREDNISOLONE PLACEBO
1024
512
256
128
64
32
16
8
4
0 3 6 9 12
MONTHS
FIGURE 
20: 
Caudal 
epididymal 
block 
affecting 
the 
right 
testicle: 
note 
the 
distension 
of 
the 
epididymis 
compared 
to 
the 
normal 
appearance 
on 
the 
left 
side 
(the 
right 
vas 
is 
held 
in 
tissue 
forceps).
FIGURE 
21: 
Vasal 
obstruction 
following 
hernia 
r
ep
a
i
r
 
childhood.
Serum
 
TAT 
T
IT
R
E
3J ^  
m  “
oNJ
00
05
05O
O
CO
00
05
00
O*
O
03
a
CO
o
3r—
3
03
T 1 H  3 
n 3* 0
0  0  CO 
09 co n  
3  (0
03
3o
*0  o
CO ,X3
o
m  c/) 
rr  n>
T rr
0
rr a ' O  
 ^ i—' 
0  03
03 CO
3 ^ F 3  ^  03
o
s  >n  CO
* o >
T3 *
0
3 O
rti
rr
0
o 3
O
a
5«
m
hO
ro
£ CO 
M* 0 
rr  r-{ 
nr c  
3
§ § 
£  a.
03
rr  co 
0 0 
* 3
03 K-
*-* 3 
03
”0
h-*
03
CO
3
03
03
* 5
H
O
n r  rr  
CO i_>.
H n  
r n s o
CO
co n r  
p*  
09nr
TD^
 rr  
O p* 
CL rr  
C fi
O  0  
0  CO
a  •
OO
3 *
rtTD 
0 & 
rr  
p*  
rr  0 
3* 3 
03 rr  
rr  co
FIGURE 23: ASA titres before and 6 months after removal of the 
obstructed testis, and on subsequent prednisolone 
therapy. Pregnancies produced by those represented 
by open circles - serum TAT titres.
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FIGURE 24: ASA titres before and 6 months after removal of the 
obstructed testis, and on subsequent prednisolone 
therapy. Pregnancies produced by those represented 
by open circles - seminal plasma TAT titres.
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FIGURE 27: Serum TAT titres in men with unilateral and bilateral
testicular obstruction following inguinal or pelvic 
surgery in childhood.
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FIGURE 31: Testicular biopsy from a man with severe 
oligozoospermia and high serum titres ( 1024) ASA:
focal infiltration of lymphocytes and plasma cells 
extending into inside of seminiferous tubules (H&E).
FIGURE 32: Epididymis with mononuclear cell infiltrate (H&E).
m m
\ <
FIGURE 33: Rete testis in patient with high vasal block, empty
epididymis and high titres of ASA ( 1024) (H&E).
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